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Abstract 
This thesis is concerned with the development of a novel methodology for the chemical 
synthesis of proteins. The methodology is expected to overcome limitations of current 
techniques for chemical synthesis of proteins that restrict the size of the target molecule 
to less than 150 amino acids. It is intended that the use of a DNA analogue, PNA, as a 
directing group will allow different short polypeptides to self-assemble into a desired 
target protein. 
The first chapter is an overview of literature concerning templated synthesis and the 
applications of PNA. Examples of simple metal-templated synthesis are discussed 
however there is a particular focus on the work of David Liu and his DNA-templated 
synthesis. The uses of PNA in a number of diverse applications are presented along 
with brief comparative descriptions of PNA and DNA. A brief discussion of current 
methodologies for protein synthesis is then used to set the context for the project aims 
and a description of the proposed methodology. 
The second chapter details the effort made in modifying literature procedures to 
successfully develop the robust and reproducible chemistry required for multi-gram 
synthesis ofPNA monomers. 
The third chapter briefly discusses the computer-aided design of a pair of linker 
molecules that act as a bridge between polypeptides and their PNA directing groups. 
,;rhe challenging synthesis of these linker molecules is detailed and synthetic routes for 
the multi-gram synthesis of both are given. 
The fourth chapter charts the development of the solid-supported chemistry used to 
construct PNA-peptide chimeras with close attention to the challenges encountered with 
incorporating the linker molecules. Of the two chimera targets required to examine 
PNA-directed ligation, a multi-gram preparative synthetic route is present€d for one 
chimera. A route that provides analytical quantities of the complementary chimera is 
also discussed. 
The fifth chapter presents the experimental procedures used for the synthesis of the 
compounds involved in this project. Analytical data and the characterisation 'of 
compounds are detailed for each compound where possible. 
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1 Peptide Nucleic Acid Directed Chemical Total Protein Synthesis 
The importance of research into the understanding of protein chemistry and biology 
cannot be understated. A massive multinational research effort into decoding the human 
genome is underway to further our understanding of how life worksYl The benefits that 
can be reaped from expanding and applying this knowledge to areas such as medicinal 
care are profound. The modem chemist is central to these efforts - organic synthesis 
can offer a path toward novel and interesting biomolecules that are inaccessible by other 
means. Designer peptides and proteins are one set of tools that can unravel the 
information presented by nature. The ability to make discrete changes to polypeptides, 
such as introducing a specific-point mutation or a fluorescent reporter group in an 
enzyme, provides a powerful way to interrogate these fascinating biomolecules and 
decipher how they work. There is no methodology that can fully address the synthesis 
of designer proteins, but we have sought to learn from nature's templated approach to 
peptide synthesis and thus provide facile access to designer peptides. This project has 
been concerned with developing a novel approach to overcome some of the limitations 
of chemical total protein synthesis that currently prevent the synthesis of large protein 
targets. It is the intent of the project to use templated reactions to organise and assemble 
smaller polypeptides into proteins much larger than those accessible by current 
technology. To achieve this goal oligomeric strands of nucleic acids will be used as 
directing groups that will orchestrate templated synthesis. In this first chapter, a review 
of some relevant literature is presented that will help set the background to the theory of 
the project. Initially the general concepts of templated synthesis are discussed with 
some representative examples that illustrate the level of design and control that can be 
achieved with this approach to synthesis. The review then continues with some elegant 
work by Liu that is closer in context with the aims of this project, DNA-templated 
organic synthesis, and highlights the power of nucleic acids as directing groups for 
chemical reactions. Next the surveyed literature centres upon Peptide Nucleic Acid 
(PNA), which provides the template element for this project, and current applicatlons of 
PNA are presented to demonstrate its utility in chemistry. Finally, a contrasting 
reminder of how nature effortlessly makes proteins is given to complete the review, and 
this leads into an explanation of the general theory and idea behind this project. 
.1 
1.1 Ternplated Synthesis 
Exerting control over how molecules interact and react together becomes increasingly 
difficult as their size and complexity increase. In the mass and size domain of natural 
product synthesis, this can be a considerable challenge. The outcome of a reaction 
between large molecules is often dictated by large entropic molecular energies that lead 
to poor and disabling reaction kinetics. Consequently, there is a need for methodology 
that can control the regiochemistry and rate of macromolecular reactions. 
An approach used in both nature[2, 3] and the lab[4, 5] to overcome such difficulties is to 
preorganise reactants upon a template (Figure 1.1). Molecules can be anchored via 
in_termolecular forces or covalent tether to a scaffold and brought to a sustained close 
proximity. The template arranges the reactive centres into a desired configuration, thus 
reducing the activation entropy of the reaction and increasing the rate of the desired 
reaction . By ordering the components in this way, control can be exerted over the course 
of the reaction pathway. 
o o 
• 
Organisation 0.0 
( l ~ ~ ) 
Reaction 
rt? 
. .) 
Figure 1.1 Schematic representation of templated synthesis 
1.1.1 Metal-mediated templated reactions 
1.1.1.1 Crown ether synthesis 
Dissociation 
A classic example of metal-templated chemistry is the use of potassium salts in the 
synthesis of crown ethers[4, 6] (Figure 1.2): 
2 
(i) 
1'1:0 
(i) BulOK 
Figure 1.2 Potassium templated synthesis of 18-crown-6 
-
The potassium cation draws the reactants together by coordination to the oxygen atoms, 
reducing the degrees of freedom the molecules possess. The reacting centres are now 
held in close proximity, and crucially the intramolecular SN2-like reaction is now 
favoured ahead of polymerisation via intermolecular SN2. Without the potassium's 
preorganisation of the reactants, the reaction yields a mixture of linear polyethylene 
glycols. 
1.1.1.2 Synthesis of Glucolipsin A 
An impressive extension of this methodology was utilised by Fuerstner et al. in the 
synthesi.s of the macrodiolide 1, Glucolipsin A (Figure 1.3).[7.8] 
Figure 1.3 Glucolipsin A 
An obvious disconnection of the core structure reveals it to be a dimer of carbohydrate 
origin. It was thought that synthesis of the elaborated sugar and subsequent dimerisation 
3 
would represent the most expediant route to the target molecule. Prior work suggested 
that the central dilactone core of the two structures would possess a significant level of 
ionophoric character; by implication the dimerisation reaction could be templated by a 
suitable metal cation, akin to the synthesis of crown ethers. 
The fragments were synthesised and treated with potassium hydride, which acted with 
dual capacity to deprotonate the precursor 2 and act as the source of admixed templating 
cation. The acids were activated with 2-chloro-I,3-dimethylimidazolinium chloride 3, 
and the protected form of Glucolipsin A 4 was formed as the major cyclisation product 
(Scheme 1.1). Quantitative reductive cleavage of the benzyl protecting groups 
completed the synthesis of Glucolipsin A. 
2 
(i) KH. CH2CI2• DMAP. 3 
(ii) H2• Pd(OH)2 
(i) 
OBn 
(ii)COH 
1 
Quantitative 
Scheme 1.1 Potassium templated dimerisation of hydroxy glycosyl acid 2 
This approach was also used successfully in the synthesis of some of Glucolipsin's 
• ;tereoisomers and structurally related compounds such as Cycloviracin B 1 [91. 
4 
.1 
1.1.1.3 Catenand synthesis 
The use of metals for organising ring forming events is more potent than the feats 
achieved by Fuerstner et al. would suggest. There is great interest in the development of 
large topologically interesting macromolecules within the field of molecular machinery. 
The supramolecular assembly of big molecules into structures with useful and 
controllable properties could one day provide the means to implement the promises of 
nanotechnologyyo-J3] A simple example of a supramolecular structure is the catenand; a 
chain of two (or more) macrocycles, interlocked via the central cavities. Early efforts in 
this area using non-templated methods were synthetically unproductive, giving minimal 
amounts of product. The first methodology to give rapid access to useful quantities of 
an interlocked-ring substance was published by Sauvage et al. with the introduction of 
the Catenands. [14, 15] 
It was realized that suitably functionalized organic ligands bound to a metal complex of 
well defined geometry could be elaborated such that they could encircle each other, 
forming two linked rings. Copper (I) was demonstrated to bind strongly enough to 
modified phenanthroline ligand 5 to allow such manipulation. The ligands occupy two 
coordination sites on the metal, and by virtue of the tetrahedral bonding geometry, are 
opposing and perpendicular to each other (6). The two ligands are converted to 
macrocycles by joining their common phenolic ends together with a diiodopolyglycol 
(Scheme 1.2). Cyclisation of one ligand traps its partner in the newly formed 
macrocyclic central cavity; cyclisation of both ligands therefore gives two linked ring 
structures (7). The copper cation can be extracted quantitatively from the product with 
tetramethyl ammonium cyanide. 
OH HO 
(i) 
OH 
5 6 
(i) [Cu(NCCH3),JCI 
(ii) ICH2(CH20CH2)4CH21 
Scheme 1.2 Copper templated synthesis of [2] catenand 7 
(ii) 
7 
19% 
5 
" 
This result demonstrated that template control could be used to preorganise substrates to 
give an otherwise unlikely outcome. The catenand strategy is however still subject to 
large unfavourable entropic energies during the final cyclisation event; the tethered but 
long polyglycol iodide can adopt many configurations that do not facilitate closure. This 
represents the major limitation with this technology. 
The advent of Ring Closing Metathesis (RCM) allowed Sauvage et al. to revisit the 
catenand work and develop new methodology to overcome the difficult kinetics of 
previous attemptsY6j New phenathroline ligands (8) were synthesized that possessed 
phenolic cyclisation motifs and were precomplexed with copper (9). RCM of the alkene 
units and reduction of the cyclised product gave the catenand 10 in much improved 
yield (Scheme 1.3). 
11 
(i) Cu(MeCN)4PFe 
(ii) 11 
(iii) 12, H2 
(iv) KCN 
(i) 
12 
Scheme 1.3 Improved [2] catenand synthesis 
9 
100% 
10 
92% 
The use of two shorter tethered chains (as opposed to one long chain) reduced·,the 
entropy of the system, but the remarkably high efficiency of the cyclisation is attributed 
to preorganisation of the alkenes. [17] The locked conformation of the ligands is thought 
to reinforce interactions between the glycol oxygen atoms and the phenanthroline rings 
that result in reduced mobility of the phenolic arms. Consequentially, it is believed that 
the alkenes lie in closer proximity than expected, resulting in improved RCM efficiency. 
6 
" 
The yields of ReM product 12 without the metal template (non-catenane macrocycle 
product) are markedly reduced, supporting this theory (Scheme 1.4). 
(i) 
(i) 11 
Scheme 1.4 Untemplated ReM of modified 1,10 phenanthroline ligands 
1.1.1.4 Borromean rings 
12 
70%, E»Z 
The most complex structure to date synthesized by use of metal templated synthesis is 
the Borromean rings (BR) by Stoddart et al.[1 8-20j The BR are three interlocked rings in 
which scission of any ring separates all three from each other (Figure 1.4). 
_~~-- Inner face of the end of the green ring 
:I~~- Outer face of the middle of the red ring 
Figure 1.4 Borromean rings[201 
It was envisaged that three perpendicular ellipsoid rings could be constructed whereby 
the inner ends of one ring were complexed to the outer middle edges of the next ring, in 
a circular fashion (Figures 1.4, 1.5). To enable a good yield and facilitate BR formation, 
the complex was designed so that the assembly of the rings is reversible and that the BR 
are the thermodynamic product. 
7 
" 
To achieve this it was necessary that the metal templated the required ligand assembly 
with extreme prejudice: A metal was needed that could discriminate between the inner 
middle of one ring and the outer ends of another, and orientate them to be perpendicular 
to each other. Furthermore, the ring formation had to be reversible, yet able to be driven 
to a thermodynamic minimum. 
Using molecular modeling, a macrocycle was designed that had differing number of 
coordination sites on its inner and outer surfaces. Careful choice of metal (with the 
correct number of coordination sites and geometry) would only give a stable complex 
when complexed to both of one inner and one outer ring coordination site (Figure 1.5). 
3 Inner 
coordination sites 
2 Outer 
coordination sites 
Figure 1.5 Metal organization of imine-derived macrocycles 
Outer coordination sites of one 
ring and inner coordination sites 
of other ring are perpendicular. 
Modeling determined that penta-coordinating Zinc(II) satisfied the geometric and 
bonding requirements of the BR complex design. In addition to the metal complex 
bonding, the BR were designed such that Jt-Jt stacking interactions could occur (twelve 
in total), further stabilizing the design to be the major thermodynamic product (Figyre 
1.6). 
8 
1\ 
Figure 1.6 Computer modeled synthetic borromean rings 
In order to assemble the BR and take advantage of the design features, the ring 
construction had to operate under thermodynamic control. The rings were considered to 
be products of reversible imine-formation from the aldehyde and amino subunits 
(Figure 1.7). 
ril I~N~ Q Q 
&0 O~ I '-':: 1 N ..,:;; . ..-:: N N"" ~ N 1 ~ I ~ ¢ ¢ 
N~N ~ 
1 " 
..,:;; 14 
Figure 1.7 Reversible formation of macrocycle 
QNH2 1'-':: ..,:;; 
&,"",,0 N ..,:;; N"" :;",.1 ¢ 
NH2 O~N ? 
1 " 
..,:;; 15 
H2NQ ~ I ~ 
O~I :::,.. N 
"N 
I..,:;; 
9 
H2N 16 
When equimolar amounts of the amine (16, as TF A salt) and aldehyde (15) components 
were combined in deuterated methanol, no reaction was detected by NMR studies after 
several hours of stirring at room temperature. Addition of Zn(OAc)2 immediately 
9 
" 
caused a dramatic change in the NMR spectrum. The reaction was heated under reflux 
for three days; periodic monitoring determined that the equilibrium had been attained 
after 48 h, giving one highly symmetrical construct as the major product. The reaction 
was repeated on a preparative scale and the product was obtained in 90% yield after 
recrystallisation. NMR, mass and ultimately x-ray crystallographic analysis proved that 
the product obtained was the BR (14, TFA salt) .. 
1.1.2. DNA templated organic synthesis 
Helical DNA can be considered as an excellent directing group for templated 
synthesis.[21-29] The binding of two complementary DNA strands yields a predictable 
and programmable structure. ssDNA will hybridise with its complementary strand to 
form a stable duplex of dsDNA - however if one of the base pairs in the dsDNA is 
mismatched, then the resultant duplex is significantly destabilised (relative to a fully 
matched duplex). For short strands of ssDNA therefore, a stable double helix will only 
be formed with complementary ssDNA. With increasing length of dsDNA, a 
mismatched base pair becomes more tolerated, as an increasing number of stabilising 
(matched) base pair interactions overcome the disruptive affects of the mismatched pair. 
In general however, ssDNA discriminates readily between complementary and c1ose-
complementary partner strands of ssDNA with a high degree of fidelity. In context, 
ssDNA and complementary ssDNA only exhibit very high selectivity for each other, 
fulfilling 'a prime requirement for directing groups of chemical reactions. 
The most important template directed reactions that exist are those found in nature ie. 
DNA replication, transcription and mRNA translation. These are discussed in section 
1.3.1.2 (vide infra). This nucleotide-based chemistry is enzyme-mediated and chemists 
have sought to adapt and free it from enzyme-dependence. In doing so, a greater 
diversity in the reactions that are directed and templated by nucleotides could be 
achieved, given that enzymes work with a very limited set of substrates and 
environmental conditions. Seminal work by Orgel examined the parameters for self-
replication of simple oligonucleotides under possible prebiotic-like conditions (no 
enzymes).[30-35] This work followed a natural path toward more sophisticated systems 
involving unnatural nucleotide polymers and laid the foundation for the use of DNA as 
directing groups. Von Kiedrowski was also concerned with the prebiotic origins of 
10 
" 
oligonucleotide replication and successfully demonstrated nucleic-acid directed 
replication of DNA analogues without enzymic control.[36-38j Lynn further developed 
the idea of using nucleotides as directing groups for organic synthesis and produced 
chemistry for the exponential self-amplification of DNA analogues [39-43) The important 
groundwork laid out by Orgel, Von Kiedrowski and Lynn paved the way for broader 
research into nucleotide-directed organic synthesis. 
Later attempts to exploit DNA as a template for orgamc synthesis were initially 
concerned with the synthesis of unnatural nucleotide polymers via modifications of the 
phosphate backbone. A leading example is the work of Kool et af. whom ventured to 
improve the detection of point mutations (single base mismatch) in DNA.(44) 
Established methodology utilised a DNA strand to template the ligation of two shorter 
oligonucleotides that together comprise the complementary strand. This enzyme (DNA-
ligase) mediated reaction can be studied using Fluorescence Resonance Energy 
Transfer[45-49j (FRET, Figure 1.8) labelling to determine if the strands have been united. 
FRET is the non-radiative transfer of energy from an excited donor dye to a relaxed 
acceptor dye. 
hv 
'" . .. 
Donor 
excitation FRET 
Figure 1.8 Schematic representation of FRET 
Acceptor 
relaxation 
hv' 
/ 
FRET is initiated by the light-induced excitation of a donor dye molecule. If the FRET 
donor is isolated, it relaxes by emitting light at a slightly reduced frequency relative to 
that it absorbed. If an acceptor dye is located within close permanent proximity of ~he 
excited donor dye, then FRET can occur. The acceptor dye is excited by the donor 
molecule and subsequently relaxes with the emission of light. This light is of a m~ch 
lower frequency (red-shifted) than that emitted by an isolated donor dye. Detection of 
donor or acceptor emitted light determines if the two probe dyes are held in close " 
proximity or not. 
11 
The DNA ligase assay requires each of the templated oligonucleotides to bear a FRET 
probe near the residues adjacent to the ligation junction. If there is a point mutation 
present upon the template then the enzyme will not ligate the two DNA strands together, 
as the requirement for absolute sequence specificity has not been honoured. Without 
ligation the probes cannot be held in sustained proximity and FRET cannot occur; the 
donor dye undergoes radiative relaxation and a point mutation is identified in the 
template strand. 
The dependence on enzyme mediation for the ligation process was considered a 
limitation of this technique for a number of reasons. Shorter oligodeoxynucleotides 
exhibit greater sequence specificity (point mutation sensitivity), yet ligase enzymes are 
rendered inefficient when joining oligodeoxynucleotides of less than nine bases in 
length. The technology cannot be extended to give direct detection of RNA point 
mutations as DNA ligases show low activities with RNAs. The technique cannot be 
utilized for in vitro studies as the ligase cannot be easily delivered into cellular 
structures. 
1.1.2.1 Auto-ligation of nucleic acid derivatives 
Kool et al. theorized that chemically modified oligonucleotides bearing FRET probes 
could be organised upon the DNA template and undergo auto-ligation. By grafting 
mutually'reactive chemical handles onto nucleotides adjacent to the ligation junction, an 
unnatural backbone linkage would form upon templation. This would exclude the need 
for DNA ligase. 
To test this hypothesis auto-ligation probes (a 7-mer and a 13-mer) were designed that 
would be complementary to a H-ras protooncogene template sequence. The sequence 
contains a characteristic codon-12 G ~ T mutation that has been well studied. Two 7-
mer probes, one wild-type (WT) and one mutant strand (MU, complementary with O'~ 
T mutation) were constructed with different acceptor FRET probes(Figure 1.9).[50-52] 
Tl~e WT probe was labeled with yellow-emissive hexachlorofluoroscein (HEX) dye and 
the MU strand was labeled with red-emissive Rhodamine (ROX) dye. The 7-mer 
strands were designed so that the point mutation occurred midway along the 
oligonucleotide, to maximize selectivity of the MU strand. The 13-mer was equipped 
12 
with a 'universal' donor probe, the green-emissive 5-carboxyfluorescein (F AM) that can 
engage in FRET with either 7-mer. The 7-mers were backbone-modified to hold a 
nucleophilic 3' -Phosphorothioate group; The 13-mer was adapted to contain a 5'-
Iodothymidine. 
MU probe (ROX label) 
Universal probe (FAM label) 
HO 5' 3' 9??T<::?? 
: : : : : 
18 
CI Ci 
HO OH WT probe (HEX label) 
3' 
????~~?~?T 
: : : : : : : : -I~"""""""""'OH 
CI CI 
17 
19 
Figure 1.9 DNA tagged FRET probes 
Conceptually, the H-ras 40-mer would template the ligation of only the MU 7-mer and 
the universal 13-mer in a mixture containing both 7-mers (Figure 1.10). Displacement 
of the io"dide with the phosphorothioate would form the unnatural backbone linkage, 
enabling FRET to occur. 
~~~~~~~~~~'I :: :: :: :: :: :: :: :: :: :: :: :: :: 
TGAGAACGGGTGT 
''-------0 
f?TyTT?yy?t?f 
: : - : : - - - : : : -
e s 
o-P::o 
e d 
999~999 
: : : : - : : 
- - - - - - -: : : : : : -
Universal probe cannot ligate 
to WT probe due to G-A mismatch_ 
Donor dye cannot undergo FRET. 
Universal probe ligates to MU 
probe as reagents are fully 
matched. FRET can occur. 
13 
" 
Figure 1.10 Auto-Ligation Energy Transfer experiment 
It was found that the Auto-Ligation Energy Transfer (ALET) experiment was 
successful. A solution containing equimolar amounts of 18, 19 and the universal DNA 
strand 17 was agitated and warmed at 32°C over 18h to give an intense red FRET 
signal, unique to the F AM-ROX pairing. The yellow FRET signal that signifies the 
F AM-HEX pairing was absent. Control experiments confirmed that false-positive and 
false-negative results had not occurred. A more quantitative test revealed that the 
ligation of the MU and Universal strands occurred 180 times faster than with the 
mismatched WT -Universal strands. 
Two further interesting results were observed. Introduction of a RNA strand as the 
template resulted in near identical ligation rates and sequence fidelities when compared 
to its DNA counterpart. The formation of the unnatural backbone linkage had altered the 
structure of the mutant-template helix. The backbone imperfection lowered the helix Tm 
sufficiently to allow dissociation and catalytic turnover of the template strand without 
thermal cycling; a phenomenon not possible with the DNA ligase system. In practice, a 
40-fold turnover was observed under optimal reaction conditions, giving 280 fM of 
ligated probes from 7 fM of template (per hour). The formation of unnatural backbone 
linkages between oligonucleotides had demonstrated the potential for other DNA-
templated chemistries across the helix backbone. 
1.1.2.2 Small molecule synthesis 
Liu et al. have demonstrated that DNA can template the synthesis of small organic 
molecules.[23, 53] Two architectures were initially considered, the End (E) and Hairpjn 
(H) structures (Figure 1.11), to foster templation of a simple conjugate addition 
reaction. Initial concerns were raised on possible disruption of the helix; bulky reactants 
clashing across the ligation junction could potentially retard or arrest the reaction. 
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Figure 1.11 DNA templated conjugate addition of a thiol to a maleimide 
The reaction was performed in pH 7.5 buffered solution at 25 °C with 60 nM 
concentration of all reagents. Within minutes, both E and H structures had complete 
turnover of the starting materials, giving the thiomaleimide as the sole product. It was 
found that both E and H architectures reacted at identical rates where kapp - 105M·I S·l. 
The reaction was repeated unsuccessfully with template that had been pre-quenched 
with ~-mercaptoethanol, proving the template thiol was the active nucleophile. 
The successful proof of concept study for DNA Templated Synthesis (DTS) was 
expanded further to probe the scope of electrophile and nucleophile pairings (Figure 
1.12). 
o 
Template ~~ 0 ~N~I 
H 
19 
o 0 
Template N~N~Br 
H H 
22 
o 
Template N~I 
~ .• H 
25 
o On 
Template~~N1 
20 
T.mpl'''N~~ 
H 0 
23 
o 0 
TemplateN~:p 
H !J 
21 
o 
o -
Template ~~ .' ~s/.:::::: 
6"0 
24 
Figure 1.12 Electrophiles reacted via DTS with thiol and amine nucleophiles 
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On both Hand E templates, all reagents 19 - 25 reacted in good yield and excellent 
sequence specificity with sulfur and nitrogen based template nucleophiles. No reaction 
was observed with mismatched reagents. These results are significant as the wide 
variance in reaction geometries required for all the possible reactions was tolerated 
without deleterious effects. 
The selectivity of DTS was examined by studying the effects of introducing a single 
point mutation in the centre of the template for the reaction of 20 with the thiol 
nucleophile. Mismatched thiol reagents reacted - 200 times slower relative to the fully 
matched case. Furthermore, by elevating the reaction temperature above the T.n of 
mismatched reagents, the undesired side products were not observed. 
Interestingly, a number of different reaction types were found to exhibit 'distance-
independence' when templated using DTS. It was found that the rate of these reactions 
was not affected by the number of intervening bases between the reacting components, 
for both the E and H architectures (Figure 1.13). 
~SH ~ ~ o N 0 ~ '----
~ 
5' 
3' 
o 
n bases; n = 0 - 30 
Figure 1.13. Distance-independence ofDTS 
For the largest gap tested, n = 30, a massively large pseudo-macrocyclic transition state 
is passed through during the reaction lifetime. The apparent ease with which this occu.rs 
is in stark contrast with untemplated macrocyclisations. To discover the origin of 
distance independence, a number of unnatural strands were synthesised wherein the 
region of unpaired bases was modified. Different structural motifs (Figure 1.14) 
replaced the oligodeoxynucleotides to determine any possible contribution of the 
following parameters toward distance independence: Interbase interactions (27); 
Conformational preferences of the backbone (28); Electrostatic interactions of the 
backbone (29) and backbone hydrophilicity (30). 
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Figure 1.14 DNA backbone surrogates 
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Substitution of the intervening bases with any of the analogues in Figure 1.14 had no 
effec! on the rate of product formation; the backbone structure of the template has no 
profound influence on the rate of DTS. However when a 10 base strand of DNA was 
added (complementary to the central portion of the n = 30 oligomer) the reaction was 
severely impaired, suggesting that unhindered mobility of this region is critical to 
distance independence. Based on this evidence, it was proposed that distance 
independence is a consequence of DNA annealing being rate determining. On the 
reaction timescale, formation of the helix is much slower than the templated reaction, 
regardless of the number of bases between the reacting centres. If this hypothesis is 
correct, the reaction will slow down at lower concentrations of reagent; for n = 1 - 10, 
there was a marked decrease in rate when reagent concentration was lowered. The 
observation implies that the rate accelerating effects of DTS can be substantial enough 
to have DNA annealing become rate determining. Distance independence is an 
important discovery as potentially one DNA template could code for different reagents 
at different regions on the strand. This would allow multistep reaction sequences to be 
programmed for a single substrate on the same template. 
1.1.2.3 Amplifiable and evolvable small molecule libraries 
Liu et al. hold an interest in the creation of amplifiable and evolvable libraries of non-
natural small molecules. [22. 26. 54] The programmability of DNA and the potential for 
multistep reactions presents the opportunity to achieve this using DTS (Figure 1.14). 
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Figure 1.14 Evolvable small molecule libraries using DTS 
Templated 
Synthesis 
Cleave 
Linker 
Templated 
Synthesis 
Cleave 
Linker 
In-vitro 
selection 
Product with desired 
property identified via 
DNA sequence analysis 
Conceptually, a pool of unique DNA templates (each consisting of three codons) are 
tagged onto a basic core structure (one template per structure) and are then treated with 
a reagent library. Each member of the reagent library is tagged with a single anticodon 
that is complementary only with a codon located in the codon-l region of the DNA 
templates. The tagged reagents locate and anneal with the correct template and react 
with the core structure that the template is attached to. The vestigial linker and anti-
codon are then separated from the template and removed from the pool. Another reagent 
library is then added to the template pool that is coded to react with the codon-2 region 
of the templates and the iterative sequence is continued. A third and final reagent library 
that is encoded for the codon-3 region of the templates is used to complete the chemical 
elaboration of the original core structure. With a sufficient number of properly encoded 
templates, the final library of compounds will contain every possible permutation of the 
reagent-modified core structure. These compounds are screened in-vitro for a desired 
property and isolated. Successful candidates of the screening process are identified by 
their unique DNA template tag and used as the basis for further chemical evolution. 
Initially a proof of concept study was undertaken to validate the potential for multi-step 
DTS. A library of 1025 E-template (Figure 1.11) linked maleimide reagents were 
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assembled to react with 1025 complementary thiol-linked templates in a single reactor 
(Figure 1.15). One reagent was labelled with Biotin. A total of 1025 programmed 
products were expected from a total of 1 050 625 potential products, of which only one 
product would be labelled with biotin. 
_
__ B.io.ti.n) } Only present on product anticodon 
HS""'" • o~O ~======~~~----~)~C======~ ~NH 
o 10 base codon PCR primer 
Product template codon : GTGACGGGTG 
Product reagent anticodon : CACTGCCCAC 
Non·product template codon : GNCNANCNN 
Non·product reagent anticodon : CNGNTNGNN 
N = A,C,T,G (N is complementary to N) 
Figure 1.15 Programmed synthesis of thiomaleimide library 
Equimolar amounts of the reagents and templates at 60nM total concentration were 
mixed at 25°C for 10 min. The resultant mixed products were selected in vitro for 
binding to immobilised streptavidin; biotin exhibits very strong streptavidin affinity. 
The surviving molecules were amplified via PCR using primers (attached beyond the 
coding region) and analysed with a restriction endonuclease that digests the biotin anti-
codon only. The ratio of biotin-labelled sequences to non-biotin labelled sequences 
amplified during PCR was found to be 1: 1; this is in excess of a WOO-fold enrichment 
of the biotin containing product. It should be noted that the experiment was designed to 
elicit success by virtue of the product template never being more than 50% matched to 
the non-biotin labelled reagents. 
Liu et al. have expanded the scope of DTS and reported a broader range of chemistries 
that have been performed upon an E template (Figure 1.16). 
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Figure 1.16. Reactions enabled by DTS 
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EDC coupling 71% 
Sequence selectivity was absolute in all cases with untemplated or mismatched reaction 
products not being observed. Yields generally ranged from 40 - 90%, except in the case 
of cycloadditions of un activated alkenes «10%). 
It was found that the Wittig, nitroaldol, Heck and EDC coupling reactions operated with 
distance independence (vide supra) for a range of 0-10 intervening bases. There is no 
conclusive explanation at this time to determine or predict whether a reaction will 
operate with distance independence or not. 
1.1.2.4 Stereoselective DTS 
Liu et at. reported that DTS exhibited "stereoselectivity" for a simple SN2 reaction on 
both the E and H template architectures (Scheme 1.5).[27] In this instance, 
"stereoselectivity" is used to describe a marked difference in rate of a DTS mediated 
reaction between a nucleophile and two electrophiles that have their reactive centre set 
in opposing configurations. By measuring the apparent relative rates of reaction of an 
alpha-keto bromide with a thiol (for both the S and R electrophiles), it was possible to 
determine how structural changes to the DNA helix influenced the stereoselectivity. 
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;:-P 
HS H I~O 
12 bases 
. 
~' 'HMe -N. * I( 'Br H 0 
12 bases 
~SH 
NH 
o~Me 
Br 
4.0 ±0.2 
5.0 ±0.7 
4.6 ± 1.1 
Scheme 1.5 Relative rates of reaction for enantiomers of an a-bromo amide with a thiol 
It was found that the selectivity observed was independent of whether the bromide was 
bound to the template or reagent DNA strand. Separating the reacting components with 
12 nucleotides did not appreciably alter the apparent ratio of rate constants. These 
findings suggest that the conformation of the DNA scaffold imposes itself upon the 
transition state of the templated reaction. To determine the effects of the backbone 
. 
conformation on the stereoselectivity, the 12 base unpaired region was replaced with an 
achiral poly( ethylene glycol) linker of similar length. Stereoselectivity was no longer 
observed for either the thiol or bromide linked template systems. To further understand 
this phenomenon, a template was constructed in which 11 of the 12 unpaired 
oligonucleotides (all except the one immediately adjacent to the reacting centre) had 
their nucleobases excised and replaced with a proton. Stereoselectivity was lost, 
demonstrating that the configuration of the terminal template nucleotide is not (solely) 
-' 
directing the stereoselectivity of the reaction. As the nucleotides were sequentially 
restored to the template (from either 5' to 3' or 3' to 5') stereoselectivity gradually 
incr.eased, however no effect was observed until at least 5-6 bases were in place. This 
implies that base-stacking is an important feature in the stabilisation of single-stranded 
DNA and crucial in the induction of stereoselectivity in DTS. By corollary, it was 
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argued that this mode of stereoselection would be affected by global conformational 
changes in the template-reagent complex (changes in secondary structure, the sense of 
the helix); inversion of the helix handedness should reverse the stereoselectivity. 
It is known that DNA helices rich in (S-Me-C):G repeats can adopt the unnatural left-
handed (Z) form at high salt concentrations. Such a helix was constructed and tagged 
with the bromide and thiol motifs. At low (100mM) salt concentrations, circular 
dichroism (CD) experiments gave spectra characteristic of a natural (B) right-handed 
helix. At high (SM) salt concentrations, the CD spectra was indicative of the Z-form 
DNA helix. Normal mixed sequence templateiregeant complexes were of the B-form at 
both low and high salt concentrations. Templated reactions were performed for both the 
mixed- sequence and (S-Me-C):G rich helixes in both low and high salt environments 
(Figure 1.17). 
B - DNA 
Z-DNA 
normal sequence 
100 mM NaCI 
normal sequence 
5mM NaCI 
C-G rich sequence 
100 mM NaCI 
{ 
C-G rich sequence 
5 mM NaCI 
ks,appi kR,app 
4.3 ± 0.8 
3 .2 ±0.6 
4.4 ± 0.6 
0.31 ± 0.05 
Scheme 1.17 Stereoselectivity inversion upon reversal of template secondary structure 
The Z-DNA form gave a dramatic change in stereoselectivity. The results are consistent 
with the theory that the conformation of the helix is the stereochemical origin of the 
stereoselectivity observed with this DTS reaction. 
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1.1.2.5 Multi-step DTS large molecule libraries 
Liu et at pursued the potential of DTS for the generation of an evolvable library of 
molecules. [55, 56] It was considered feasible to construct a diverse library of macrocyclic 
compounds using a three step templated synthesis (Figure 1.18). 
PCR 
primer 1 Codon 2 
~
Codon 2 
1. Anneal reagent 1, EDC coupling, basic cleavage of linker 
2. Remove biotin labelled DNA-linker with streptavidin beads 
3. Repeat steps 1 and 2 with reagent 2 
4. Repeat steps 1 and 2 with reagent 3 
5. Nal04 cleavage of diol to unmask aldehyde 
6. pH raised to 8.5 for Wittig macrocyclisation 
with concomittant release of product from template 
7. Elute product from strepavidin-bound template 
8. In-vitro selection and PCR amplification of products 
Figure 1.18 Three step synthesis of a macrocycle library 
Reagent 3 
. . Ph Ph O ~ 
Biotin Ar-P~ R3 OH )m... ~ ED N 
.. " \t.U.I H 0 
A pool of 64 templates were constructed that coded for each combination of four step 
1,2 and 3 building blocks (Figure 1.19). 
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Step 1 reagent library H 0 H 0 H 0 H 0 
XNJOH XN~NH2 yXOH x N00H 
O~NH2 
Step 2 reagent library H 0 H 0 HH O H 0 
XNyAOH XN'¢O yNfOH XNyAOH \ l NH2 ~ ~ /I HO H N~N N H H H 
Step 3 reagent library H H 0 H 0 H 0 XN~OH XN~OH y N00H XNyAOH 0 
il ~ ~NMe2 
Figure 1.19 Reagent libraries used for DTS of a family of macrocycles 
A 65th template was included that coded a unique step one reagent containing a phenyl 
sulfonamide. The 65th macrocycle (Figure 1.20) served as a control for in-vitro selection 
in affinity against carbonic anhydrase (phenyl sulfonamide is known to exhibit a high 
affinity for carbonic anhydrase). 
Figure 1.20 Positive control macrocycle 
The 64 macrocycles were synthesised and isolated in 1 - 5% overall yield. Comparison 
of some of the final library compounds to authentic samples (non-DNA linked 
analogues) proved that the reaction conditions did not induce epimerisation of any 
stereocentres. Two rounds of in-vitro selection (for binding affinity against carbonic 
anhydrase) followed by PCR amplification and strand analysis gave the positive control' 
macrocycle as the only molecule surviving selection. The work proved that it is 
possiple to rapidly assemble a library of small complex molecules and screen in-vitro 
for protein affinity using DTS. 
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Using the codon methodology, an array of diverse linear molecules were also prepared 
to exemplify Iterated Branching Reaction Pathway Synthesis (IBRPS, Figure 1.21) via 
DTS[57]. IBRPS is the generation of a structurally diverse library by means of repeatedly 
executing multiple reaction pathways from each library member. With each iteration, 
the number of library members increases. 
Iterative Branching Reaction Pathway Synthesis 
Enyne coupling 
Acylation 
Compound 1 -< Acylation : 
Base compound r-_-'=O"-'le'-'!fi'-"naO!!ti""on-'--__ Compound 2 
Thiazolidination Compound 3 
Representative products of DTS mediated IRBPS 
Figure 1.21 IBRPS using three codon DTS technology 
Amidation 
Amidation < Cross COUpling: 
° HN~HAC 2 H 
N 
Product 1 
Product 2 
Product 3 
Product 4 
Product 5 
OH 
The increased chemical complexity and diversity of the final library members illustrates 
the potential of DTS for small molecule synthesis and (biological) screening. 
Recently published work by Liu et af. has centred on ordered multistep synthesis in a 
single solution.[58] By exploiting the temperature and strand length dependencies of 
DNA hybridisation it was possible to complex three reagents on one template and have 
-
them react sequentially in a desired order (Figure 1.22). 
At low temperature, the three reagents annea.!, upon the template and are held so that 
only two reagents are positioned to react. As the temperature is raised, the desired 
reaGtlon occurs between reagents 1 and 2, and some chemical structure is passed from 
reagent 1 to reagent 2. The first reagent DNA strand then dissociates from the template 
as its Trn is passed; the reagents Tm is controlled by the length of their DNA strand, the 
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longer it is, the greater it is. At the elevated temperature, the template and remaining 
reagents rehybridise to bring the second and third reagent strands into reactive 
proximity. The second reaction takes place and the growing molecule is passed to the 
third reagent. The temperature is raised again to remove the second reagent DNA strand 
and allow rehybridisation of the template and third reagent. After the third reaction, the 
final reagent DNA strand is removed to give the desired linear product. Figure 1.22 
shows a representative product of this approach, the result of three sequential Wittig 
reactions. A trimer peptide has also been prepared using this methodology. 
)~. 
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Figure 1.22 Ordered multistep synthesis in a single solution 
The power of DTS lies with its ability to program the reactivity of a mixture of reagents 
to yield exclusively a selection of predicted structures. The DNA template also acts as ~l' 
readily amplified and unique tag, allowing the conservative use of precious reagents 
without compromising ease of identification. The templated reactions proceed at a much 
enhanced rate compared to their untemplated counterparts by virtue of an effective 
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increase in reagent molarity. DTS has been demonstrated to be a powerful methodology 
for the rapid assembly of small complex molecules. 
1.2 Peptide Nucleic Acid 
PNA is a structural mimic of DNA in which the deoxyribose phosphodiester back bone 
has been replaced with homomorphous aminoethyl glycine (Figure 1.23)Y9] 
Nucleobase pu leobase f c,eObase ~t> ot> 0 HO~O'~'O o'~'o OH 
o 0 
e e 
n 
Figure 1.23 Structures of PNA and DNA 
It was originally designed for the recognition of double stranded DNA via Hoogsteen 
base pairing in the major groove. DNA-DNA duplex formation is characterised by 
Watson and Crick base pairing (Figure 1.24). 
Watson-Crick base pairing 
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Figure 1.24 Nucleic acid interactions 
Hoogsteen base pairing 
The PNA backbone is characteristically different to its DNA counterpart being that it is -
acyclic, achiral and carries no formal charge. PNA oligomers have both parallel and 
anti-parallel binding modes, although the antiparallel form is strongly preferred. 
Single stranded PNA can interact with DNA helices in more than one way (Scheme 
1.25).t6o-62) 
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Scheme 1.25 PNA modes of binding with DNA 
It should be noted that triplex-formation can only occur with oligomers which target 
poly-purine tracts in the major grove of a duplex - this is a consequence of the 
geometric constraints involved with triplex formation. The electroneutrality of the PNA 
backbone is significant. Annealed DNA strands experience repulsive interactions 
between the negatively charged phosphate backbones. PNA strands do not suffer these 
destabilising forces and bind more tightly to DNA and RNA than 
oligodeoxynuc1eotides; this is reflected in the higher T m values for any given strand 
length of PNA relative to its DNA counterpart. 
On average (for a mixed base sequence) PNA/DNA helices are 1°C more stable per 
base pair than the corresponding DNA/DNA helix.[63-65] Substitution of adenine with 
2,6-diaminopurine results in an increase of 4°C per substitution. [66] If a PNA/DNA 
complex has high purine content then a dramatic rise in T.n is observed. [67] A 
. 
homothymine 6-mer bound to a complementary DNA strand has been reported to melt 
at 31°C, whereas the same dsDNA complex dissociated at less than 1 DoC. The effect is 
more pronounced for a homothymine 1 Orner - this melts at 73°C as opposed to 23 °C for 
the dsDNA helix. 
Mismatched bases destabilise annealed PNA/DNA strands to a far greater extent than 
their DNA/DNA equivalents; on average the Tm is reduced by lOoC for a DNA/DNA 
point mutation, and 15°C for the equivalent PNA/DNA helix.[68-70] The corollary ot 
enhanced binding and selectivity is the ability to use shorter PNA strands in lieu of 
DNA to achieve the same level of affinity with a given DNA sequence. 
DNAlRNA hybridisation is dependant on the salt concentration within their medium 
whereas PNA hybridisation is not.[71] This means at low salt concentrations, DNA and 
RNA helices denature and unwind. PNA can therefore more easily invade and displace 
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complementary DNA strands of target sequences at lower salt concentrations as the 
hybridisation kinetics are more facile. 
The amino ethyl glycine backbone of PNA is not easily recognised by nucleases or 
proteases so PNA oligomers exhibit resistance to enzymatic degradation. [72,73] It is also 
stable over a wide pH range, unlike DNA. These properties allow an increased lifetime 
ofPNA (relative to DNA) for in-vitro and in-vivo applications. 
Applications of PNA as a DNA based equivalent already exist.[74-78] The enhanced 
thermal and chemical stabilities of PNA however often translate into tangible 
advantages in such applications, driving their inclusion. Greater selectivity and binding 
affinities of PNA strands relative to DNA based probes allow smaller oligomers to be 
used in most biological assays. 
1.2.1 Applications of PNA 
As a mimic of DNA, PNA can be used in many DNA-based applications. 
1.2.1.1 Molecular Beacons 
It is important in biochemical research to have the means for labelling chromosomes in 
specific places. [79-83] A popular method for the sequence specific labelling of 
oligonucleottdes is the use of a molecular beacon (MB). Molecular beacons are 
fluorescence based probes that are unable to emit light until they are bound to their 
targeted sequence (Figure 1.26). The fluorescent reporter group is anchored onto a 
terminus of a hairpin oligonucleotide. It is held in close proximity to a fluorescence 
quencher situated on the other strand terminus. While the hairpin structure is 
maintained, either through nucleobase-nucleobase interactions or hydrophobic forces, 
the quenching unit stifles any fluorescence from the reporter dye. When the MB 
successfully anneals and hybridises with the target DNA sequence the dye and quencher 
are sufficiently separated in space that quenching of the fluorophore is minimal and a 
signal is observed. 
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Figure 1.26 PNA beacon fluorescence 
There is no obligation to wash away excess unhybridised probes after treatment of the 
DNA sample because they are unable to affect the signal of the active probes. This 
translates to a tangible advantage that allows the use of MBs in-vivo where washing 
techniq~es cannot be applied. Real time monitoring of both location and concentration 
of target oligonucleotides is possible when administering large quantities of MBs into 
cellular structures. As a target sequence is replicated it hybridises with the stockpiled 
MBs; this technique is known as Fluorescence In-Situ Hybridisation (FISH).[84-86) PNA 
is an adept foundation for MBs and well suited for FISH, displaying on average three 
times greater signal intensity than its DNA counterpart, as a result of its great binding 
affinity.[87-92) 
1.2.1.2 PCR Clamping 
PNA can effect the rapid detection and identification of mutant DNA by selective 
amplification of the rogue sequences.[93-95) The high selectivity and affinity of PNA 
allows the discrimination of deviant oligonucleotides that differ by as little as one base 
pair. Detection of rare mutant targets is achieved by the selective inhibition of wild-
type DNA (WT DNA) amplification (Figure 1.27) . 
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A PNA oligomer coded to complement the WT primer sequence occupies (essentially 
irreversibly) the primer site and prevents the WT primer from docking. DNA 
polymerase is sterically blocked from recognising the primer sequence and amplifcation 
of the WT DNA is impaired. The PNA does not bind to the mutant primer sequence and 
normal amplification ensues. Under these conditions amplification of the MU DNA 
dominates over production of the WT amplicons. The final pool of amplicons is 
massively enriched with the desired mutant sequence. The approach can be applied in 
other ways; placing the clamp either adjacent to or distal to the primer sequence also 
acts to arrest primer elongation. 
1.2.1.3 Rare genome cutting 
Rare genome cutting is the infrequent scission of a strand of DNA into a small number 
of large fragments. An optical imaging technique for the sequencing of large DNA 
fragments introduced in 1993 by Wang et al. hastened genomic mapping and is 
dependent upon rare-genome cutting (Figure 1.28).[96,97] 
DNA denatured, elongated 
and immobilised with rare-
cutting enzyme in gel 
Ca2+ ions diffuse into gel; 
enzyme is activated 
Figure 1.28 Rare genome cutting of immobilised DNA 
Cleaved fragments are 
digitally imaged and 
characterised by length 
and fluoresence intensity 
In the Wang technique, the chromosome of interest is thermally denatured into single 
strands and trapped in molten agarose gel in an elongated form. The gel contains large 
quantities of a rare (infrequent) cutting enzyme but is deficient in the calcium required 
for enzymic digestion of the DNA. The gel plate is stained black to distinguish the 
fluorescently labelled DNA and permit optical imaging of the sample. Calcium then _. 
diffuses into the gel activating the enzyme and digestion process. Cleavage is observed 
as large breaks forming in the unwound strand. Digestion is imaged optically and 
computational analysis characterises the results. The primary concern with rare genome 
cutting is a lack of enzymes that can offer infrequent cutting - it is of benefit to genomic 
mapping to swell the pool of available rare-cutters. 
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Nielsen et al. devised a strategy to allow the wide range of regular restriction enzymes 
to act as rare genome cutters.[98, 99] PNA clamps are used to mask arbitrarily a small 
number of sites that are susceptible to a restriction enzyme. The partially masked DNA 
is exposed to DNA methylase that alkylates the unmasked nucleotides, thus preventing 
their recognition by restriction enzymes. Thermal unclamping of the PNA reveals the 
unmethylated regions of the chromosome that are subsequently the only regions 
susceptible to recognition by and digestion with the restriction endonuclease. 
Application of the enzyme results in the scission of the few sites eligible for digestion 
(Figure 1.29). 
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Figure 1.29 Rare cutting of a large gene using a regular restriction endonuclease 
Considered choice of PNA clamp and restriction enzyme significantly widens the 
breadth of rare cutting systems available, expediting the characterisation of large 
sections of genomic DNA. 
1.2.1.4 Antisense Gene therapy 
. 
A promising application of PNA lies within antisense gene therapy.[IOO-I02] The 
transcription of certain genes can have an adverse effects on the human body. Sickle 
cell anaemia, Hepatitis, cancer and HIV are all potential targets for antisense techniques 
as a part or whole gene-targeted therapy.[I03] Antisense therapy operates by introducing 
a nucleotide oligomer that either intercepts and incapacitates the mRNA produced by 
the harmful genes (Figure 1.30)[68] or prevents transcription of mRNA via steric 
blocking of chromosomal DNA bindingy o4] Preventing the transcription of mRNA halts 
the expression of the harmful genes, potentially curing the ailment it induces. Targeting 
mRNA (instead of genomic DNA) is often the easier and more responsive approach to 
antisense therapy as delivering PNA inside the cell nucleus is a formidable task. 
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Antisense therapy is relatively new and only one drug (based on DNA) has been 
approved for therapeutic use by the Food and Drug Administration of America -
Formivirsen.[J05] The drug, marketed as Vitravene®, is an inhibitor of the 
CytoMegaloVirus (CMV) which can cause retinitis in AIDS sufferers. CMV is a herpes 
related virus that is found in the vast majority of humans worldwide, but is held in 
remission by CD4 immunoglobin cells. AIDS patients whose immune system has been 
compromised are susceptible to CMV induced retinitis (loss of peripheral and night 
vision) as they cannot muster a sufficient defence against CMV.[106] Formivirsen 
intervenes by suppressing the viral replication via the mRNA coding for reproduction of 
the virus. It is postulated that a suitably attenuated PNA derivative would be a more 
effective drug. 
Initial development of PNA-based antisense drugs was stunted by poor cellular uptake 
of PNA. For simple prokaryote cellular organisms (bacteria) it was found that 
attachment of a cell-penetrating peptide (KFFKFFKFFK) to the PNA strand raised the 
efficiency of cellular invasion to a level suitable for therapeutic applications. [107, 108] The 
mechanism of how the peptide mediates passage through the cell wall is not understood 
at this time. [109-111] Entry into eukarotic cells requires more advanced chicanery. A PNA-
DNA chimera is prepared whereby the conjoined strands are complementary, thus 
forming a hairpin. The hybrid is treated with a cationic lipid (which is attracted to the -
anionic DNA backbone) that transports the PNA across the cellular divide.[I1 2-115] Inside 
the cell, dissociation of the lipid and hairpin nucleotide structure occurs under the .-
physiological conditions to deliver the drug in-vivo. It is critical that the stability of the 
hairpin is less than that of the PNA-target complex but sufficient that it can maintain its 
.. 
integrity to present a hydrophobic package for the lipid to encapsulate. Beyond entry to 
the cell, other challenges remain to hinder a successful antigene interaction. Nucleotide 
oligomers often show high affinity for proteins (cell surface and intracellular), non 
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target mRNA and non target-DNA and never reach the intended target. Furthennore, 
successful binding to a target region does not guarantee an inhibition of the phenotype 
coded for in the gene; often rational inhibitor design is overcome by unforeseen cellular 
events. Many sites on a gene are usually targeted and empirical data will detennine the 
successful design. PNA derived antisense therapy is very much in its infancy, although 
recent patent literature indicates that the field is moving forward.[11 6-1 20] At this time 
there is very little published work in PNA based antisense therapy, but research is still 
ongoing. [1 21] 
1.3.0 Peptide synthesis 
Peptides can be synthesised by man by either chemical methods or hijacking biological 
machinery provided by nature.[122-126] Both techniques have relative advantages and 
disadvantages but ultimately are seen to be complementary and indispensable. 
1.3.1 Biological synthesis of peptides 
1.3.1.1 Recombinant DNA synthesis 
Man is able to take advantage of natures elegant solution to peptide and protein 
synthesis. Prolonged study of the underlying biology of protein synthesis has allowed 
the inception of transgenic techniques (Figure 1.31) for the synthesis of unnatural 
peptide sequence. DNA that codes for a designer peptide is introduced into the genome 
f I • . . l 'd [1 27 128] o a save orgamsm V lQ a vector p asml . ' 
Plasmid 
/l~l ~
restriction JJ. 
. ~ Ligation 
Figure 1.31 Gene cloning 
@ Transformation @O Cl ...... -.., Organism replication. Peptide expression 
Circular plasmid DNA is cleaved open using restriction endonucleases to give an open-
fonn PWA tapered with "sticky ends. The foreign DNA is complexed with the open 
plasmid via short unpaired nucleotides that comprise the complementary "sticky ends" . 
The plasmid backbone is refonned using a DNA ligase enzyme to give the completed 
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transgenic vector. The plasmid is introduced to the host organism (eg yeast strain) via 
endocytosis and assimilated into the cell ' s anabolic pathways. Culture of the organism 
multiplies the number of copies of the designer DNA and ultimately magnifies the 
expression of the desired peptide. Cell lysis of the fermentation broth gives a crude 
mixture of cellular debris that can be purified by centrifugation and electrophoresis to 
give the required peptide. 
1.3.1.2 Mechanism of peptide synthesis from DNA 
The translation of human genetic information from DNA to a final protein is mediated 
by a school of enzymes and the catalytic ribosomes (Figure 1.32). [1 26) 
Chomosome ffi unpacks 
RNA polymerase 
mediates mRNA 
formation 
DNA uncoils 
from histone 
proteins 
DNA 
helicase 
~ unwinds DNA o -
mRNApasses 
into rjboso~e ~ 
Ribosome translates 
mRNA into peptide 
Figure 1.32 Gene translation and transcription 
RNA 
polymerase 
binds to 
ssDNA 
Supercoiled DNA unravels from structural proteins and a series of enzymes unwind the 
helical dsDNA and transcribe a gene into a mRNA oligomer. The mRNA passes from 
the nucleus into the cytosol and docks with a ribosome. Within the ribosome, the 
mRNA acts as a template for peptide construction. Three nucleotides of the mRNA 
strand that comprise the start codon, a trigger for peptidyl synthesis, are read by the 
ribosome and peptide synthesis begins. The next three nucleotides in the sequence bind 
to a tRNA molecule (which carries an amino acid) bearing the complementary three 
nucleotides, and this represents the start of the peptide. The next three mRNA nucleic 
acids similarly code for another tRNA molecule which docks along side the first. The 
two amino acids carried by the tRNA molecules are now in sustained close proximity 
and react together. The second amino acid initiates an addition-elimination reaction with 
the first' amino acid; amino acid one is liberated from its tRNA carrier molecule and 
forms an amide bond to amino acid two (Figure 1.33). The process is repeated until the 
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stop codon IS encountered, at which point the fmal peptide is passed out from the 
ribosome. 
Figure 1.33 mRNA templated synthesis of peptides within the ribosome 
The peptide is then transported to other cellular organelles for post-translational 
modifications to give a fully-fledged protein. 
The ribosome that houses the peptide synthesis is itself an awesome array of proteins 
and RNA that nature has beautifully assembled into an incredibly efficient and robust 
machine (Figure 1.34). 
Figure 1.34 Representation of the 30S subunit of a bacterial ribosome 
Ramakrishnan et af. have resolved ribosomal crystal structures to less than 3A 
resolution allowing detailed insight on the mRNA decoding process (i.e. how mRNA 
and tRNA interact) of ribosomal peptide synthesis.[129, 130) Additionally, the mode of 
action of some antibiotics has also been clarified. [131) This important work has served to 
highlight how the biological synthesis of peptides and proteins is immensely more 
efficient and reliable than any man-made technology. 
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However, when using the approach of nature, the limitations of this methodology apply. 
Biological systems are generally constrained to the use of 20 natural amino acids and 
the selection of post-translational modifications that are provided by nature. Research to 
further modify and manipulate these systems is on-going. Schultz et al. have engineered 
biological systems capable of translating manmade tRNA to incorporate unnatural 
amino acids into peptides.[132-134] This work has expanded the 'genetic alphabet' of 20 
amino acids to 21. To easily introduce unnatural motifs into a protein, chemical 
synthesis must be used to construct the peptide. 
1.3.2 Chemical synthesis of peptides 
The first planned chemical synthesis of a peptide was performed by Fischer in the late 
19th century. [1 35] His goal of chemical total protein synthesis could not be achieved 
using the techniques available at that time; an 18mer was the greatest polypeptide that 
was constructed. Fischer was unable to create a protein because traditional liquid phase 
chemistry cannot provide the level of reaction efficiency required to synthesise these 
macromolecules. The synthesis of large polymeric materials requires very high 
monomer coupling efficiencies and minimal loss of product material through 
purification. The introduction of Solid Phase Peptide Synthesis (SPPS) by Merrifield in 
1963 was the paradigm shift required to address these issuesJ136] Merrifield realised that 
immobilisation of a growing peptide upon an insoluble polymer matrix allows the use of 
excess reagents to maximise coupling efficiencies; the product can be filtered away 
from excess reagents at the end of the reaction. The techniques and chemistries involved 
with SPPS have constantly been improved and expanded, but it remains unable to yield 
peptides within the size domain of proteins. [122. 123, 125, 137] 
The linear stepwise assembly of amino acids becomess problematic as the growing 
peptide chain becomes more protein-like in size and structure. When the polypeptide 
attains a certain size (usually 5-15 residues in length) it begins to adopt a secondary 
structure via non-covalent forces (eg hydrogen-bonding). The N-tenninus (upon which 
the ch~in is grown) becomes obstructed and coupling efficiencies are dramatically 
lowered, resulting in failure sequences. This is known as a difficult coupling.[138-141] The 
accruement of failure sequences is fatal to the synthesis of polypeptides because they 
are not easily separated from the product peptide. This is generally overcome by 
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'capping' unreacted amino tennini with acetic anhydride/diisopropylamine to give the 
unreactive N-acyl carbamate. Capped sequences do not take part in any further peptide 
chemistry and provided they do occur near the end of a sunthetic sequence, are 
separable from the product sequence by preparative HPLC. 
Techniques such as backbone-modification or addition of chaotropic salts counteract the 
aggregation of peptides by disrupting the internal hydrogen bonding network.[142.144] 
However, the occurrence of difficult couplings becomes increasingly regular with 
increasing chain length, and linear SPPS is limited in practice to the synthesis of 40-
SOmers. 
To overcome the size limitations of linear SPPS, the convergent synthesis of shorter 
polypeptide chains is required. Large peptides with protected side-chains are not 
suitable for convergent peptide synthesis because they are not readily soluble. 
Removing the hydrophobic protecting groups will restore the aqueous solubility of a 
peptide but also creates the problem of controlling the regiochemistry of the ligating 
(unprotected) peptides. The solution requires that the ligating termini of the peptides are 
mutually and exclusively reactive; that is to say unreactive with the unprotected 
sidechains but not with each other. 
A number of strategies have been published that utilise chemos elective reactions to 
overcome the regiochemical issues when joining peptides together.[14S. 146] However 
these generate unnatural backbone linkages that are not always tolerated for the 
purposes of the peptide being synthesised. Ultimately, technology is required that 
provides a natural (native) peptide linkage post-ligation for maximal utility in modem 
peptide and protein chemistry. 
Research by Bauer et al. in 1953 set forth the beginnings of Native Chemical Ligation, a 
chemo and regioselective technology that allows for the ligation of unprotected peptides 
to give a target polypeptide with no unnatural backbone linkages. [147] Bauer found that 
(in aqueous solution) valine, activated as the thiophenol ester, would undergo addition-
elimination with the sidechain thiol of cysteine to give a S-linked adduct of the two 
amino .!lcids. This adduct would then undergo S -+ N-acyl-transfer to give a native Val-
Cys dipeptide. (Figure 1.35). 
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Figure 1.35 Bauer native peptide bond formation 
The work of Bauer was first extended to polypeptide synthesis by Kemp et al. [148-151] 
Modifying the thiol exchange/rearrangement idea, a peptide containing a terminal 
cysteine was captured by a thiol-containing auxiliary that was O-linked to another 
peptide. The auxiliary served to hold the peptide fragments in close proximity to 
facilitate the acyl transfer (Figure 1.36) 
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Although Kemp used this technology in the synthesis of a 29 residue fragment of the 
bovine pancreatic trypsin inhibitor, ultimately the methodology was too elaborate to be 
used for general purpose peptide synthesis.l 152] The lengthy and non-trivial use of 
sulfur-deprotection and disulfide chemistry ultimately limited its applicability and 
potential. 
Kent expanded upon the work of Bauer and published an elegant solution with the 
introdu"Ction of cysteine-mediated Native Chemical Ligation (NCLi153] (Figure 1.37). 
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Taking the original chemistry reported by Bauer, Kent developed it further into a 
working technology that is able to ligate (relatively) large peptide fragments. 
A peptide bearing a terminal cysteine reacts reversibly with the thioester (under 
reducing conditions, to prevent disulphide formation) to join the two peptides together 
via thiol exchange. Spontaneous sulfur to nitrogen acyl shift forms a native peptide 
linkage between the two peptides and regenerates the cysteine side-chain. A number of 
small proteins have been synthesised using this approachJl54. 155] 
There are two potential drawbacks to this technology. The first is the difficulty III 
preparing large peptides as their thioester analogues. 
The second is that a cysteine residue is required to be present at the ligation junction, 
limiting the choice of target proteins to those that possess a cysteine residue suitably 
disposed along the peptide chain. 
The challenge of preparing peptides as their thioester analogues has been answered with 
more than one useful solution and both traditional SPPS techniques and biological 
. 
techniques have been employed for this cause. 
Traditional SPPS of peptidyl thioesters requires that a peptide is grown upon a solid 
support and subsequently cleaved from it under nucleophilic conditions. Using a thiol as 
a cleavage reagent, the peptide is liberated as a thioester (Figure 1.38). 
Oo~pePlidel .. o RS~ peptide) RSH 
Figure 1.38 Standard SPPS of thioester peptides 
The p'f0blem with this approach is that it is not compatible with basic fmoc-based SPPS 
conditions used for the majority of manual peptide synthesis. Ellman et at solved this 
issue by developing the 4-sulfamylbutyl "safety-catch" linker for use in SPPS of 
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thioesters.[I 56, 157] The 4-sulfamylbutyl aminomethyl resin used in this method can be 
loaded with an fmoc-protected amino acid using a standard DIC coupling and peptide 
elongation can be carried out using standard fmoc SPPS reagents and conditions. The 
"safety-catch" linkage is invulnerable to nucleophilic attack until it has been chemically 
activated (via mild alkylation conditions), after which the protected peptide can be 
cleaved by the sulfur nucleophile of choice (Figure 1.39). 
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Figure 1.39 Ellman "safety-catch" linker activation 
This method is used routinely to prepare sidechain-protectcd thioester peptide fragments 
of up to 50 residues (general SPPS size limit for peptides) in length. 
While NCL excels at joining short peptide fragments together, it is less able to effect the 
solution-phase ligation of larger peptide fragments together, with hydrolysis of the 
activated thioester rapidly becoming dominant with increasing peptide fragment 
size.[1 58] Muir developed an elegant semi-synthetic solution, expressed protein ligation, 
to overcome the stability and reactivity problems of larger peptide thioesters that restrict 
the size of pep tides accessible by NCL.[1 59, 160] Expressed protein ligation makes use of 
protein spli~ing, the process in which a protein undergoes an intramolecular 
rearrangment to excise an internal sequence (intein) and ligate the sequences that had 
previously flanked it (exteins) (Figure 1.40). 
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> 
Exteins ligate and extrude intein; 
protein splicing is completed 
Figure 1.40 Protein splicing - extrusion of intein protein sequence 
> 0 -
Protein splicing IS mediated in-vitro by a splicing protein. The pathway of intein 
extrusion is directly analogous to NCL, involving an activated thioester intermediate 
made from the C-terminus of one extein and the thiol sidechain of an N-terminus 
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cysteine of the intein (Figure 1.41). Muir evolved a strain of E. coli with a defective 
splicing protein that would express a desired recombinant protein but could only 
partially undergo intein extrusion. The mutant splicing protein was unable to effect the 
final acyl transfer step of the NCL-like extein ligation process - thus rendering the large 
recombinant protein as an activated thioester. Muir intercepted this reactive 
intermediate with thiophenol to (transiently) produce a very large recombinant peptide 
as its thioester. In addition to the thiophenol a synthetic peptide (bearing aN-terminus 
cysteine) was also administered to the mixture and reacted with the thioester via NCL to 
give a semi-synthetic protein. 
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Figure 1.41 Expressed protein ligation 
Semi-synthetic protein 
Using expressed protein ligation, Muir successfully ligated a phosphotyrosine peptide 
with a 50 kDa protein, C-terminal Src kinase, to create a semi-synthetic protein far 
beyond the size domain previously accessible by standard NCL chemistry.[J60] 
Traditional NCL is not only dependent on access to thioester peptides, but also requires 
the N-terminus residue of the partner peptide to be cysteine. Both Kent and Dawson 
moved to overcome the limitation of cysteine-dependence by attaching cleavable thiol 
auxiliflt:y units to the N-terminus of a peptide to imitate the function of a cysteine side-
chain. The chemical premise of thiol exchange and acyl shift are preserved, but the 
amino acid side-chain is no longer involved in the reaction (Figure 1.42). 
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30 can be cleaved using TF A after acyl transfer has occurred; the benzylic amine bond 
is rendered sufficiently labile for proto lysis upon formation of the amide. 31 requires 
treatment with HF for cleavage, although if an additional methoxy substituent is placed 
at the 2 position on the ring, TF A can be used instead. The Kent auxiliary was used 
successfully in a series of test-ligations and later in the synthesis of a wild-type 
cytochrome b562 protein[161] and an unnatural variant (Met -7 SelenoMet substitution at 
position 7). The 106 residue protein was synthesised in two halves, cyt b562[1-63] and 
cyt b562[64-106], and converted to the benzyl thioester and auxiliary-linked units 
respectively. Ligation under aqueous conditions (pH 7.5 buffered) proceeded to give 
the target protein via formation of a His-Gly junction. Dawson applied his auxiliary 
during the synthesis of the SH3 domain of a-spectrin.l 161 ] The 62 amino acid unit was 
divided into the fragments a-spectrin[ 1-27] and a-spectrin[28-62] and converted to the 
thiophenol thioester and auxiliary linked derivatives, respectively. Ligation across a 
Lys-Gly junction and subsequent TF A cleavage of the auxiliary proceeded smoothly to -
give the SH3 domain of a-spectrin. 
Auxiliary-mediated NCL has addressed some of the problems associated with 
convergent peptide synthesis, but there remains scope for improvement. The Kent 
auxiliary is prepared as a racemate to give diastereomeric peptides when attached; this 
complicates HPLC and NMR analysis. Both auxiliaries are sensitive to steric bulk about 
the ligation junction and require one of the ligating residues to be a Gly to effect an 
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efficient ligation. The synthesis of thioesters is difficult, and as of yet there is no good 
method to synthesise a protected thioester that would allow multicomponent 
synthesis. [162] 
1.4 Project Aims 
The chemical synthesis of proteins holds the potential to access structures not accessible 
using biological methods. However current chemical methodologies are limited to the 
synthesis of small proteins of low molecular weight that are not representative of the 
majority of protein targets. It is clear that a new methodology is required that can enable 
the multt-component convergent synthesis of polypeptides. 
This project aims to overcome the size restrictions of current techniques by developing 
methodology that will enable the programmed ordering (to arrange in a desired 
sequence) and simultaneous ligation of multiple unprotected polypeptides (Figure 1.43). 
Mixture of 
short peptides 
Programmed recognition 
and self assembly amongst peptides 
Simultanaeous and spontaneous 
ligation of peptides to give protein 
Figure 1.43 Idealised schematic of peptide self-assembly and ligation 
It is thought that the simultaneous ligation of several smaller polypeptides will avoid 
solubility and ligation difficulties encountered with the stepwise assembly of a fewer 
larger peptides. 
1.4.1 Concept and theory 
In order to effect the self-assembly of peptides into a specified sequence, the peptides .-
will have to be tagged with programmable auxiliaries. These units will template the 
directed sequencing and auto-ligation of the peptides. The auxiliaries will ideally be 
~ 
removable under mild chemical conditions. 
Liu et at have demonstrated that DNA can orchestrate a programmed reaction 
exclusively between two specific reactants within a diverse mixture of mutually reactive 
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partners (vide supra). However, DNA is not suited for use in this project as the 
conditions for SPPS and DNA synthesis are very different; creating a peptide-DNA 
chimera would be non-trivial. [72, 163] An alternative nucleic acid based directing group 
that is fully compatible with SPPS protocols is PNA. PNA has been shown to be an 
excellent DNA mimic that exhibits enhanced selectivity and thermodynamic stability 
(vide supra) when complexed to oligonucleotides. 
It is proposed that attaching PNA via some linker unit to a peptide will enable the 
hybrid to selectively anneal with a peptide bearing the complementary PNA strand. The 
peptide - PNA chimeras will be synthesised upon a solid support using standard Fmoc 
chemistry (Figure 1.44). 
C - terminus C - terminus 
N - terminus 
N - terminus 
Figure 1.44 Solid supported synthesis of PNA-peptide chimeras 
The annealed duplex PNA will hold the peptides termini in close sustained proximity 
driving a pseudo intramolecular acylation to form a native peptide bond. Tagging PNA 
strands on the C and N terminus of a peptide should allow the cascade ligation of 
peptides at both junctions; this would allow the simultaneous ligation of multiple 
peptides (Figure 1.45). 
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Figure 1.45 PNA directed ligation of peptides 
The ligation reaction has been designed such that it will be proximity driven. The 
C-terminus peptide will be joined to the PNA via a phenolic ester linkage; it is believed 
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that this will spontaneously react with the N-terminus of a partner peptide when held 
close together to form the native peptide bond. The linker units will be designed with 
the assistance of computer modelling. A crystal structure of a PNA duplex will be used 
as a scaffold upon which the linkers will be 'grown' from either terminus toward a 
partially ligated peptide (Figure 1.46).[164] 
~--------------- - -----.-.-- ~ o 
o 
o 
PNAduplex 
I Peptide I,,:J-0H ~. l'\ 
~ '" rf''N 
I ~eptide l 
Tetrahedral intermediate dosely models ligation 
transition state 
Figure 1.46 Design of linker units upon a PNA duplex 
The linkers will meet at a motif representing the addition of the N terminus amine of 
one peptide to the C terminus phenolic ester of the other peptide. This tetrahedral unit 
models the transition state of the ligation. Designing the linkers to occupy the space 
between the PNA helix and this unit will maximise the probability of a proximity-driven 
ligation upon duplex formation; at equilibrium, the reacting centres will be at the 
transition-state reaction coordinate. Ultimately, a mixture of unprotected peptides 
. 
tagged with the appropriate PNA directing groups will be spontaneously ordered and 
ligated to yield a target protein (Figure 1.47). 
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PNA-peptide chimeras are mixed together In an 
aqueous buffer 
~1l 
The reaction Is cooled slowly to allow the hybrids to 
locate their partners ...... 
The PNA directing groups are cleaved from the 
polypeptide ..... . 
The solution is heated to overcome non-specific 
interactions and allow free movement between chains 
.... at a critical temperature the helices anneal, 
prompting spontaneous and simultaneous ligations 
... the protein is then purified and folded Into its 
native tertiary structure 
Figure 1.47 Chemical total protein synthesis directed by PNA 
The proposed methodology provides a number of advantages compared to the prior art. 
No noxious and difficult thioester/thiol chemistry is required and the methodology will 
also deliver a much higher degree of convergence; potential targets could be much 
larger than those previously achieved. Furthermore there is broad scope for the 
introduction of unnatural components into a protein eg probes, non-genetic amino acids, 
carbohydrates 
The success of DTS by Liu et al. and the nature of the proximity-driven acylation in 
ribosomal peptide synthesis supports strongly the hypothesis that PNA-directed peptide 
assembly is a fully viable strategy for protein synthesis. 
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Results and Discussion 
Chapter 2 
Chapter 2 - Results and Discussion 
The first objective for the project was to establish reliable synthetic routes for the 
synthesis of the four PNA monomers and prepare them in multigram quantities. 
2.1 Synthesis of PNA monomers 
PNA monomers are commercially available as the Bhoc protected nucleobase / Fmoc 
protected backbone monomers (Figure 2.1). This orthogonal protection Scheme allows 
the use of standard SPPS reagents and materials for the construction of PNA oligomers 
under relatively mild conditions. Fmoc protection (ie base labile) of the aminoethyl 
glycine (AEG) amino group is vital for the PNA to be useful in this project. Reagents 
used for PNA oligomerisation must not repeatedly or excessively expose the growing 
polymer to harsh acidic conditions; to do so would curtail the potential to involve other 
(relatively fragile) biological motifs, such as carbohydrates, within the scope of the 
methodology. 
NHBhoc 
~Nn 
N N O~ 
HO C N. /'-.. 
.2 ............... ......" -NHFmoc 
32 
A-PNA monomer £239 per gram 
):~hOC 
lN~O 
OO~ 
33 
G-PNA monomer £266 per gram 
o I[NH N~O 
O~ 
HO~N~NHFmoc 
34 
H02C ............... N~NHFmoc 
35 
C-PNA monomer £239 per gram T-PNA monomer £211 per gram 
Fig 2.1 Commercially available PNA monomers 
Multigram quantities of each monomer are required for this project and so the PNA 
must be prepared in house as the monomers are prohibitively expensive. This is more 
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readily appreciated if the cost of constructing a small PNA duplex is considered (Figure 
2.2). 
5 equivalents of monomer are used per coupling 
To synthesise 0.05 mmol of the duplex, 0.25mmol of each monomer is required -
0.50 mmol (A) : 0.50 mmol (T) : 0.75 mmol (G) : 0.75 mmol (C) 
Price per mmol of Monomer - (A) £173 : (T) £107 : (G) £197 : (C) £167 
TOTAL COST OF PNA USED TO MAKE 50 JlMol OF DUPLEX - £413 
Figure 2.2 Cost of PNA monomers used in synthesis of a small PNA duplex 
The example highlighted in Figure 2.2 is scaled for use in a single test reaction. If the 
reaction _were scaled to preparative amounts (1 mmol or greater), the cost would 
increase 20 fold, or greater, per duplex. 
Clearly, there was a significant financial cost that required that the PNA monomers to 
be synthesised in-house. However, it should be noted that synthesis of the linker units 
required the knowledge of how to synthesise PNA monomers because they (the linkers) 
are modified PNA monomers themselves. Without being able to synthesise PNA 
therefore, the linker units could not have been made and the project could not have been 
attempted. There was therefore a synthetic requirement that was as equally compelling 
as the financial premise for the synthesis of the PNA monomers. 
Syntheses of -the commercially available PNA monomers have not been published, 
however PNA monomers bearing different amine protecting groups have been 
described. [1-7] 
Thompson et al. published the synthesis of PNA monomers that used a CBz 
(nuc1eobase)/Fmoc (backbone) protection Scheme and these were thought suitable for -
our needs.[6] These monomers retain the critical Fmoc protection for the AEG, but 
exchange the mild acidic conditions of Bhoc Cleavage (10-20% TF A in CH2Ch) for " 
neutral hydrogenation removal of the CBz group. 
Thompson details full syntheses of the backbone and nuc1eobase acids however 
Dueholm has reported the synthesis of PNA monomers bearing a CBz 
(nuc1eobase)/BOC (backbone) protection SchemeP] The BOC protected backbone is 
unsuitable for this project but the reported syntheses of the CBz-protected nucleobases 
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are more efficient than those of Thompson. The synthesis of the monomers was 
therefore comprised from a combination of the Thompson and Dueholm procedures to 
maximise the efficiency of the procedures. 
The synthesis of PNA monomers was broken down into three parts - synthesis of each 
nucleobase acetic acid, synthesis of the backbone and coupling of each nucleobase to 
the backbone. 
2.1.1 Synthesis of CBz Protected Nucleobase acetic acids. 
2.1.1.1 Thyminyl Acetic Acid 
Thymine is unique among the four nucleobases in that it lacks an exocyclic amino 
group and does not require a protecting group for inclusion with the Thyminyl PNA 
monomer. Thymine was alkylated with methyl bromoacetate in the presence of 
potassium carbonate to give the intermediate ester 37. Hydrolysis of 36 under harsh 
alkaline conditions gave the target compound upon acidification (Scheme 2.1). The 
crude product was contaminated with inorganic salts that are removed by aqueous 
washes on a sinter funnel - this also removed some product from the isolated material. 
0 
(i) 
'CNH .. N~O 
yO 
OMe 
36 37 
Not isolated 
(i) DMF, K2C03, Methyl bromoacetate, RT, 18 h 
(ii) 2M NaOH , 1 aaoc, 1 a min 
Scheme 2.1 Thymine acetic acid synthesis 
. 
0 
(ii) 
'CNH .. N~O 
yO 
OH 
38 
55% (62% Lit.) 
A more direct procedure by Finn that discarded the saponification step was investigated 
to improve the overall yield of 38 (Scheme 2.2). [8] 
56 
° + Br0 . 
OH 
39 
(i) H20, 36, 2M KOH (Aq.), 40°C, 30 min 
(ii) Cool to RT, 2 h 
(i-iii) 
(iii) Conc. HCI, filter off 36 at pH 5.5; cool to -4°C add conc HCI 
until pH 0, 2h stirring 
Scheme 2.2 Improved thymine acetic acid synthesis 
H 
0yNyOo 
~NJOH 
38 
65% (85% Lit) 
36 was dissolved in aqueous potassium hydroxide and alkylated with 39. 38 was 
isolated upon acidic work up without inorganic salt contaminants and in slightly better 
overall yield. The procedure however involves a difficult workup to remove unreacted 
36 from the reaction and results in the loss of some product. Although this method gives 
a slightly greater overall yield, the simpler procedure of Dueholm was preferred and 
used as the method of choice. 
2.1.1.2 CBz-protected Cytosyl Acetic Acid 
40 was stirred in pyridine at O°C and treated dropwise with CBz chloride to give the 
desired carbamate 41. Alkylation of 41 with methyl bromacetate was then attempted 
(Scheme 2.3). 
(i) 
40 
NHCBz AN 
lNAO 
H 
37% (56% Lit) 
41 
(i) Benzylchloroformate, pyridine, RT, DoC, 24 h 
(ii) Methyl bromoacetate, K2C03, DMF, RT, 18 h (iii) H20/4M HCI (80:3, v/v), DoC, 15 min (iv) H20/2M NaOH (6:1, v/v), RT, 30 min (v) 4M PlCI 
Scheme 2.3 Dueholm CBz-cytosyl acetic acid synthesis 
(ii-v) 
------------------- .. 
~~BZ 
lNAO yO 
OH 
Trace (40% Lit) 
42 
57 
The results of Dueholm could not be reproduced. The reaction gave a complex mixture 
of products that were inseparable by chromatography. 
An alternative synthesis of 42 (Scheme 2.4) by Schwergold et al. was then attempted. 
(i-ii) 
40 
(i) NaH, DMF, ODC, 2 h 
~~ lN~O Oy 
OR 
43 R = Me: 56% (64% Lit.) 
44 R = Et : 39% 
(ii) Methyl or Ethyl bromoacetate, RT, 16 h 
(iii) Benzylchloroformate, -15°C, DMAP, 15 min then RT, 6 h 
(iv) Dioxane, 1 M NaOH, RT, 16 h 
Scheme 2.4 Schwergold CBz-cytosyl acetic acid synthesis 
(iii) 
(iv) 
NHCBz AN lN~O Oy 
OR 
45 R = Me: 32% (77% Lit.) 
46 R = Et : 77% 
• 
NHCBz AN lN~O Oy 
OH 
81% (87% Lit.) 
42 
Cytosine was deprotonated with sodium hydride to allow the selective alkylation of the 
N-l nitrogen with bromomethylacetate. The crude product was recrystallised once to 
purity with aqueous methanol (l: 1). DMAP catalysed acylation of 43 gave N-7 
protected carbamate 45 as the major product. 45 was readily hydrolysed to give cytosyl 
acetic acid 45. Acylation of the exocyclic amine did not proceed as efficiently as stated 
in the literature - it was thought that the low solubility of the intermediate 43 was 
responsible for the low yield. The synthesis of homologue 44 was attempted with ethyl 
bromoacetate. It was thought that 44 would be more soluble in DMF and therefore 
react more readily with the acylating agent. Alkylation of 40 proceeded less efficiently 
than when using methyl bromo acetate but the acylation of 44 did indeed proceed with 
much improved yield. Hydrolysis of the esters 45 & 46 was found to be equally 
efficient and acid 42 was recovered in -80% yield irrespective of the starting material. 
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2.1.1.3 CBz-protected Adenyl Acetic Acid 
The procedure of Thompson was followed for the synthesis of CBz Adenyl acetic acid 
(Scheme 2.5). [6] 
(i-ii) 
• 
47 
(i) NaH, DMF, RT, 3.5 h 
(ii) Ethyl bromoacetate, <30°C, 19 h 
NH2 
%,~N~ 
N N~O 
OEt 
64% (73% Lit.) 
48 
(iii) Benzylchloroformate, DMAP, -15°C, 15 min then RT, 6h 
(iii) 
--------- ... 
Scheme 2.5 Attempted synthesis of Cbz-protected Adenyl acetic acid 
NHCBz 
%,'):N~ 
N N'-f0 
OEt 
No Reaction 
49 
Adenine was deprotonated at N-9 with sodium hydride and alkylated with 
bromoethylacetate to give 48. The acylation of the exocyclic N-6 amino group is 
difficult; it is only weakly nucleophilic and was found to be unreactive toward 
benzylchloroformate at RT under DMAP-mediated catalysis. At elevated temperatures, 
the reaction produced an inseparable mixture of products. The procedure of Dueholm 
stated that protection of the relatively unreactive amino group had been achieved using 
Rapoport's reagent 52. Thompsons route to 49 was exchanged for that of Dueholm and 
acylation of 48 was attempted with Rapoport's reagent. 52 is not commercially 
available, and was prepared according to the procedure of Watkins (Scheme 2.6).l9] 
0 0 0 (i) 
Nl'N
A OBn 
(ii) 8 )l 
CIAOBn 
• • Bj-~l'N OBn 
W W 
-100% crude (78% Lit.) Not isolated 
50 51 52 
(i) Imidazole (2.0 equiv.), RT, 1 h 
(ii) 1 M Triethyloxonium tetrafluoroborate in CH2CI2, O°C, 2 h 
Scheme 2.6 Synthesis of Rapoport's reagent 
-
Intermediate 51 was synthesised as a colourless oil that could not be recrystallised from 
petrol to purity as stated in the literature; it was found to contain trace impurities in the 
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IH NMR. Reagent 52 was prepared in-situ from crude 51 and combined immediately as 
a crude solution with a solution of 48 dissolved in DMF at O°C. The reaction failed to 
give clean acylation as expected but rather gave an inseparable mixture. The high-
reactivity and low stability of reagent 52 is believed to make this reaction capricious 
and unreliable. An alternative acylation reagent was sought, and the analogous salt 50 
utilised by Haaima was prepared (Scheme 2.7) from the previously synthesised 51. 
(i) 
51 
(i) Methyl triflate, CH2CI2, DoC, 5 min 
Scheme 2.7 Preparation of alternative acylating reagent 
- 99% (Lit. Quant.) 
53 
Unlike 52, triflate salt 53 is an air stable solid that is easily handled and was used 
successfully to acylate 48 (Scheme 2.8). Hydrolysis of 49 under standard conditions 
gave the the CBz protected adenyl actic acid 54 in moderate yield. 
(i) 
48 
(i) 53, DMF, DoC, 18 h 
(ii) Dioxane, 1 M NaOH, RT, 16 h 
NHCBz 
t~N~ 
N N'--f0 
OEt 
70% (73% Lit.) 
49 
(ii) 
Scheme 2.8 Completed synthesis of Cbz-protected Adenyl acetic acid 
2.1.1.4 Oxybenzyl Guanyl acetic acid 
.. 
NHCBz 
t~N~ 
N N~O 
OH 
70% (Lit. 104%) 
54 
Dueholm and Thompson did not prepare the same Guanyl acetic acid derivitive to 
synthesise their respective PNA monomers (Figure 2.3). 
60 
fN~NH 
(JlNANHC8Z 
C02H 
55 
OBn 
~N+N NJlN~NH 
" 2 C02H 
56 
Thomson's guanyl acetic acid Dueholm's guanyl acetic acid 
Figure 2.3 Different guanyl acetic derivitives 
Thompson prepared CBz guanyl acetic acid over 4 steps (Scheme 2.9). 
CI CI 
N:(:N (i) N:(:N ~ I ~ I 
N N~NH .. N N~NH H 2 ~ 2 
57 
(ii) 
.. 
59% (Lit.) 
0 
(iii) Nt: (iv-vi) ~ I NH .. L NA NHC8Z .. t~NH NJlN~NHCBZ 
"rOH 
91 % (Lit.) o 75% (Lit.) 
(i) Allylbromide, K2C03, DMF (ii) 1 M HCI, reflux 
(iii) CBz-lmidazole, 18-crown-6, KH, THF 
(iv) 0 3, CH2CI2, MeOH 
(v) Me2S 
(vi) NaC102, NaH2P04, H20, THF, (CH3bOH, 2-methyl-2-butene 
Scheme 2.9 Thompson synthesis of guanyl acetic acid derivitive 
55 
56 was prepared by Dueholm in only two steps, albeit in less overall yield than 55 
(Scheme 2.10). 
61 
CI CI N£N (i) N£N ~ I ~ ~ I 
N NANH N NA NH2 H 2 ~OH 57 
0 
49% (Lit.) 
58 
(i) Bromoacetic acid, K2C03, DMF, RT, 2 h 
(ii) Sodium, benzyl alcohol, aoc, 1 h 
(iii) Recrystallise from ethanol/water (3:1) at pH 2 
Scheme 2.10 Dueholm synthesis of guanyl acetic acid derivitive 
OBn 
(ii-iii) N£N ~ I 
N NA NH2 ~OH 
0 
52% (Lit.) 
56 
Dueholm stated that the exocyclic amine of guanine is unreactive toward solid phase 
chemistry reagents and does not need protecting. Thompson states that it is difficult to 
protect the amine but it is necessary to do so. Dueholm claimed that the oxybenzyl 
group, not present in 55, is crucial to the solubility of the final monomer. It was decided 
that the synthesis of Dueholm would be attempted first as it was the shortest synthesis. 
If 56 or its derived G-PNA monomer were found to be unsuitable for PNA synthesis, 
then the approach of Thompson would be used instead. 
Guanine cannot be selectively alkylated at the N-7 position; attempting to do so gives 
inseparable mixture of N-7 and N-9 isomers. [10] For this reason, the synthesis of any G-
PNA monomer described in the literature begins with 2-amino 6-chloropurine 57, a 
masked guani~e equivalent that can only be alkylated at the desired N-7 position. 
2-Amino 6-Chloropurine is commercially available but was not readily available in 
large quantities; 57 had to be synthesised in house. The synthesis of 57 is known 
(exclusively) in patent literature. Of the methods published, chlorination of guanine is 
the only suitable method to access multigram quantities of 57. [11-14] 
Initially the method of Reiner was attempted (Scheme 2.11) as this quoted the greatest 
yield.[14] 
62 
o 
(i-ii) Nt.: ~ I NH 
N NAN ..... ™S 
I I 
TMS TMS 
60 - Not isolated 
(i) DMF or DMA, HMOS, NH4S04, reflux, 4 h (ii) Distill off solvent and excess HMOS 
(iii) POCI3, TEBAC or TEBAB, MeCN, reflux 1 h (iv) Distill off excess POCI3, MeCN 
(iii-v) 
---------- ... 
(v) Neutralise with 2M NaOH then reflux until remaining organics distlled off 
Scheme 2.11 Reiner synthesis of 2-amino 6-chloropurine 
0% (80% Lit.) 
57 
This reaction was attempted first using the phase transfer catalyst TEBAC in both DMA 
and DMF. The method returned an insoluble brown fibrous precipitate upon the 
hydrolysis of the crude reaction oil at neutral pH. Repeating the experiments using the 
alternative catalyst cited by Reiner (TEBAB) in both DMF and DMA gave the same 
result. The precipitate could not be characterised. 
The less technically challenging but lower yielding procedures of Taketo were then 
investigated (Scheme 2.12). [13] 
0 CI 
l£NH (i) l£N NMe, • 
N A N A J H N NI:I2 H N N 
59 61 
(i) POCI3, DMF, 100°C, 5 h then neutralisation with NaHC03 
(ii) 35% HCI, RT, 20 h 
(iii) 25% ammonia (aq), 60°C 
Scheme 2.12. Taketo synthesis of 2-amino 6-chloropurine 
CI 
(ii - iii) N£N ~ I 
N NANH H 2 
0% (60% Lit.) 
57 
The reaction ultimately yields a dark brown solid that, despite attempts to purify, could 
not be characterised. 
The reaction was repeated without external heating (however the reaction is exothermic 
and th~ -temperature was elevated to 30DC). A pale yellow solid was recovered that was 
identified as 2-formaminidineamino purine 62 (Scheme 2.13). 
63 
This result demonstrated that the exocyclic amino group is readily reactive with the 
Vilsmeier reagent and rapidly generated an exocyclic formamidine. 
However, the guanyl oxygen did not react with the chlorinating agent until the reaction 
was heated to 95°C. Desired intermediate 61 was isolated as pale brown crystals strictly 
when the reaction was run above 95°C yet below 100°C; above 100°C the reaction 
yielded an unidentifiable and insoluble brown precipitate. It was also found that the use 
of fresh dry POCh is critical to the success of the reaction. 
0 CI 
<t£NH (i) • tJC:N NMe, ~ NA NH2 N A J H N N 
75% (75% Lit.) 
59 61 
(i) POCI3, DMF, 95DC, 5 h then neutralisation with solid K2C03 at ODC 
Scheme 2.13 Synthesis of key intermediate 61 
0 
t£NH NMe, 
N A J H N N 
62 
Intermediate 61 was treated with harsh hydrolysis conditions (as used earlier, Scheme 
2.12) and was destroyed. Slightly milder hydrolysis conditions (2M NaOH, 40°C) fully 
hydrolysed 61 into 59. 
Milder conditions for the hydrolysis of 61 were given in Taketo's patent (Scheme 2.14) 
and were used· successfully to convert 61 into 63 and then 57. 
CI CI CI 
fNJC:N NMe, (i) NJC:N 0 (ii) NJC:N ~ I A jJ • ~ I N A J N N N N NANH H N N H H H 2 
88% (70% Lit.) 
61 63 57 
(i) 12% a~tic acid, 70DC, 3 h 
(ii) 10% sodium hydroxide, RT, 2 h then conc. HCI 
Scheme 2.14 Mild hydrolysis of 2-formaminidineamino purine 
Thorough washing and drying of the intermediate 63 was found to be critical to the 
success of this reaction; acetic acid interfered with hydrolysis of the formyl group. 59 
and 57 are very difficult to difficult to dry (and therefore handle) on a large scale due to 
64 
agglutination problems. It was found that briefly heating 57 in water at 85°C and then 
rapidly chilling to RT solved the agglutination problem. 
With precious 57 in hand, a guanyl acetic acid derivative for the construction of a G-
PNA monomer could be synthesised. Initially the method of Dueholm (Scheme 2.11) 
was followed to gain access to target 58, however this work could not be reproduced. 
Alkylation of 64 was attempted to determine if the acetic acid could be introduced 
instead during the synthesis of 57 (to give 64 instead), but 64 could not be isolated 
(Scheme 2.15). 
CI 
#N-r\N NMe2 
'NJl .. A) H N N (i) -------- ... 
61 
(i) Bromoacetic acid, K2C03, DMF, RT, 3 h 
CI 
~N0N NMe2 NJl .. A ) 
)-
N N 
OH 
64 
o 
No reaction 
Scheme 2.15 Attempt to introduce acetic acid during the synthesis of 54 
Kofoed and co workers reported an improved synthesis of 57 in response to difficulties 
they encountered with the procedure of Dueholm (Scheme 2.16).£4] 
CI CI 
N:(:N (i) N:(: ~ I .. ~ I""N 
N NANH N NA NH2 H 2 
)-osn 57 
0 
47% (76% Lit.) 
65 
(i) Benzyl bromoacetate, K2C03, DMF, RT, 2 h 
(ii) Sodium, benzyl alcohol, DOC, 1 h 
(iii) Recrystallise from ethanol/water (3:1) at pH 2 
Scheme 2.16 Kofoed synthesis of guanyl acetic acid derivitive 
OBn 
(ii-iii) N:(:N 
_ .. _------ ... ~ I 
N NA NH2 
)-OH 
0 
N/A (83% Lit.) 
66 
65 was obtained in lower yield than that reported. It was then considered if the lower 
yield was due to 57 being of poor quality. To verify the purity of 57, 1.0 g of " 
commercially sourced 2-amino 6-chloropurine (Aldrich) was converted into 65. The 
yield obtained was identical, affirming that 57 was not the cause of the poor yields 
encountered. 
65 
The conversion of 65 into 56 was then attempted (Scheme 2.17). The reaction yielded a 
small quantity of crude material that contained intermediate 66 (as evidenced by crude 
NMR and MS analysis). However, after acidic recrystallisation, 66 was fully hydrolysed 
into 67 instead of giving 56. 
(i) 
• 
65 
OBn 
~N0N 
NJLNA NH2 ~OBn 
o 
25% (crude) 
66 
(i) Sodium benzyloxide (1 M) in benzyl alcohol, RT, 13 h 
(ii) Recrystallise from ethanol/water (3 :1) at pH 2 
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Scheme 2.17 Modified Kofoed synthesis of guanyl acetic acid derivitive 
Before the synthesis of 56 could be completed, the linker unit designs were generated 
and they were found to be incompatible with the CBz protected PNA monomer targets. 
Both of the linker unit designs were based on an aryl core with benzylic linkages. It was 
thought that the hydrogen lytic cleavage conditions required for removing the PNA Cbz 
protecting groups would almost certainly cleave the chimeras apart at these sensitive 
linker junctions (Figure 2.4). 
Q-i--p-ep-tl-'d-e--'r-~MJ::::se PNA 
H 
Q-i PNA ~~)('N~o-(~ __ pe~p_tid_e~ 
OO~V 
Nucleobase 
Linkers shown in bold - bonds sensitive to hydrogenolysis circled in red 
Figure 2.4 Linker deSigns - incompatible with Cbz protected PNA 
66 
A new set of PNA monomers that were compatible with the linkers were needed 
therefore to replace the redundant CBz protected monomers. 
A previously undiscovered patent by Coull detailing the synthesis of the commercially 
available PNA monomers 32-35 was foundPl Bhoc/Fmoc protected PNA is the most 
appropriate form of PNA for this project. Compared to the CBz monomers, Bhoc PNA 
has many advantages. One step global deprotection of chimera sidechains with 
simultaneous cleavage from solid support is possible, and without the use of heavy 
metals. Crucially the monomers would be compatible with the linker designs. 
The syntheses of the Bhoc protected nucleobase acetic acids was undertaken. The four 
nucleobases would be joined with the common backbone Fmoc AEG to give the four 
PN A monomers required. 
It should be noted that the experiences of the syntheses of the CBz-protected monomers 
were still valuable.; many of the intermediates were common to the preparation of the of 
the new target monomers. 
2.1.2 Bhoc-Protected NucIeobase Acetic Acid Synthesis 
2.1.2.1 Thyminyl acetic acid 
The T-PNA monomer described by Coull does not require protection and the thyminyl 
acetic acid 37 synthesised earlier using the method of Dueholm is suitable for its 
construction .. 
2.1.2.2 Bhoc Cytosyl Acetic Acid 
69 can be synthesised from previously prepared intermediate 44. The first challenge was 
to protect the exocyclic amine group of 44 with a Bhoc group. This was to be achieved -
by converting amine 44 into isocyanate 68 and quenching with benzhydrol (Scheme 
2.18). 
67 
N~ 
c~o f~ IN~O (i) eN IN~O 
yO yO 
OEt 
OEt 
Not isolated 
44 
(i) Carbonyl Diimidazole, DMF, RT, 1.5 h 
(ii) Benzyhydrol, 6aoC, 6 h 
68 
Scheme 2.18 Attempted Bhoc protection of 44 
NHBhoc 
eN IN~O (ii) 
----------- ... 
yO 
OEt 
0% (77% Lit.) 
69 
The fomiation of intennediate 68 was followed by tIc analysis of methanol quenched 
reaction aliquots and this appeared to be complete after lh. Recrystallisation of the 
crude orange oil from ethanol returned only starting material 44. 
A modified procedure by Wins singer was attempted wherein the benzyl cytosylacetate 
70 was used instead of 44 (Scheme 2.19).[I5l lt was thought that the benzyl ester would 
be much more soluble that 44, and thus its derived isocyanate would be present in 
solution in much greater quantity than 68. It was hoped that increased solubility would 
allow for benzhydrol to react with the isocyanate.and give the desired product. Ester 70 
was observed to have fully reacted with the carbonyldiimidazole after 2h. The 
isocyanate was then reacted with benzhydrol for 6h at 60°C. Quenching the reaction 
with methanol and recrystallising from ethanol only yielded starting material 70. 
f~ 
I N~O (i-ii) 
H • 
40 
(i) BuOK, DMF, 1 aaoc, 2 h 
(ii) Benzyl bromoacetate, 1 aoc, 3 h 
(iii) Coull conditions (Scheme 2.18) 
f~ IN~O 
oy 
OBn 
80% (91% Lit.) 
70 
NHBhoc 
eN 
(iii) IN~O 
-----------~ 
oy 
OBn 
0% (76% Lit.) 
71 
Schel'!l9 2.19 Winnsinger modification for Bhoc cytosine PNA monomer synthesis 
Recovery of the starting material led us to believe that the isocyanate was not being 
fonned. 
68 
(i) 
• 
70 
(i) Carbonyl Diimidazole, DMF, RT, 1.5 h 
(ii) Longer reaction time and/or heat? 
Figure 2.20 Isocyanate formation 
(ii) 
----------- ... 
72 73 
It was speculated that after the 1.5 h reaction of 70 with carbonyl diimidazole at RT that 
the starting material had been fully converted into intermediate 72, and not 73 as 
required (Scheme 2.20). To explain the recovery of starting material, 72 was assumed to 
be (effectively) unreactive at RT or 60°C and was hydrolysed back to 70 during aqueous 
recrystallisation at the end of the reaction. It was therefore required to determine a 
method of converting 72 into 73. 
It was suspected that a longer initial reaction time would allow 73 to form in useful 
quantities and that 73 would react with benzhydrol as desired. The reaction was 
repeated with .an initial aim of allowing 24 h to preform 73. 
However after 5 h stirring at RT, the reaction rapidly solidified to become an immobile 
colourless mass (Scheme 2.21). The Rf(ethyl acetate) of the original (single component) 
reaction mixture after 1.5 hr was 0.20. After 5h that spot had disappeared and one new 
component was then observed at an Rf of 0.40. Under the assumption that 73 had now 
formed, benzhydrol was added and the temperature was raised to 60°C. The colourless 
solid melted between 40 and 55°C and after 6h of continuous heating,71 was obtained in 
good yield. 
69 
~~ NHBhoc eN 
I N~O (i)-(iii) IN~O 
.. 
yO yO 
OBn OBn 
82% (76% Lit.) 
70 71 
(i) Carbonyl Diimidazole, DMF, RT, 5h 
(ii) Benzyhydrol, 60°C, 6h 
(iii) Methanol quench, recrystallization (MeOH/H20, 3:1) 
Scheme 2.21 Bhoc protection of benzyl cytosylacetate X 
• < I R,0.40,5h 
• < I R,O.20, 1.5h 
- t- - + - Eluent: EtOAc/petrol (1 :1) 
The procedure of Winssinger was followed further to carefully hydrolyse 71 and 
complete the synthesis of 73, although this was not without complications (Scheme 
2.21). (15] The rapid hydrolysis was monitored regularly for the total consumption of 71 
and quenched immediately with 20% citric acid solution (to prevent the hydrolysis of 
the Bhoc group). Bhoc cytosyl acid 73 was recovered initially as the citrate adduct 72. 
The citric acid would interfere with the final step of the monomer synthesis and had to 
be removed. 
NHBhoc 
AN lN~O 
oy 
OBn 
71 
(i), (ii) 
(i) O°C, LiOH solution, pH 14, - 6 min 
(ii) 20% citric acid solution 
(iii) Saturated brine 24h 
Scheme 2.22 Benzyl ester hydrolysis 
(iii) 
.. 
72 
OH 
83% (93% Lit.) 
73 
Unfortunately the hydrolysis reaction cannot be quenched by any other acid than citric 
acid. It was found that other acids (acetic acid, hydrochloric acid) in varying 
concentrations (O.OIM-IM) would partially or fully remove the Bhoc group below pH 5 
and 73 would not precipiate above pH 3. Citric acid has a high affinity for 73 and could 
not be washed out with water or weakly basic solutions (Na2C03, NH4Cl). Strong base 
solutions (Eg KOH, NaOH, 25% NH3(aq)) dissolve the salt and destroy the Bhoc group. 
70 
Hydrophobic 73 was slurried with a minimal amount of saturated brine and stirred at 
RT for 24 h. After 6 h most of the citric acid had been sequestered by the sodium 
chloride solution (as evidenced by NMR). After 24 h 73 was recovered by filtration and 
no traces of citric acid were detectable by NMR. 
2.1.2.3 Bhoc Adenyl acetic acid 
Using intermediate 48 (synthesised earlier), the target 75 was made according to the 
method of Coull, albeit with some modifications (Scheme 2.23).(7] Intermediate 74 did 
not crystallise upon quenching of the reaction with water as stated in the literature. The 
crude sticky yellow oily gum that formed instead was intractable and found to be 
soluble only in DMF and DMSO. This material could not be purified by means of 
recrystallisation or chromatography. With some effort, it was found that quenching the 
reaction with a solution of water/acetone (1: 1) effected the crystallisation of the crude 
compound. 
NH2 Bh~ Bh~ 
t=n:J N "N N "N (i-ii) ~ I (iii-iv) ~ I N N .. N .) N .) 
(C02Et 
( N ( N 
C02Et C02H 
65% (75% Lit.) 99% (Lit. 90%) 
48 74 75 
(i) Carbonyl diimidazole, DMF, 105°C, 2 h 
(ii) 105°C -> 95°C then benzhydrol, cool to RT over 16 h; H20/acetone (1:1) quench (iii) LiOH, O°C, 6min then 20% citric acid, 2 h 
(iv) Saturated brine, 18 h 
Figure 2.23. Coull synthesis of Shoc adenyl acetic acid 
The impurities formed an oil in this solvent mixture and upon standing were partitioned -
as the less dense layer and decanted from the solid product. The crude amorphous 
product was recrystallised to purity from ethanol to give 75. 
2.1.2.4 ,!3hoc GuanyI acetic acid 
The procedures of Coull and Wins singer both use triphosgene as the reagent of choice 
for the formation of guanyl isocyanate formationY· 15] Triphosgene is a crystalline 
71 
reagent that is, as the name suggests, a phosgene equivalent. Under standard reaction 
conditions, triphosgene will react with an amine to form an isocyanate and in doing so 
generates two equivalents of phosgene in-situ (Scheme 2.24). 
CI CI 
N:(:N (i) N:(:N ~ I ~ I ~ ,C~O 
N N~NH N N N' ( 2 ( 
C028n C028n 
[CI~p1 [ fNEtiPr2 ] (ii) (OH • CI~CI CI 
(i) C03(CCI3h, dimethylformamide, O°C, 30 min 
(ii) Diisopropylethylamine 
Scheme 2.24 Isocyanate formation with triphosgene 
Although triphosgene is easier and safer to handle than phosgene solution, it still 
requires very careful use and represents a significant potential hazard for use in large 
scale chemistry. The literature does not mention the use of any other reagents or 
methods for converting 65 to 76. It was thought worthwhile to attempt the 
transformation using the conditions for making 76; these would be safer and scalable 
conditions (Scheme 2.25). 
(i-iii) 
----------- .... 
65 
(i) Carbonyl diimidazole, DMF, 105°C, 2 h 
CI 
~N+N 
tJLNANHBhOC 
C028n 
No reaction 
76 
(ii) 105°C -> 95°C then benzhydrol, cool to RT over 16 h 
(iii) Ethanol quench 
Scheme 2.25. Investigating the use of carbonyl diimidazole for isocyanate formation 
The reaction was not successful, demon stating that the relatively unreactive C-2 amine 
group of guanine required the more ~active triphosgene to undergo isocyanate 
formation. The method of Winssinger was used, with some modification, to obtain 76 
72 
(Scheme 2.26).[15] 76 was purified by recrystallisation from methanol in the literature 
procedure, but this was found to be difficult and unreliable. Changing the 
recrystallisation solvent to acetonitrile was found to improve the reliability of the 
purification, albeit in lower yield (35%) than the cited literature recovery of 76 (63%). 
The mother liquors can be concentrated and recrystallised for further recovery of up to 
15%. It was found that direct purification of the crude reaction mixture by 
chromatography reliably gives an acceptable yield of 55% of 76; this was deemed the 
most suitable method for purification of 76. 
CI CI 0 
N=CN N=CN N£ !( I - (i-iii) !( I (iv-vii) • !( I NH 
N NANH Z. NANHBhOC Z. NANHBhOC 
" 2 C02Bn C02Bn C02H 
55% (63% Lit.) 82% (Lit. 86%) 
65 76 77 
(i) Triphosgene, THF, DoC, 1 h 
(ii) Diisopropylethylamine, DoC, 30 min 
(iii) Benzhydrol then warm to RT over 16 h 
(iv) NaH, 3-hydroxypropionitrile,THF, -78DC then add 76, warm to ODC and stir 2.5 h 
(v) Benzhydrol then allow to warm to RT over 16 h 
(vi) Quench with 10% citric acid (aq.) 
(vii) Saturated brine solution, 24 h 
Scheme 2.26 Modified Winssinger synthesis of Bhoc guanyl acetic acid 
76 was transformed into the target guanyl acetic acid 77 by reaction with 3-
sodiumhydroxypropionitrile at low temperature as according to the procedure of 
Winssinger. [15] 
2.1.3 Fmoc protected amino ethyl glycine 
The common backbone upon which the nucleobase acetic acids are grafted onto is 82. A 
number of different approaches to 82 have been reported in the literature. Initially a 
high yielding procedure by Xu et al. (Scheme 2.27) for the synthesis of PNA monomers 
with chiral backbones was thought to be suitable for modification for the synthesis of 
82. 
73 
(i)-(iii) FmocHN~CHO 
83% (Lit.) 
(i) Isobutylchloroformate, NMM, THF, -20°C, 15min 
(ii) NEt3 , HCI.NHMe(OMe), DMF, -20°C, 30min (iii) Lithium Aluminium hydride, THF, O°C, 30min 
(iv) 
.. 
85% (Lit.) 
(iv) Glycine ethyl ester hydrochloride, 10% Pd/C, hydrogen, MeOH, RT, 24h 
Scheme 2.27 Wu & Xu synthesis of chiral PNA backbone 
In place of alanine, Fmoc glycine would be used to allow rapid access to 81. Wu cites 
conditions for hydrolysis of the ethyl ester with minimal loss of the Fmoc group 
(Scheme 2.28). 
Me 
I (i),(ii) 
78 
.. FmocHN ~N'OMe 
o 
83% 
79 
(vi) H (v) 
,-------~ ./"'.... _N CO Et FmocHN' .......... ........"" 2 .-------~ 
81 
(i) Isobutylchloroformate, NMM, THF, -20°C, 15min 
(ii) NEt3, HCI.NHMe(OMe), DMF, -20°C, 30min (iii) Lithium Aluminium hydride, THF, O°C 
(iv) Glycine ethyl ester hydrochloride, 10% Pd/C, MeOH, RT 
hydrogen, O°C, 24h 
(v) 2.5M NaOH, H20ITHF, O°C, 5min 
Scheme 2.28 Modified Wu & Xu synthesis of PNA backbone 
(iii) FmocHN~ 
o 
85% 
80 
H 
FmocHN~N........""C02H 
82 
rNHFmoc 
FmocHN ~N ........""C02Et 
83 
The method of Wu was used to convert 78 into 80. Reductive amination of aldehyde 80 
with glycine ethyl ester did not give the desired product 81 using the literature 
conditions. The substance isolated was found to be the doubly-reductively aminated 
product 83. The secondary amine product 81 is much more reactive than the starting -
material (glycine ethyl ester) and thus cannot be isolated in the presence of the very 
reactive aldehyde 80. It is most likely that without substitution at the alpha carbon, 80 
cannot be prevented from further reacting with 81(Figure. 2.5). 
74 
Minimal repulsion; 
no barrier to imine NHFmoc 
formation "- " ~O 
,-, H 
FmocHN ~ N ............. C02Et 
Imine rapidly formed 
NHFmoc & easily reduced ~ ~<f)1 
FmocHN ~N ............. C02Et 
Alanyl sidechains clash and 
inhibit imine formation; 
Secondary amine can be 
isolated. 
Figure 2.5 Differences in reactivity between alanine and glycine derived aldehydes 
Thompson detailed a procedure for the synthesis of the 'butyl-ester 86 in his synthesis of 
Cbz protected PNA monomers. Protolysis of 86 with a strong acid (such as TF A) would 
give the desired backbone 82 (Scheme 2.29).[6] 
(i) 
84 
H 0 H2N~N00'Bu 
83% (83% Lit.) 
85 
(i) 'Butylbromoacetate, CH2CI2, O°C, 12 h 
(ii) 
-------,... 
(ii) FmocOSu, diisopropylethylamine, CH2CI2, O°C, 12 h 
Scheme 2.29 Thompson synthesis of Fmoc AEG; PNA backbone 
H 0 FmocHN~N00'Bu 
0% (50% Lit.) 
86 
o 
'BuO~ 
FmocHN~NFmoc 
87 
Low temperature addition of 'butylbromoacetate to a concentrated solution of 84 gave 
the intermediate 85 as reported. Selective protection of the primary amine of 84 (ahead 
of the neighbouring secondary amine) was attempted using the method described in the 
literature. That a primary amine was selectively protected over a (typically) more -
nucleophilic secondary amine was surprising. It was known from the synthesis of 83 
that the secondary amine of 85 would be very reactive. It was thought that the 
selectivity reported by Thompson must be due to a sensitivity of the protecting reagent 
toward ~steric bulk; that the 'butyl ester sterically shields the secondary amine from the 
FmocOSu. However, the mono-protection reported by Thompson could not be repeated 
using the conditions stated. Doubly protected ester 87 was the only product recovered. 
The procedure of Coull was then attempted. This was designed to overcome the 
75 
problem encountered with the previous synthesis; Coull masked the secondary amine of 
88 with a trimethylsilyl group before reacting with FmocOSu (Scheme 2.30). 
(i-ii) 
84 
H 0 H2N~N~OH 
45% (45% Lit.) 
88 
(i) Chloroacetic acid, 5°C, 18 h 
(iii-iv) 
(ii) Evaporate off excess ethylene diamine, trituration with DMSO 
(iii) Trimethylsilylchloride, DMF, 40 min 
(iv) DoC, FmocOSu then NMM, 2 h 
Scheme 2.30 Coull synthesis of Fmoc AEG; PNA backbone 
H 0 FmocHN~N~OH 
35% (53% Lit.) 
89 
Alkylation of 84 proceeded initially in higher yield than rep0l1ed - 65% of colourless 
crystals were recovered that were characterised to be pure by NMR, MS, LC-MS. 
However it was found that if this material is not recrystallised (ethanol/water, 2: I) to (at 
the expense of the higher than lit. yield), it would not react with silylating reagents to 
give 89. 
Treating 88 with trimethylsilylchloride selectively silated the secondary amme and 
carboxylic acid ahead of the primary amine. Treatment of the masked intermediate with 
FmocOSu resulted in only the free primary amine being protected. Methanolysis of the 
TMS groups afforded a colourless amorphous solid that was very insoluble in organic 
solvents and was difficult to characterise. The mass spectrum of the material was 
observed to Gorrespond to the mass of 89, however the NMR was very noisy and 
difficult to assign. Furthennore it was found that this material reacted very sluggishly 
with the nucleobase acetic acids in the final coupling experiments. Poor solubility of 
this material meant it was not suitable for the synthesis of the PNA monomers. It was 
not possible to find the direct cause for the insolubility, although it was suspected that 
byproducts from the silating agent were contaminating the sample and retarding its _ 
solubility. 
An analogous reaction by Breipohl that used bistrimetylsilylacetamide 90 in place of 
TMSCI as the silylating agent was attemptedY 6] Repeating the method of Breipohl gave 
89 as 'a 'colourless amorphous solid (Scheme 2.31). Characterisation of 89 (made using 
the method of Breipohl) was straightforward (the material was readily soluble in 
organic solvents) and proved the material to be pure 89. 
76 
(i-vi) 
" 
H ° FmocHN~N0oH 
65% (66% Lit.) 
88 
(i) N,O-bistrimethylsilylacetamide 90, DMF, RT, 40 min 
(ii) FmocOSu, DMF, RT, 3 h 
(iii) MeOH, H20, SoC, 10 min 
(iv) 6M HCI, O°C, 10 min 
(v) Evaporate to dryness then O°C, triturate with CH2CI2 
(vi) MeOH, sodium hydroxide, H20, O°C 
89 
Scheme 2.31 Breipohl synthesis of Fmoc AEG; PNA backbone 
Me3Si,O 
~N ... SiMe3 
90 
2.2 Nucleobase coupling onto the backbone - PNA monomer synthesis 
The final synthetic step for making each PNA monomer is the same. The nucleobase 
acetic acid is activated as a mixed anhydride and coupled to backbone 89 (Figure 2.6). 
-",-,-(i) __ [NUcleObasel:t j--,--(ii) _" 
° ° ° (i) NMM, Pivaloyl chloride, MeCN, -15°C, 30 min 
(ii) Triethylamine, backbone, MeCN/H20, RT, 1-18 h 
(Nucleobase 
O~N~NHFmoc 
l.C02H 
Figure 2.6 General method for coupling nucleobase acetic acids to Fmoc AEG 
The coupling reaction is not 100% efficient and the crude reaction mixture contained 
small amounts of starting materials in addition to amine salts and other byproducts. A 
PNA monomer and its two primary starting materials are carboxylic acids - purification 
of the monomers from byproducts and starting materials is thus not trivial. PNA 
monomers are very hydrophobic and sensitive to both basic and acidic pH conditions 
(by virtue of their protecting groups) and are only appreciably soluble in DMF and 
DMSO at RT; purification at neutral pH, given the poor solubilities, is not trivial. Each 
monomer required its own optimised set of conditions for purification. 
2.2.1 Thyminyl PNA monomer 
The four nucleobase acetic acids are coupled with the backbone using essentially the 
same reaction conditions (Figure 2.6). The three Bhoc protected nucleobase derivatives 
(73,75,77) required significantly more labour to prepare than thyminyl acetic acid 38. It 
77 
was decided to use the coupling of thyminyl acetic acid to 89 as a model system to 
establish good working conditions for the general coupling of nucleobase acetic acids 
onto 89. The reliable and reproducible synthesis of T -PNA would, in theory, minimise 
any potential loss of precious 73, 75 and 77 when the synthesis of the A,C and G PNA 
monomers was attempted. 
The procedure of Coull was followed (Scheme 2.32).[7] 
(i-iii) 
----------------~ 
38 
(i) Pivaloyl Chloride, NMM, MeCN, O°C, 25 min 
(ii) 89, NEt3, H20/MeCN (3:4), RT, 30 min (iii) Adjust to pH 3 with 3M HCI at O°C then stir at RT, 18 h 
Scheme 2.32 Attempted T-PNA synthesis 
o 
lC):o yOo 
FmOcHN~NJOH 
0% (65% Lit.) 
35 
The reaction did not give a colourless precipitate as stated. Instead a brown intractable 
sticky gum formed. Analysis of the crude reaction mixture indicated that a small 
amount of product had formed but it was not possible to recrystallise the gum from any 
common solv~nt. The reaction was thought to be failing for one or more reasons; 
Activation of the thyminyl acetic acid, to form the mixed anhydride, was not going to 
completion; unreacted pivaloyl chloride was affecting the reaction in some adverse way; 
the activated acetic acid was degrading into one or more byproduct(s) before 89 could 
react with it; backbone 89 free nitrogen could not be acylated with the anhydride. 
Activation of the thyminyl acetic acid was achieved by dropwise addition of pivaloyl 
chloride at O°C. The reaction turned gradually yellow and then brown over the 25 
minute activation period. It was known that the T-2 oxygen can react with the activated 
acid 9! Jo give an unstable intermediate (Figure 2.7). 
78 
o 
.. 'CJl N 0 Further reaction? 
~ 
91 
Figure 2.7 Possible degradation pathway of activated thyminyl acetic acid 
It was postulated that the yellow colour of the reaction was caused by the presence of 
the anhydride in the mixture and that a side reaction of the anhydride generated a brown 
byprodu.ct. The time required for the activation of 38 was examined to establish an 
optimal time for anhydride formation (Table 2.1). For all of the experiments 35 failed to 
precipitate during the reaction workup (as expected from the method given by Coull). 
Evaporation of each crude reaction gave a crude residue that was inspected for 35 by 
mass spectrometry. 
Reaction N° Activation time Reaction colour on Product detectable in mass spectrum of 
(min) addition of backbone crude reaction? 
5 No colour No 
2 \0 Pale yellow No 
3 15 Bright yellow Yes 
4 20 Brown/yellow Yes 
5 • 25 Brown Yes 
Table 2.1 Effect of activation time at O°C on anhydride formation 
Entry 3 in table 2.1 was thought to be the optimal reaction time. Analysis of crude 
reaction 3 by NMR estimated the product and starting materials to be approximately 
equimolar; no side products were apparent. Based on the evidence it appeared that the ~ 
anhydride decomposed as the reaction exceeded 50% completion. Suppression of the 
side reaction was achieved with temperature control. The reaction was performed at ., 
-15°C (ice/salt, 3:1) and took on a bright yellow colour after ten minutes, and remained 
so indefinitely at that temperature. After 30 minutes 89 was added to the reaction then 
and a1lowed to stir while reaching R T over 1 hr. The reaction was worked up, however 
after 48h the product had failed to precipitate. NMR analysis of the crude reaction 
mixture showed equimolar amounts of product and starting materials. Anhydride 
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formation should have been closer to completion gIven the greater reaction time, 
implying that another variable was affecting the yield of 35. 
It appeared that amine 89 was reacting sluggishly with the anhydride, possibly because 
the amine did not react well with, nor was easily acylated by, anhydrides. Additionally, 
the anhydride might be sufficiently sterically hindered to the point where the rate of 
amine acylation is retarded to be comparable with the rate of hydrolysis. 
An attempt was made to acylate 89 using acetic anhydride under the same reaction 
conditions (Scheme 2.33). 
. ° FmocHN~~~OH (i-iii) 
89 
(i) Acetic anhydride, triethylamine, H20/MeCN (3:4), -15°C, 25 min (ii) RT, 30 min 
(iii) Adjust to pH 3 with 3M HCI at O°C then RT, 18 h 
Scheme 2.33 Acylation of backbone with acetic anhydride 
yeo 
FmocHN~N~OH 
-60% 
92 
92 was obtained in approximately 3:2 ratio with unreacted 89. Given that acetic 
anhydride is both small and very reactive, this result suggests that steric congestion of 
91 was not to blame for incomplete acylation of 89. It is probable that the basic aqueous 
solvent necessary for dissolution of 89 is partially hydrolysing 91. N-Hydroxysuccimyl 
esters are known to be relatively stable in aqueous conditions and competent 
electrophiles for amines; the nucleophilicity of 89 could be better gauged by reaction 
with such an ester. Thyminyl acetic acid was converted to 93 and treated with the 
standard aqueous solution of 89 (Scheme 2.34). 
80 
" 
° 
° 
"CNH "CNH (i-ii) N~O 
° N~O • )'0:6 lC02H 
° 38 93 
(i) N-hydroxysuccinimide, NMM,CH2CI2, DoC, 5 min (ii) Dicyclohexylcarbodiimide, 30 min, RT 
(iii) 89, H20/MeCN(3:4), NEt3, 30 min 
(iii-vi) 
-------- ..... 
(iv) Adjust to pH 3 with 3M HCI at DoC then stir at RT, 18 h 
° 
"CNH N~O yeo 
FmocHN~NJOH 
35 
Scheme 2.34 Attempted T-PNA monomer synthesis via N-hydroxysuccinimyl Thymine acetate 
The reaction returned only starting materials. Intermediate 93 was not isolated but the 
precipitation of insoluble dicyclohexylurea before addition of 89 inferred its presence in 
the reaction. In hindsight, the use of CH2Clz as the solvent was probably to blame for 
the failure of the reaction. Backbone 89 is not soluble in CH2Clz and the reactants may 
have partitioned between the aqueous and chlorinated organic solvents in the reaction. 
It was decided to investigate the purification of 38 by chromatography. 
Chromatographic purification of 35 was not trivial and after a great deal of effort, 35 
was recovered pure in 10% yield. 
Synthesis of the other monomers was then attempted - revealing an interesting 
experimental detail, noted during the activation of Bhoc cytosyl acetic acid. Activation 
of the pyrimidine 73 was accomplished with inverse-addition of pivaloyl chloride; 73 
was added to pivaloyl chloride. An apparently innocuous difference at first glance, 
inverse-addition results in C-PNA precipitating readily from solution (vide infra) under 
the (nearly identical) reaction conditions used for T-PNA synthesis. Given the structural 
similarities between cytosine and thymine (and the urgent need for a better method to 
isolate T -PNA), the coupling of 38 and 89 was attempted with this method of activation 
in an otherwise unaltered procedure. The experiment was successful and the T-PNA 
monomer precipitated from the crude worked up reaction mixture and was recovered in 
45% yield. The reaction was repeated twice on large scale and the results were 
reproducible and reliable. 
81 
y y '-r-' Y 
1.82 4.32 1.95 1 
Y Y Y L,J '-r-' 
0.801 1.78 0.917 3.26 5.7 
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Figure 2.8. lH NMR spectrum of C-PNA purified by trituration 
2.2.2 Adenyl PNA monomer 
Initially the method of Coull was followed. (7) Activation of 75 at O°C gave similar 
problems encountered with the activation of 38; the crude anhydride became brown 
after 10-15 min and no product could be retrieved. Applying the modifications learnt 
during the synthesis of35, a crude mixture consisting mostly of A-PNA was generated 
(Figure 2.9) . 
-L 
y y y y y y ..,.. y y 
1.04 . 1.99 4.63 5.1 1.1 1 0.833 2.67 1.06 1.24 
Y Y Y Y Y Y Y Y Y 
I 0.909 2 6.81 0.985 0.82 0.906 0.86 1 1.85 
-,----.' . 0 I 0 , 1 1 1 I 1 
11 8 7 6 5 4 3 
Figure 2.9. lH NMR spectrum of impure A-PNA 
The purification method of Coull did not work. The crude reaction residue was 
dissolved in a minimum amount of hot methanol and added drop wise to stirred ice-
water. Recrystallisation of the recovered colourless precipitate was attempted from 
ether/dioxane; the recrystallisation caused the solid to oil and would not crystallise. 
Y 
0.941 
It was not trivial to separate 32 from the other components of the crude reaction mixture 
under the constraints imposed by the labile protecting groups (Figures 2.l0 and 2.11). 
82 
" 
NHBhoc NHBhoc 
>lyO t~N~ t~N~ FmocHN ~ N ",-/C02H N N N N 
yO ~C02H 94 
FmocHN ~ N ",-/C02H 75 I 
lNJ 32 H + eN) ~N COH ) FmocHN "'-/ 2 C02H 0 
89 
Figure 2.10 Crude reaction mixture components in A-PNA monomer synthesis 
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Figure 2.11 LC-MS traces of crude A-PNA 
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The crude reaction was dissolved in hot methanol and adsorbed onto silica to examine if "' 
the Bhoc group would survive flash chromatography. Despite rapid chromatograpghy, it 
was found that the Bhoc group was cleaved (Figure 2.12). 
83 
" 
I I I 
ppm a 7 6 
Figure 2.12. 'NMR sprectrum of deprotected A-PNA 
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Reverse phase chromatography was then investigated to detennine if it was viable to 
purify PNA in this way. Gradient elution enabled Smg of pure A-PNA to be 
successfully purified and recovered (Figures 2.13 and 2.14) 
I ppm a I 7 
NHBhoc 
~JCJ N N 
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Figure 2.13 'H NMR of A-PNA purified with reverse phase C-18 cartridge chromatography 
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Figure 2.14 LC-MS data for A-PNA purified with C-18 reverse phase chromatography 
84 
Although this method works, it is not suitable for the purpose of large scale purification. 
The maximum loading (20 mg) and yield (5 mg) were especially limiting considering 
purification required 45 minutes for one run and that upwards of 50mg were required 
per coupling per monomer. Another means of purification was sought. 
Given that the impurities were all soluble in aqueous acid (3M HCI), it was hoped that 
they could removed from the reaction mixture by dissolution in weakly acidic 10% 
citric acid solution. It was known that 32 was insoluble in citric acid solution and that 
the Bhoc group is stable for short periods of time in that media. The method devised 
was a modification of the Coull procedure whereby the crude reaction mixture was 
dissolve~ in a minimum amount of hot methanol but added to 10% citric acid instead of 
water. 
A methanolic solution of the crude monomer was added dropwise and a colourless 
precipitate formed upon contact with the cold stirred citric acid. LC-MS analysis 
showed a marked reduction in the level of impurities present in this material. After 2 
cycles of dissolution/precipitation, the material was sufficiently pure for PNA synthesis 
(Figure 2.15). 
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Figure 2.15. NMR spectrum and UV trace of A-PNA purified by trituration 
It is important to note is that all PNA monomers do not fly well under positive 
ionisation mass spectrometry conditions and are not readily observed. They are however 
85 
1/ 
(like the starting materials they are made from) UV active. A UV trace that only 
contains UV activity from the target monomer (and no signal from the materials used to 
make the monomer) is the most useful indication that the monomer does not contain any 
starting-material contaminants. 
Figure 2.15 showed that after two cycles of purification the material is essentially 
complete. There is a significant loss of material using this approach however; 
approximately 50% was lost before the desired level of purity is achieved. The process 
is scalable however and multigram quantities of pure A-PNA have been isolated in this 
manner. 
2.2.3 Cytosyl PNA Monomer 
In the same manner as all other PNA monomer syntheses, the method of Coull was 
found to work when the reaction temperature was lowered to -15°C. The reaction used 
inverse addition of the acid 73 to neat pivaloyl chloride to form the anhydride (Scheme 
2.34). The crude material required an additional24h stirring as a slurry in saturated 
brine to remove all the citric acid from the mixture. 
(i-iv) 
• 
73 
81% (89% Lit.) 
(i) NMM, MeCN, -15°C, 5 min, 34 
(ii) Add to neat pivaloyl chloride, -15°C, 25 min 
(iii) 89, H20/MeCN (3:7), triethylamine, RT, 30 min (iv) DoC, acidify to pH3 with 20% citric acid then stir 18 h 
Scheme 2.34 Modified Coull synthesis of C-PNA monomer 
After recovery from the brine, only 73 remained as a minor contaminant of the C-PNA 
(Figu~e~2.16). 73 could not be removed using the citric acid method. 
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Figure 2.16 LC-MS data of impure C-PNA 
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Acid 73j s sparingly soluble in all common solvents and difficult to remove from 34. It 
was found that warming the crude mixture in a minimal amount of DMF dissolved only 
34 and allowed the 73 to be removed by filtration. 34 could then be precipitated from 
the filtrate by dropwise addition to stirred ice water and was recovered with minimal 
loss of material. 
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Figure 2.17 NMR and UV data of C-PNA purified by trituration 
2.2.4 Guanyl PNA monomer 
Following the procedure of Coull, enhanced with the same modifications used to purify 
32 and 34, the G-PNA monomer was obtained (Scheme 2.35, Figure 2.18). 
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(i-iv) 0=0 N HN I ~ BhocHN ~ N yOo 
77 
(i) NMM, MeCN/OMF (3:2), -15°C, 5 min, 
(ii) Pivaloyl chloride, -15°C, 25 min 
(iii) 89, H20/MeCN (2:3) , triethylamine , RT, 30 min (iv) DoC, acidify to pH4 with 20% citric acid then stir 18 h 
Scheme 2.35 Modified Coull synthesis of G-PNA monomer 
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Figure 2.18 NMR and UV data of G-PNA purified by trituration 
2.3 Summary 
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The literature procedures had been found difficult to reproduce on a large scale. 
Extensive optimisation was required. Modified routes (Scheme 2.36) that are able to 
produ.ce all four PNA monomers on a multigram scale,were developed. Summaries of 
the routes are shown in Scheme 2.36 
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36 ° 
yNH lN~O 
H 
(i-ii) (iii-vi) 
• 
55% 
(i) DMF, K2C03, Methyl bromoacetate, RT, 18 h; (ii) 2M NaOH ,100°C, 10 min; (iii) NMM, MeCN 
, -15°C, 5 min;(iv) Add to neat pivaloyl chloride, -15°C, 25 min;(v) 89, H20/MeCN (3:7), NEt3, 
RT, 30 min; 
(iii-v) 
80% 68% 81% (89% Lit.) 
(i) tsuOK, DMF, 100°C, 2 h;(ii) Benzyl bromoacetate, 10°C, 3 h; (iii) Carbonyl Diimidazole, DMF, 
RT,5h;(iv) Benzyhydrol, 60°C, 6h; (v) O°C, LiOH solution, pH 14, - 6 min;(vi) NMM, MeCN, 
-15°C, 5 min;(vii) Add to neat pivaloyl chloride, -15°C, 25 min;(vii) 89, H20/MeCN (3:7), NEt3, 
RT, 30 min 
(i-vii) 
• 
76 CI 
~N-rN (viii-xii) Jt .. A ( N NHBhoc 
C02Bn 
° 
:O=N HN I ~ BhocHN ~ N lyoo 
FmocHN~NJOH 
33 
13% 40% 
(i) POCI3, DNlF, 95°C, 5 h then neutralisation with solid K2C03 at 0°C;(ii)12% acetic acid, 70°C, 
3 h;(iii) 10% NaOH(aq), RT, 2 h then conc. HCI;(vi) Benzyl bromoacetate, K2C03, DMF, RT, 2 h; 
(v) Triphosgene, THF, O°C, 1 h;(vi) Diisopropylethylamine, O°C, 30 min;(vii) Benzhydrol,warm to 
RT over 16 h;(vii) NaH, 3-hydroxypropionitrile,THF, -78°C then add 65, warm to O°C and stir 2.5 h; 
(ix) Benzhydrol then allow to warm to RT over 16 h;(x) NMM, MeCN/DMF (3:2), -15°C, 5 min; 
(xi) Pivaloyl chloride, -15°C, 25 min; (xii) 89, H20/MeCN (2:3), triethylamine, RT, 30 min 
(i-iv) (v-viii) 
G% n% 
(i) NaH, DMF, RT, 3.5 h;(ii) Ethyl bromoacetate, <30°C, 19 h;(iii) Carbonyl diimidazole, DMF, 
10s.°C, 2 h;(iv) 105°C -> 95°C then benzhydrol, cool to RT over 16 h;(v) LiOH, O°C, 6min;(vi) 
NMM, MeCN, -15°C, 5 min;(vii) Pivaloyl chloride, -15°C, 25 min; (viii) 89, H20/MeCN (1:1), 
NEt3, RT, 30 min 
Scheme 2.36 Summary of PNA monomer synthesis routes 
With the four PNA monomers in hand the synthesis of the linker units was undertaken. 
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Chapter 3 
Chapter 3 - Linker Synthesis 
Before the chimeras could be assembled, a pair of linker structures needed to be 
designed and synthesised. These linker units would be used to join PNA and 
polypeptides together so that PNA-directed ligation would be possible. The aim was to 
design and synthesise these linker units on a multigram scale. 
3.1 SPROUT aided design ofPNA linkers 
To enable PNA to direct the ligation of pep tides, the PNA cannot be attached directly to 
the peptides, intervening spacer units must be placed between each PNA strand and its 
associated peptide. These linker units perform two critical roles. The first function of 
the linker units is to bridge the inter-strand region and allow the peptides to meet and 
ligate. Each linker also acts as a temporary tether to allow attachment of the PNA 
directing groups to the peptides; post-ligation the linker can be induced to detach from 
the polypeptide, allowing the isolation of a natural peptide target. 
Design of the linker units is critical to the success of the ligation reaction as their 
structure and conformation will have a strong bearing on the ligation reaction. 
Computer aided design of the linker units was used to expediate the design of a pair of 
linker units that would promote the ligation reaction. The molecular docking suite 
SPROUT wa~ modified to accommodate this task. [I] It was thought that the quickest 
way to generate a pair of suitable linkers would be to modify the terminal PNA base-
pair from a PNA helix (Figure 3.1). By removing the ends of the PNA backbone but 
retaining the base pair a useful scaffold for growing the linkers would be generated 
rapidly. Furthermore, as these linkers are derived from a PNA helix, disruption to helix 
formation during a ligation experiment is minimised. 
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Figure 3.1 PNA duplex crystal structure 
A crystal structure of a short PNA helix (Figure 3.1) was uploaded into the SPROUT 
program and the C and N terminus from one end of the helix were trimmed back and 
tagged as the site of attachment (node) for each linker (Figure 3.2). 
- Unwanted portions of PNA 
c====> 
Figure 3.2 Modification of PNA duplex into partial linker units 
SPROUT was instructed to 'grow' the linker units simultaneously from both nodes and 
join together in the middle. Growth was subject to the restrictions that fragment 95 has 
to appear once and only once in the final bridging structure and that growth may not _ 
occur outside a well defined boundary (Figure 3.3). 
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Growth area boundary 
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Figure 3.3 Growth of linkers 
8 0 . 
.J<!:ePlide ~-o NHPeptide 
..L 
95 
Fragment 95 represents one of the two tetrahedral intermediates that could be formed by 
the addition of one peptide N-terminus to the activated C-terminus of another (bond 
formed shown in bold red in Figure 3.3); effectively the transition state structure. 
Inclusion of this fragment optimises the linker design to promote formation of the 
transition state structure and thus promotes the ligation reaction. Both enantiomers of 95 
were created and tested for each complete candidate structure generated by SPROUT. 
Growth is accomplished by SPROUT attaching a chemical fragment to a node (such as 
a methylene group), chosen from a preselected list, and determining if the choice is 
valid within the constraints mentioned. In the event of more than one chemical unit 
being valid, each was developed further as a separate candidate linker. Each candidate 
was then subjected to another round of 'growth', generating yet more candidates via 
branching pathways of structural diversification. The iterative process of growth and 
evaluation was continued until union of the developing node structures was achieved. 
At this point human judgement was employed to select a handful of linker candidates 
with suitable designs, from which the final linker units were derived. In the initial bout 
of candidate design, two sets of related linker candidates were deemed promising 
(Figures 3.4, 3.5). These linkers were chosen as they included an aryl core; this feature 
was desired to allow for the opportunity of post-ligation cleavage of the linker/PNA 
from the peptide by protolysis of the benzylic linkages (Figure 3.6). 
The two candidate structures were identical except that the aryl core of the PNA to 
peptide linker has a 1,4 (para) substitution pattern (Figure 3.4) on one structure while 
the other has 1,3 (meta) substitution (Figure 3.5). The 1,4 linker was rejected on the 
grounds that the overall bridging structure formed during ligation was sufficiently more 
crowded than that made using the competing 1,3 linker. 
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Figure 3:4 Sprout modelled ligation transition-state using rejected candidate linker structures 
Figure 3.5 Sprout modelled ligation transition-state using best-candidate linker structures 
Studying the best-candidate structure generated by SPROUT and regressing to a period 
pre-ligation revealed the linkages that would be required to join the PNA and peptides 
together (Figure 3.6). 
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PNA 
\. y 
Linker 
J 
Acid labile bond shown in bold red; bond is activated to cleavage after ligation has occurred 
PNA 
\. .... _-....., ...... ----) Y 
Linker 
Figure 3.6 Diagram to show how the linkers are incorporated into the chimeras 
To incorporate these linkages (Figure 3.6, bold bonds) into the final PNA-peptide 
chimeras, linker units that would be suitable for use with fmoc-based SPPS were 
required. The final linker designs from the SPROUT design for use in the construction 
of the PNA-peptide chimeras were therefore derived using a bhoc/fmoc protection 
strategy are shown in Figure 3.7. 
,---..,.. 0 
Peptide attaches OFmoc Nucleobase Peptide attaches &: Nucleobase 
here via EDC o:.~) her.e vi~ reductive J 0,) 
coupling I"":: 1 amlnatlon I"":: 1 
~ N ............... C02H ~ N~ NHFmoc 
96 
Figure 3.7 SPROUT designed linkers 
97 
With the final linker targets in hand, planning and execution of the linker syntheses was 
undertaken. 
95 
3.2 PNA to peptide linker: Linker 1 
The SPROUT designed linker 96 was retrosynthesised as shown in Figure 3.8. 
OH 
o ~'"\.~~C02Et 
96 98 
99 
Figure 3.8 Retrosynthesis of 96 
Nucleobase 
~C02H 
100 
The first intermediate 98 was prepared using the reductive amination procedure of 
Gebert (Scheme 3.1).[2] 
Et02C/"""-. NH2 .HCI 
100 
(i-iii) 
(i) EtOH, potassium hydroxide, BO°C, 10 min 
(ii) 3-hydroxybenzaldehyde, RT, 90 min 
(iii) NaBH4, RT, 30 min 
Scheme 3.1 Synthesis of 98 via reductive amination 
58% 
98 
Condensation was not promoted by addition of dessicating agents (MgS04' 3A 
molecular sieves) or increasing the time allowed for reduction. Indeed, the conditions of 
Gebert were found to be optimal, and deviation resulted in a more challenging 
chromatographic purification and lower yield. 
Amine 98 was then to be acylated with one of the four nuc1eobase acetic acids (38, 73, .. 
75 or 77). It was decided to use thyminyl acetic acid 38 for the initial synthesis of 96, 
given that it is the most readily prepared of the four nuc1eobase acetic acids. However, 
to enable a full and robust development of the project methodology, it will be necessary 
that the linker 96 can be adorned with any of 38, 73, 75 or 77. The chemistry required to 
convert intermediate 98 into the final linker unit therefore had to be tailored to tolerate 
96 
the acid sensitivity of 73, 75 and 77. It was planned that all four possible permutations 
of 96 would be synthesised after conditions for PNA-directed ligation had been 
developed. 
The conversion of 98 into 101 was analogous to the final step in the synthesis of PNA 
monomers. The intermediate 101 was prepared from 38 (Scheme 3.2). 
(i-iv) 
(i) MeCN, NMM, RT, 5 min 
(ii) add to pivaloyl chloride, -15°C, 25 min 
(iii) 98, NEt3, MeCN/H20 (1:1), 16 h, RT (iv-a) 20% citric acid, extract with EtOAc 
(iv-b) Evaporate to dryness then triturate with 6M HCI 
Scheme 3.2 Synthesis of linker 1 intermediate 101 
24% (iv-a) 
86% (iv-b) 
101 
Intermediate 101 is soluble in citric acid solution and exhaustive extraction with a 
variety of organic solvents (toluene, ether, CH2CIz, ethyl acetate) gave an optimal yield 
of 24% using ethyl acetate. These conditions are suitable for the synthesis of the 
intermediate 96 when any nuc1eobase is present. However, since 101 did not bear an 
acid sensitive protecting group the workup was modified to use stronger acids (as per 
the T-PNA monomer synthesis) and a dramatic increase in yield was achieved. The 
crude reaction was evaporated to dryness and triturated with a minimal amount of 6M 
HCI solution to obtain 101 as a slurry. Filtration and simple washing of the slurry _ 
precipitate gave 101 in much improved yield. Although untested, it was predicted that 
the Shoc group would not survive this procedure. 
Hydrolysis of ester 101 is the penultimate step in the synthesis of96 and the method for 
this tFansformation is derived from the prior experience with PNA monomer synthesis 
(Scheme 3.3). The hydrolysis conditions that were selected had previously been used to 
97 
convert 71 and 74 to their corresponding acids, and were used (without modification) to 
effect near quantitative conversion of 101 into 102. (Scheme 3.3). 
(i-iii) 
101 
(i) H20, lithium hydroxide, DoC, 5-10 min (ii) 20% citric acid solution, DoC, 1 h 
(iii) Saturated brine solution, RT, 24 h 
Scheme 3.3 Synthesis of linker 1 intermediate 102 
97% 
102 
The final step in the synthesis of 98 was the protection of the phenol group. It was 
attempted to form the Fmoc carbonate under weakly basic conditions (Scheme 3.4). The 
Fmoc protection of phenol 102 was considered to be potentially challenging as the 
phenol nucleophilicity was predicted to be relatively poor. To minimise sluggish 
reaction kinetics, the most electrophilic Fmoc transfer reagent that was available, Fmoc 
chloride, was used for the synthesis of 96. 
o 
yNH OH lN~O AOy 
~N'-./C02H 
(i-iii) 
.---------------------~ 
102 
(i) Sodium bicarbonate solution, DMF, RT, 5min 
(ii) Fmoc Chloroformate, DMF, 48h 
(iii) Neutralise with 1 M NaHS04 
Scheme 3.4. Attempted Fmoc protection of phenol 102 
No reaction 
96 
The crude reaction mixture was purified by chromatography to recover both starting 
materials. Under the basic conditions, the carboxylate group should not have interfered 
with the reaction, however to ensure that this was a valid assumption, the reaction was 
repeated with the ester 101. The result was identical and only starting materials were 
98 
recovered. The phenol 101 is not sufficiently nucleophilic to react with Fmoc 
chloroformate, and so it was decided that a new protecting group was required. 
The new protecting group had to fulfil the same criteria as the Fmoc group. Both 
protection and deprotection conditions must not affect the acid labile Bhoc group and 
the protecting group must be stable under standard SPPS conditions. 
The immediate and obvious choice for protection of the phenol, partly inspired by solid 
phase carbohydrate chemistry, was the acetate group. An efficient procedure by Phukan 
in which phenol is acylated quantitatively seemed a promising approach for the 
protection of 102 (Scheme 3.5), however the reaction failed to acetylate 102. [3] 
(i-ii) 
._-------------------- .. 
(i) Neat acetyl chloride, 10 mol % iodine, 1 min 
(ii) Quench with saturated sodium thiosulfate solution 
Scheme 3.5 Attempted acetyl chloride mediated phenol protection 
No reaction 
103 
Why acetyl chloride is unable to convert 102 into 103 is not clear. It is counterintuitive 
to suggest that the carboxylate anion is more nucleophilic than the phenol or that the 
presence of thymine should interfere with this reaction. 
Using the Schotten-Bauman conditions of Chattaway, 102 was successfully acylated to 
give the first target linker 103 (Scheme 3.6).l4] 
99 
(i-ii) 
(i) Acetic anhydride, 10% NaOH solution, ice, 1 min 
84% 
103 
(ii) Quench with 2M hydrochloric acid solution, extract with EtOAc 
Scheme 3.6 Schotten-Bauman type acylation of phenol 102 
Interestingly the fmal product was not initially recovered in good yield - 103 has a high 
affinity for magnesium sulfate and using this drying agent dramatically lowered the 
yield to ~ 18%. Changing the dying agent to the less acidic sodium sulfite increased the 
yield to 65%. To recover the optimal yield for 103 (Scheme 3.6) it was found that 
drying by azeotropic evaporation of water with toluene is required 
3.3 Peptide to PNA linker: Linker 2 
SPROUT designed linker 97 was retrosynthesised as according to Figure 3.9. 
o &: Nucleobase ~ O~ 1 -& 7J' ~NHFmoc HO~ YUCleobase ~ H02C 1-& ~ ~NHFmoc 
97 104 
se _ 
-& C02Me 
105 106 
Figure 3.9 Retrosynthesis of 97 
Starting from commercially available 106 it was planned to desymmetrise 106 into the 
mono acid 107. Activation of this carboxylic acid and subsequent reaction with a excess 
of ethylenediamine would give intermediate 105. A global reduction of 105 with lithium 
100 
aluminium hydride was anticipated to deliver alcohol 107 that could be protected 
selectively with the Fmoc group to give 104 (Figure 3.10) It was planned to selectively 
protect the secondary amine with the same methodology used to make 89. 
6:?H2 £?H2 OH &?HFmOC I ~ NH (i) (ii-iii) 
• I fi NH • I ~ NH 
0 
105 107 104 
(i) Reduction 
(ii) Protection of secondary amine 
(iii) Fmoc transfer reagent; unmask secondary amine 
Figure 3.10 Proposed synthetic route to 104 
The synthesis of 97 would then be completed with the coupling of 104 with an activated 
nucleobase acetic acid and a final oxidation of the alcohol into the aldehyde 97. 
Initially a set of conditions that would allow the selective partial hydrolysis of 106 were 
required. Isolation of 108 was thought to be achievable by performing the reaction in a 
solvent in which the starting ester 106 is soluble but that the product 108 would be 
insoluble. In effect, the product salt would precipitate as it is formed, removing itself 
from the reaction and avoiding complete hydrolysis. The hypothesis was tested by 
adding a methanolic solution of sodium hydroxide to a solution of 106 dissolved in 
toluene while briefly heating at reflux (Scheme 3.7). 
5 e (i) 5 e (; ~ C02Me fi C02H ~ C02H 
106 69% 16% 
108 109 (i) PhMe, KOH, MeOH, reflux, 20 min 
Scheme 3.7 Partial hydrolysis of dimethylisophthalate 
108 did precipitate (very rapidly) from solution as planned but a significant quantity of 
the diacid 109 was also formed and found to be inseparable from 108. A number of 
101 
modifications were made to eliminate the formation of the diacid 109 from the reaction 
(Scheme 3.8). 
~Me 
UC02Me 
106 
(i) PhMe, NaOH, MeOH, RT, 16 h 
(i) 
Scheme 3.S Improved synthesis of monomethylisophthalate 
43% 
10S 
Employing sodium hydroxide as the base and performing the reaction at RT gave a 
lower yield but there was no contaminating diacid. Unreacted starting material is 
recovered easily and can be recycled. 
Slow addition of a dilute solution of activated 108 to neat ethylene diamine was 
attempted to gain direct access to 105. Activation of 108 was attempted by conversion 
of 108 into the acyl chloride and was followed by in situ reaction with ethylene diamine 
(Scheme 3.9). 
~Me 
U C02H 
10S 
(i) PhMe, SOCI2, reflux, 90 min 
(i-iii) 
(ii) Evaporate to dryness then dissolve in 25 volumes of CH2CI2 (iii) Add dropwise to stirred ethylene diamine, RT 
Scheme 3.9 Attempted mono-acylation of ethylene diamine with 10S 
O:CNH2 
o 
Could not be purified 
105 
Even though the concentration of acyl chloride was low and EDA was high, the .. 
diacylated side-product 110 was formed in greater yield than the desired product 105, as 
determined by LC-MS (Figure 3.11). 
102 
100 (1) _ 
098 C02Me ~OH~ 
o 
(2) 
5.36 
Figure 3.11 Attempted monoacylation of EDA with thionyl chloride-activated 108 
Ultimately 105 could not be separated from the excess ethylene diamine present in the 
reaction. 
It was decided to monoprotect EDA to overcome the diacylation problem. 
The procedure of Eisenftihr was followed to make monoamine 111 and that was 
acylated using the mixed anhydride methodology to give 112 (Scheme 3.10) 
(ii-iii) 
108 
(i) CHCI3 , Boc anhydride, RT, DOC, 15 min (ii) MeCN, NMM, RT, 5 min 
(iii) Pivaloyl chloride, -15°C, 30 min 
(iv) 111, RT, 25 min 
(i) 
Scheme 3.10 Synthesis of Boc protected intermediate 113 
(iv) 
H H2N~Nlot 
>99% 
111 
0:0 
BocHN~NH 
67% 
113 
With 113 in hand, the Hoc deprotection and global reduction was attempted (Scheme 
3.11). 
103 
0:0 0:0 H~ (i) (ii) 1'-':: • -------- .... a 
~NH H2N~NH H2N~NH BocHN 
86% Could not isolate 
113 105 107 
(i) Trifluoroacetic acid, CH2CI2, 2h then neutralise (ii) THF, Lithium Aluminium Hydride (6 eq.), reflux, 11 h 
Scheme 3.11. Attempted total reduction of amine 105 
Deprotection of 113 was essentially quantitative however it was not possible to 
completely extract it from the neutralised aqueous reaction. 
Reduction of 105 was monitored by LC-MS. The reaction is sluggish and after 1 h only 
40% of the starting material had been consumed; total reduction of 105 was found to 
take 11 h in total (Figure 3.9). Small aliquots of the reaction were worked up with 
Glaubers Salt, Rochelles Salt and water/sodium hydroxide to determine a suitable 
work-up for the reaction. [5-7] It was found that only the sodium hydroxide method 
hydrolysed the crude aluminates. Extraction of the colourless aluminate salts with 
boiling THF did not give 107 as a pure compound. The NMR spectrum (Figure 3.12) of 
the recovered material appears to be of more than one compound although the number 
of aliphatic and aromatic protons are in the correct ratio. 107 should not be sterically 
congested enough to exist in rotomeric forms, suggesting that the material was partially 
chela ted with metal ions or salts. 
(020) £ ~ o ~~NH2 
y Y L.-.--J Y 
1.88 1.19 1.23 6.41 
...... , ~ '-r' 
2.03 4.28 4.01 2.02 
, I I I , I I I ppm 7 6 5 4 3 2 
Figure 3.12 Lithium aluminium hydride reduction of 105 
105 is potentially an excellent metal cation ligand. The recovery of 107 from the metal 
salts (generated post-reduction) is made difficult probably due to this multi-dentate 
104 
capacity. Attempts to sequester the aluminium using alternative work-up conditions 
(triethano lamine) fai led. 
There was concern that the free amino group of 105 was affecting the reduction in some 
adverse way. It was predicted that a reduction in which the amine was in a masked form 
before the reduction and unmasked during workup of the reaction would circumvent this 
problem. It was thought that this could be accomplished if the oxidation level of the 
amine was raised to that of a nitrile.; the amine would only be liberated during post-
reductive reaction work-up and would therefore not be available to interfere with the 
course of reaction. 
Nitrile 114 was prepared from isophthalate (Scheme 3.12). 
108 
(i) NEt3 , HOBt, DMF, RT, 5 min (ii) EDC, RT, 1 h 
(iii) Aminoacetonitrile, RT, 16 h 
(i) 
Scheme 3.12 Synthesis of nitrile reduction precursor 114 
72% 
114 
The use of alternative activating agent DCC gave a yield of 48% when used under 
otherwise identical reaction conditions. 
Initially a partial reduction of 114 was attempted usmg a solution of borane 
dimethylsulphide complex. The borane was anticipated to reduce the nitrile and amide -
functionality, leaving the ester functionality intact as an extraction/purification handle. 
In practice the intermediate 115 could not be isolated as a pure compound and the _. 
reaction yielded an inseparable mixture. The reaction was heated at reflux for 3 days in 
aqueous acetic acid, but this failed to generate a major or isolable compound. 
Giannis[8] reported that TMSCI and Lithium borohydride are combined to give a potent 
reducing cocktail that is suitable for substrates that struggle to fully reduce with 
105 
standard THF borane solutions. (8) 114 was treated with a solution of the reduction 
cocktail at RT for 2h, as according to the procedure of Giannis. A mixture of the starting 
material 114 and compounds 116 and 117 were observed in addition to 115 within the 
reaction mixture (Figure 3.13). 
M> ES+ :TCSmooI1 (M1,2>Q) 
100 
116 
(5)115 
C0 2Me 5.77 I (8) ~- +634 ~~ N- (7) 
6.04 
(11) 
218.00 
7Il9 C02Me _~~~N 
o 114 
Figure 3.13 LC-MS trace of attempted partial reduction of 114 using LiBH4 
7.1...007 
After a further 3h the LC-MS profile of the crude reaction mixture had not changed and 
so the reaction was heated at reflux for 24 h in an effort to complete the reduction. After 
this 24 h period the starting material was still observed in the reaction mixture however 
the number of side products had increased (Figure 3.14). 
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Figure 3.14 Extended reaction time in attempt for partial reduction of 114 by LiBH4 
It was decided to forgo the partial reduction approach and attempt total global reduction "' 
instead. 114 was treated with lithium aluminium hydride in THF at reflux and worked 
up with aqueous sodium hydroxide. Extraction of the crude metal salts with refluxing 
THF -failed to give any organic extract. The reaction was repeated and worked up with 
triethanolamine over 16 h to give a colourless gel of metal salts that were filtered and 
106 
" 
washed repeatedly with CH2Ch. Evaporation of the combined crude organics gave an 
inseparable mixture of product 107 and triethanolamine (Figure 3.15). 
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Figure 3.15 Triethanolamine contaminated sample of 107 
The approach of assembling the core carbon framework at a high oxidation level and 
reducing down to desired 107 proved to be too troublesome to continue with. The 
obvious change to the strategy was to assemble 107 using fragments already at the 
correct oxidation state. The revised approach to 107 is shown in Figure 3.16 
I--C°
H 
c:l'~~NH2 
107 
~OH I~ o 
x 
Figure 3.16 Revised retrosynthesis of linker precursor 107 
~OH I~ o 
CI 
118 
NHBoc 
~ 
NH2 
111 
It is well known that addition of a benzyl halide to a primary amine will generate a 
mixture of products because the starting material can be alkylated more than once. This 
problem was anticipated and it was hoped that control of reagent concentration would 
minimise side-product formation. The method of Dodziuk for the synthesis of benzyl 
halide 121 was followed to effect the conversion of 120 to 121 (Scheme 3.13); diol 120 -
was prepared from commercially available 119 under standard conditions. [9J 
107 
~ I: ~O (i) .. 
119 
(i) NaBH4 , MeOH, RT, 1 h (ii) SOCI2, CHCI3, DoC, 15 min (iii) Stirring, RT, 18 h 
OH £OH 
94% 
120 
Scheme 3.13 Synthesis of benzyl halide 121 
121 was isolated after difficult chromatography. 
OH CI 
(ii-iii) 
.. £CI £CI 
69% 25% 
121 122 
A slightly modified method of Naghipour was used to prepare 121 as a single product 
without chromatography (Scheme 3.14). 
(i) 
120 
(i) PhMe, concentrated hydrochloriC acid, RT, 18h 
Scheme 3.14 Alternative synthesis of benzyl halide 121 
72% (Lit.>99%) 
121 
For the approach to 122 depicted in Figure 3.17 to be useful, the monoalkylation 
product must effectively be the only polar product; it was known from prior experience 
that the amine 111 and product 122 were inseparable using silica chromatography. 
Careful monitoring and adjustment of the reaction conditions were used in an attempt to 
obtain 122 as the only product generated by addition of 121 to neat 111(Table 3.1). 
(i) H NHBoc R~N~ 
R NHBoc 
R~N~ 
R R NHBoc . EBN, H I -' R~ --../ 
122 123 124 
121 
(i) Dropwise addition of 121, CH2CI2, RT, 20 min R= HO~~ 
Figure 3.17 Experiment for synthesis of intermediate 122 
108 
[BenzyICI] 
0.500M 
0.250M 
0.125M 
111 
o 
o 
200 
120 
o 
o 
200 
122 
1 
1 
1 
123 
4 
1 
1 
124 
5 
o 
o 
Table 3.1 Approximate ratios of crude reaction components, relative to monoalkylation product 
122, for reactions run under different concentrations of benzyl chloride 121 
Even at (relatively) high dilution, the formation of the side pr?duct 123 is unavoidable 
(Figure 3.18). 
~"'-~'-'-~~i""""~'i""~r-"--"--""'-T·l·---.:--r"-·~·"·r-·r- ,.-- •... ,.. .---'" -. .,. • ,--' -r-. , 1 Time 
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Figure 3.18. LC-MS traces for attempted monoacylation of Boc EDA with O.125M 121 
The starting materials were clearly seen to be the dominant peaks in the mass-ion trace 
of the 0.125M reaction, and small equimolar amounts of the product and 123 (in 
addition to 124) are also visible. The UV trace revealed that the actual amounts of 122 
& 124 formed are negligible and that the two amines are present on the mass-ion trace -
because they easily ionise, not because they are present in any meaningful quantities. 
The data strongly suggests that with a 1: 1 stoichiometry of starting materials that the'~ 
reaction cannot be run under concentration control to generate solely the desired 
product. The enhanced nucleophilicity of the product relative to the starting material 
overcomes the high dilution effects and dialkylation side product 123 cannot be 
avoided. 
109 
A final attempt to directly synthesise 107 was attempted by slow addition of neat 121 to 
neat ethylene diamine . Without the carbamate protecting group both of the EDA amino 
groups potentially could have been acylated by 121 additional side products. However it 
was hoped that at low temperature, with EDA in excess to 121 , that only 107 could 
form ; As 107 was formed its concentration would remain insignificant to that of EDA 
and therefore it would have been statistically very unlikely to encounter a second 
equivalent of 121 and react further to give byproducts. 
It was found that adding neat 121 by syringe pump (l.0 mL per hour) to a tenfold molar 
excess of neat EDA at low temperature «O°C) gave exclusively 107. Separation of 107 
from the excess EDA was difficult but was accomplished with 5 h of reduced-pressure 
evaporation at 60°C (Figure 3.19). 
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Figure 3.19 NMR data for intermediate 122 
To make use of 107 it must be possible to discriminate between the primary and 
secondary amine. Synthesis of linker 97 was envisioned to be completed by the 
selective protection of the primary amine of 107 with an Fmoc group followed by -
acylation with adenyl acetic acid 75 (Scheme 3.l5). Initially it was hoped that the 
chemistry used to synthesise backbone 89 could be applied to the synthesis of 104 . .. 
There was concern however that 104 had the potential to deprotect itself, that the Fmoc 
carba"1ate could be destroyed by attack of the free secondary amine. If auto-degradation 
was occurring had to be determined empirically. The reaction was carried out at pH 7.0 
(unbuffered) and dibenzofulvene, a distinctive byproduct of deprotection, was not 
110 
detected (by mass spectrographic analysis of the crude reaction mixture) during the 
reaction. 
&OH (NH2 (i-iv) --------- ... I ~ NH 
107 
HO -~ ~moc 
QNH 
Not isolated 
104 
(i) Sistrimethylsilylacetamide, DMF, 1 h, RT 
(ii) Fmocsuccinimide, DMF, 1 h, RT 
(iii) MeOH then H20, 10min, ice bath (iv) Evaporate to dryness, triturate with CH2CI2 
(v-vi) 
--------- .. 
(v) Shoe-Adenyl acetic acid, N-methylmorpholine, MeCN, RT, 5 min 
(vi) Pivaloyl chloride, O°C, 20 min then 104, 1 h, RT 
NHShoc 
N~N 
HO ~ .. Jl ~ 6: N I '-=:::: Oy NHFmoc ~ N~ 
125 
Scheme 3.15 Attempted synthesis of Fmoc protected linker precursor 125 
The crude residue (recovered after evaporation of the OM F) was highly insoluble. It 
was possible to dissolve a small amount of the crude residue in a mixture of deuterated 
water and OMSO (1 :4) and measure the proton and carbon NMR spectra. Analysis of 
the crude material spectra did not provide a conclusive answer if the reaction had been 
successful. The product was not observed in the mass spectrum of the crude residue and 
given its poor solubility and the difficulty of its characterisation, this route was 
abandoned .• 
Laduron and coworkers reported that a primary amine could be selectively condensed 
with methyl isobutylketone (MIBK) to give the corresponding imine in the presence of 
a primary amine (Scheme 3.16).[10] 
111 
" 
oS MN MN NH2 (i) . ~ (ii) cDBOC (iii). ~ • .. 1.& NH Q:NH 1.& NBoc 
126 
(i) MIBK, reflux, 2 h 
(ii) ooe, Boc anhydride, 30 min 
(iii) Evaporate to dryness then waterlisopropanol (1 :1), 50oe, 1 h 
Scheme 3.16 Laduron selective acylation of secondary amine in presence of primary amine 
107 and benzyl EDA 126 are very similar in structure and it was thought that the 
conditions given in Scheme 3.16 could be used to convert 107 into 127 and then into 
either 128 or 129. Either of these compounds could then be converted to 125 (Figure 
3.20). 
&~~NH' 
128 
NHBhoc 
OH tt:; &O~ N 1.0 N 
............... NHFmoc 
125 
Figure 3.20 Approaches to 125 using the Laduron methodology 
The imine 130 was successfully formed under the conditions described by Laduron 
(Figure 3.21). 
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Figure 3.21 MIBK imine of 107 
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Addition of the boc anhydride caused the reaction to become a dark brown colour, and 
after hydrolysis of the imine there was no product (127) present. NMR analysis of crude 
isolated material showed that the starting material had been transformed into something 
else that could not be identified. The reaction was repeated and identical results were 
observed. It is not clear why this reaction failed in light of the reported results depicted 
in Scheme 3.16 . 
Another approach to the intermediate 104 was required. It was decided that 104 could 
be made from reductive amination between 131 and 132. 
~ ~ & C; NHFmoc ==> 1'-':: 1'-':: ~ 10 ~ 0 0 ~ NHFmoc NH2 I NH2 
X 0 
104 131 132 
Scheme 3.17 Revised retrosynthesis of linker precursor 104 
This approach had been previously considered but was not pursued for a number of 
good reasons. There is a known difficulty with reducing aryl imines - Schiff base 
complexes (aryl imines) are used as ligands for reduction catalysts, highlighting that 
such imines are stable to reducing conditions and as such, harsh conditions are required .-
to reduce them. Such conditions could be incompatible with the Fmoc group. Previous 
experience with purifying 107 from metal reductant and waste metal salts proved to be 
troublesome and the potential for inseparable side products (forming via reductive 
amination of the product) could also occur and render the reaction inefficient. 
113 
" 
It was thought that the acid 108 from earlier work could be used to access 131 via the 
Weinreb amide 133 (Scheme 3.18). 
C02Me ~OH (i-iii) 
o 
108 
(i) NMM, THF, RT, 5 min 
(ii) Isobutylchloroformate, -20°C, 10 min 
88% 
133 
(iv) 
.. 
(iii) NEt3 then N,D-dimethylhydroxylamine, DMF, -20°C, 30 min then RT, 30 min 
(iv) Lithi~m aluminium hydride, THF, O°C, 1 h 
Scheme 3.18 Synthesis of aldehyde 131 
94% 
131 
A more direct route of synthesis was also developed. The partial reduction of 
isophthalaldehyde 119 was attempted to access 131 in one step. The procedure of 
Takemoto et al. was followed and 131 was isolated in slightly greater yield than that 
expected for a statistical reduction. [11] 
(i) 
119 58% 31% 
131 120 
(i) 0.34 equiv. NaBH4' EtOH, o°C, 1 h 
Scheme 3.19 Alternative synthesis of aldehyde 131 
Amine 132 was prepared as according to the procedure of Boeijen (Scheme 3.20).[12] 
(i) 
111 
~NHBoc 
FmocHN 
89% 
134 
(i) H20, MeCN, Fmocsuccinimide, pH 9.0,10 min (ii) MeCN, 6M HCI, 18 h 
Scheme 3.20 Synthesis of FmocEDA hydrochloride 
(ii) /'0.... .NH CI .-
FmocHN' "'" 3 
-99% 
132 
114 
With both the aldehyde and amine in hand, the reductive amination was attempted 
(Scheme 3.21). 
(i) 
• 
131 135 
(i) 1320.5 equiv., DIPEA, MeOH, RT, 1 h 
(ii) NaBH4 1 equiv., RT, 1 h 
(ii) 
.. _------ .... 
OH 1:-.. ?HFmOC 
QNH 
Not observed 
105 
Scheme 3.21 Attempted synthesis of intermediate 105 via reductive ami nation 
Salt 132 was suspended in stirred methanol and diisoproylamine was added until the 
reaction pH reached 7.0, wherein 132 was assumed to be the free base. An excess of 
aldehyde 131 was added to the reaction and allowed to stir for 1 h to complete imine 
formation. The reaction was placed in an ice bath and sodium borohydride was added to 
the suspension and stirred for 30 min before the reaction was quenched and worked up. 
The reaction returned only diol 120 and a baseline mixture of amines and borate salts. 
The results suggest that either imine 135 did not form or was not reduced and 
subsequently hydrolysed on workup. 
The difficulty associated with introducing the Fmoc group into 97 was now thought to 
not be worth the convenience of its use as a familiar protecting group. The 
allyloxycarbonyl (Alloc) protected equivalent of 97 was thought to be a suitable 
analogue. The Alloc group is established in solid phase synthesis as a more chemically 
robust alternative to the Fmoc group for amine protection. It is removed under neutral 
conditions (Pd(PPh3)4, cation scavenger (eg PhSiH3)) that are orthogonal and 
complementary to the acidic cleavage conditions used for the cleavage of peptide and _' 
PNA sidechain protecting groups. It was anticipated that 137 would be a superior choice 
of partner for 131 in imine formation for more than one reason. It should withstand 
harsher, more forcing reducing conditions that could be required to successfully 
reducing the aryl imine. It should not possess the solubility issues that accompany, and 
are peculiar to, the Fmoc group with this class of molecule. Furthermore, it will be 
115 
possible to accurately gauge imine formation by IH NMR without the Fmoc aromatic 
signals obscuring changes in chemical shift of the aryl protons of 131 or the presence of 
the imine proton. 
137 was prepared in an analogous manner to FmocEDA 132 (Scheme 3.22): 
(i) 
111 
(i) NEt3, CH2CI2, RT, 5 min 
~NHBoc AliocHN 
89% 
136 
(ii) 
(ii) Allylchloroformate (dropwise), CH2CI2, DoC, 30 min then RT, 24 h (iii) Acetyl chloride 3 equiv" MeOH, DoC, 30 min then 136, RT, 3 h 
Scheme 3.22 Synthesis of Alloc EDA 137 
-99% 
137 
Concurrent to the synthesis of Alloc EDA 137, it was decided to test reductive 
amination conditions using sodium triacetoxyborohydride and aldehyde 131 with the 
readily available Boc EDA 111 (Scheme 3.23).[13] 
OH &0 (i-iii) 
131 
(i) Boc EDA 1.0 equiv., RT, 20 min 
(ii) AcOH (2% total volume) 
OH 6)BOC 
I ~ NH 
Minor «5%) 
122 
(i) Sodium triacetoxyborohydride 2.0 equiv., RT, 3 h 
Scheme 3.23 Reductive amination of 131 using Nagalingam conditions 
~~ ~ ~ ~ I ~ G:.lN~ ~ I 
Major (>95%) 
122b 
The product (122) was found to be very reactive and could not be isolated (Figure 
3.22). 
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Figure 3.22 LC-MS traces of crude reductive amination mixture 
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Under the mildly acidic conditions, formation of imine 138 must be readily reversible, 
and the untethered product 122 outcompetes Boc EDA in the formation of an iminium 
ion with free aldehyde 131 (Figure 3.20). 
OH J:-'~BOC 
WNH 
OH J:-'~BOC 
QNH -
131 138 122 
-
122b 123 
Figure 3.23 Formation of single and double reductive amination products 
Product 122 is a much more competent nucleophile than Boc EOA, due to the +1 effect 
from the aryl ring that raises the energy of the nitrogen lone pair of electrons, and 
readily sequesters aldehyde 131. The overall observed reaction is therefore a mixture 
117 
consisting overwhelmingly of imine 138 and iminium ion 122b, demonstrating the 
reactivity of aldehyde 131 and the difficulty of reducing the iminium ions; that an 
excess of the reducing agent was used yet only a relatively small amount of the side 
product 123 is present indicates that the secondary iminium ion is reduced much more 
slowly than protonated 138. The iminium ion 122b can be partially hydrolysed into 
amine 122 and the aldehyde 131, however separation of all the reaction components is 
not practical and a clean reductive amination that yielded only 122 was required. 
Based on this result it was decided to find conditions whereby 137 and 131 could be 
condensed quantitatively and then rapidly reduced into amine 139 (Figure 3.24). 
(i) 
131 
(i) Quantitative condensation 
I~OH 
~N~NHAIIOC 
138 
(ii) 
(ii) Rapid reduction to prevent side-product formation under reductive conditions 
Figure 3.24 Approach to key amine 139 
&OH I ~ ~ ~NHAlioc 
139 
To establish conditions for the reduction of 138, imine formation and reduction was 
followed with IH NMR and LC-MS. It was decided that initially an excess of amine 
would be used, to drive the full conversion of aldehyde into imine and remove the 
possibility <?f double-reductive amination side-products. To effect full and rapid 
reduction of the imine, sodium borohydride was chosen as reductant. 
Although methanol is a preferred reaction solvent for borohydride reductions, imine 
formation is poor (-50%) in this solvent and cannot be forced to completion. The best 
organic solvent for imine formation was found to be CH2Ch. Starting with an excess of 
the amine component it was found that the aldehyde was effectively consumed and 
transformed to the imine (Figure 3.25). 
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Figure 3.25 1H NMR spectrum of imine formation with an excess of the amine component 
To estimate the excess of free amine present in the reaction, the ratio of the imine 
proton (8 .30 ppm) and allyl protons in the IH NMR spectrum was calculated. It should 
be noted that the percentage of imine formation is identical in both deuterated 
chloroform and dichloromethane. An amount of aldehyde equal to the excess of amine 
was then added to the reaction and the crude IH NMR spectrum was measured once 
more (Figure 3.26) 
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Figure 3.26 1H NMR spectrum of incomplete imine formation from equimolar reactants 
I 
3 
Prolonged stirring and the addition of drying agents such as magnesium sulphate and 
3 A molecular sieves did not change the amount of imine present in the reaction. Imine 
formation was known to be sensitive to pH and an amount of DIPEA was added to the 
reaction to raise the pH to approximately 9.0 in the hope of driving imine formation. 
This was successful and imine formation was essentially quantitative at pH 9.0 or -
greater (Figure 3.27). 
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Figure 3.27 1H NMR spectrum of completed imine formation with equimolar reactants at high 
pH 
An aliquot of the reaction was treated with solid sodium borohydride and no reduction 
was observed after 1 h of stirring. This was not an unexpected result given the 
insolubility of sodium borohydride in CH2Cb. To effect reduction, the reaction was 
evaporated to dryness and a solution of sodium borohydride (2 equivalents)dissolved in 
THF was added. After 3 h of stirring, an aliquot from the reaction was analysed by LC-
MS. (Figure 3.25). 
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Figure 3.25. LC-MS traces of incomplete imine reduction with sodium borohydride 
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While~ a small amount of 139 was present in the mass spectrum trace, the UV trace 
revealed that the product was almost exclusively the imine 138. The reaction was 
allowed to stir at RT for 12 h but no change was observed. The reaction LC-MS trace 
120 
remained constant despite an additional 3 equivalents of sodium borohydride being 
added to the reaction and the temperature being raised to 40°C for a further 24 h. A final 
attempt to drive the reduction was made by adding a massive excess of the reductant 
and heating the reaction at reflux for 48 h. The imine was destroyed and became a 
mixture of unidentifiable compounds. 
This demonstrated that sodium borohydride is not sufficiently reactive III THF or 
CH2Ch to be able to reduce the imine and that the imine is unstable under harsh 
reductive conditions. 
Reduction of imine 138 (dissolved in CH2Ch) was revisited with the idea of using a 
solution of sodium borohydride dissolved in a minimum amount of methanol. It was 
hoped that the miscibility of methanol with CH2Ch would allow reactive hydride to be 
delivered to the imine and thus facilitate reduction. There was concern about the 
methanol disrupting the imine/amine equilibrium. It was hoped that using the least 
volume of methanol possible would minimise any such disruption, while providing the 
most concentrated solution of hydride possible to effect a rapid reduction (Scheme 
3.24). 
(i-iv) 
• &OH I~ ~ ~NHAlloc 
131 
(i) 137, diisopropylethylamine, CH2CI2, RT, 1 h (ii) Evaporate to dryness then sodium borohydride/MeOH, O°C, 30 min 
(iii) Stir, RT, 3 h then O°C, 3M HCI quench, neutralise, evaporate to dryness 
(iv) Dissolve residue in MeOH adsorb onto silica, chromatography 
Scheme 3.24. Reduction of imine 138 with methanolic sodium borohydride 
10 - 30 % 
139 
The reaction was successful although the yield of 139 was poor and variable. 139 could .. 
not be extracted from aqueous solution and required multiple bouts of chromatography 
(methanol/ethyl acetate, 3:7) to separate it from the borate/diisopropylethylamine salts 
and "traces of Alloc amine 137. The yield was maximised by allowing the sodium 
borohydride to stir for 10 - 15 min once fully dissolved in the methanol. This 
presumably resulted in the imine being reduced by a methoxyborohydride deriviative, 
121 
such as BH(OMeh that was almost certainly more miscible with the imine than sodium 
borohydride. 
The poor yield was caused largely with the difficulty in separating 139 from the 
diisopropylethylamine used in the reaction. It was desired to remove nitrogenous base 
from the reaction to improve the reaction yield and expediate access to 139. It was 
thought that the imine formation could be achieved in aqueous conditions with an 
inorganic base instead. 
The aldehyde and amine were stirred in saturated sodium hydrogen carbonate solution 
water for 3 h to give an orange oil floating on a colourless solution. A small portion of 
the oil was dissolved in aqueous acetonitrile and analysed by LC-MS (Figure 3.28 ) 
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Figure 3.28 Imine formed in saturated sodium hydrogen carbonate solution 
The reaction was concentrated and an excess of sodium borohydride (dissolved in 
water) was added and the imine was rapidly reduced to give 139 as the major 
component of the crude reaction solution (Figure 3.29). 
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Figure 3.29 LC-MS trace of crude reduction mixture 
Initially chromatography was used to recover the product to give an average yield of 55 
- 60%.- However a workup procedure was later developed that recovered the crude 
product much more cleanly (Figure 3.30) and in up to 90% yield. 
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Figure 3.30 LC-MS trace of amine 139 recovered by new workup procedure 
The crude mixture of amines were separated using ion exchange on a prepacked sex 
column eluted first with methanol and then ammonia saturated methanol to give 139 as 
a single compound in 90% overall yield (Figure 3.31). 
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Figure 3.31 LC-MS trace of amine 139 purified via prepacked SCX column 
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Intennediate 140, the penultimate compound in the synthesis of the linker, was seen to 
be accessible via a mixed anhydride coupling as per PNA monomer synthesis 
(Scheme 3.26). 
(i-iii) 
(i) N-methyl morpholine 2 equiv., MeCN, RT, 5 min 
(ii) Pivaloyl chloride, O°C, 20 min 
(iii) 139, MeCN/H20 (1:1),30 min, RT 
NHBhoc 
N-AN HO&: ~NY.N.J ~ Oy 
1.& N ~NHAlioc 
20% 
140 
Scheme 3.26 Synthesis of 140 using PNA monomer synthesis conditions 
The poor yield was unexpected and reproducible. It was known from the synthesis of 
PNA monomers that activation of the nucleobase acetic acids using standard reagents 
other than pivaloyl chloride resulted in their destruction. However a mild carboxylate 
activating reagent (that cannot be used for the synthesis of the PNA monomers) that 
could be used to couple 75 and 139 was made investigated. N-Isobutyloxy-carbonyl-2-
isobutyloxy-I,2-dihydroquinoline (IIDQ) 141 is an unusual peptide coupling reagent 
because it activates carboxylic acids without base and can do so in the presence of 
amines (Figure 3.32).[14. 15] In practical tenns an amide can be synthesized by simply 
mixing equimolar amounts of an acid and amine with a slight molar excess of the IIDQ 
coupling reagentJl6. 17] 
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• 
141 
Figure 3.32 1100 activation of Bhoc adenyl acetic acid 
An attempt was made to couple 75 and 139 (Scheme 3.27). 
(i) 
• 
139 
NHBhoc 
N~N 
HO ~ .. JL ~ ~ N I "'=: o~ NHAlloc o N~ 
140 
(i) 75, 1100, NEt3 2.0 equiv., CH2CI2, RT, 24h 
Scheme 3.27 1100 mediated coupling of 75 and 139 
NHBhoc 
N~N~ NHBhoc ~)--N N:rN~ 
C(°Y NHAlioc ~N J "'=: ° ( (01( 10 NH ~ ° 
142 143 
In this instance the IIDQ activated intennediate did not discriminate (at RT) between 
the amine or alcohols present in the system and gave an inseparable mixture of-
compounds (Figure 3.33). 
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Figure 3.33 LC-MS trace of crude reaction mixture of liDO mediated formation of 140 
It was decided that it would be easier to optimise the original mixed anhydride method 
than the (slow) IIDQ reaction and this approach was abandoned. 
A procedure optimised for the conversion of 139 into 140 was developed (Scheme 
3.28). 
(i-iii) 
.. 
(i) N-methyl morpholine (3.0 equiv.), MeCN, RT, 5 min 
(ii) -15°C then pivaloyl chloride (1.0 equiv.), -15°C, 30 min 
NHBhoc 
HO t~N~ -~ ~~:; 
QN~NHAIIOC 
96% relative to 139 
140 
(iii) 139 (0.66 equiv.), MeCN/H20 (1:1), Et3N (1.0 equiv.), RT, 36 h 
Scheme 3.28 Optimised conditions for the acylation of 139 via mixed anhydride methodology 
Amine 139 was considered to be the most precious component of the reaction and its 
conversion to 140 was maximized by increasing the amount of activated 75 in the_ 
reaction by 50% 
The final step in the synthesis of the linker was the oxidation of the benzylic alcohol to 
the aldehyde. A mild oxidation procedure was required that would not disrupt the fragile 
Bhot: ~protecting group and ideally give complete conversion into 144 (ie no over-
oxidation). TPAP mediated oxidation was initially selected (Scheme 3.29). 
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NHBhoc 
HO ()(; . 
&:~~ 10 N ~NHAlloc 
140 
(i-H) 
(i) NMO (1.5 equiv.), 4A mol sieves, CH2CI2, RT, 10 min 
(ii) TPAP (20 mol %), RT, 3 h 
Scheme 3.29 TPAP mediated oxidation of 140 
.. 
NHBhoc 
N:)cN 
o ~ 1 ~ &:N N ~ 0y 10 N ~NHAlloc 
49% 
144 
The reaction could not be driven to completion and separation of 144 from the alcohol 
precursor was very difficult as the two compounds co-elute. Removal of the spent 
ruthenium metal catalyst was also non trivial and contributed toward the low isolated 
yield of 144. 
Other methods of oxidation of 140 were investigated to maximize the yield of 144 and 
minimize waste of precious alcohol 140. Swem oxidation failed to improve the yield, 
however Dess-Martin oxidation gave a markedly better yield (Scheme 3.30). 
(i) 
(i) Dess-Martin periodinane (2.0 equiv.), CH2CI2, RT, 3 h 
Scheme 3.30 Dess-Martin periodinane mediated oxidation of 140 
NHBhoc 
N:)cN 
o 1:--. 1 ~ &:"::N N ~ Oy 1 0 N~NHAlloc 
88% 
144 
The reaction delivered 144 in much improved yield relative to the other methods tested. 
These conditions were deemed satisfactory for the conversion of 140 into 144 and 
completed the overall synthesis of the peptide to PNA linker. 
The objective of devising synthetic routes that could deliver both linkers on a multigram 
scaly .had been achieved (Figure 3.34). 
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Linker 1 synthesis 
100 
(i-iii) 
58% 
(vii-ix) 
97% 
(i) EtOH, potassium hydroxide, BO°C, 10 min 
(ii) 3-hydroxybenzaldehyde, RT, 90 min 
(iii) Sodium borohydride, AT, 30 min 
(iv) MeCN, NMM, AT, 5 min 
(v) add to pivaloyl chloride, -15°C, 25 min 
(vi) 98, triethylamine, MeCN/H20 (1 :1), 16 h, RT (vii) H20, lithium hydroxide, DoC, 5-10 min (viii) Acetic anhydride, 10% NaOH solution, ice, 1 min 
(x) 
86% 
(vii-ix) 
84% 
Linker 2 synthesis 
111 
~NHBOC (i-iii) H2N . 
137 
/'.. .NH CI 
AliocHN''''''''''' 3 
(;v-v;) 1391~OH H 
· QN ~NHAlioc 
83% 90% 
140 NHBhoc N~N 144 NHBhoc 
(vii-ix) HO ~_.JL;> &: N (x) 
N:):N 
o ,~ 1 ;> &:~N N ~ 0y 1.0 N ~NHAlioc 
96% 
(i) NEt3, CH2CI2, AT, 5 min 
(ii) Allylchloroformate (dropwise), CH2CI2, O°C, 30 min then AT, 24 h 
(iii) Acetyl chloride 3 equiv" MeOH, O°C, 30 min then 136, AT, 3 h 
(iv) 137, NaHC03 solution, AT, 1 h 
(v) Evaporate to dryness then NaBH4/H20, O°C, 30 min (vi) DoC, 3M HCI 
(vii)- N-methyl morpholine (3.0 equiv.), MeCN, AT, 5 min 
(viii) -15°C then pivaloyl chloride (1.0 equiv.), -15°C, 30 min 
(ix) 139 (0.66 equiv.), MeCN/H20 (1:1), Et3N (1.0 equiv.), AT, 36 h (x) Oess-Martin periodinane (2.0 equiv.), CH2CI2, AT, 3 h 
Figure 3.34 Summary of Linker synthesis routes 
~ Oy 
1.0 N ~NHAlioc 
88% 
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With the PNA monomers and two linker units in hand, the synthesis of the PNA-peptide 
chimeras was undertaken. 
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Chapter 4 
Chapter 4 - Hybrid Assembly 
With reliable synthetic routes to each of the six starting materials established, it was 
now possible to attempt the construction of the PNA-peptide chimeras. The proposed 
work was without precedent, and as such a significant amount of solid phase chemistry 
remained to be developed for the synthesis of the full size chimeras. In particular, 
conditions had to be developed to incorporate the linker constructs 103 and 144 into the 
chimeras that are also compatible with SPPS. In preparation for the synthesis of full size 
chimeras, small model systems were devised to develop the chemistry required for the 
ligation experiments. Ultimately our aim with this work was to establish reliable and 
generic routes for the synthesis of PNA to peptide and peptide to PNA chimeras that 
would scale up to preparative quantities. 
4.1 Synthesis of a PNA to peptide chimera 
We were aware that the synthesis of the large target PNA to peptide chimera (Figure 
4.1) could be non-trivial at some stages of its assembly. 
Figure 4.1 PNA to peptide chimera target molecule 
Acyla~ing the linker phenol with an amino acid had been anticipated to be potentially 
difficult, according to prior knowledge of phenolic ester formation within the group. 
Successfully growing a peptide from the amino acid anchored to linker 103 would also 
present its own set of problems if the peptidyl phenolic ester proved to be unstable to 
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standard SPPS conditions. It was decided to first make model chimeras to develop 
chemistry that would overcome these and any other problems that could arise and allow 
for a smooth synthesis of the full size chimera. The linear synthesis of the model 
chimera involved three stages before cleavage from the resin (Figure 4.2). 
O§NH2 
(ii) 
~ ~-( LINKER 1 }-OH 
~ 0-8-{ LINKER 1 H PEPTIDE) 
(i) PNA oligomer synthesis 
(iv) 
~ 81 LINKER 1 H PEPTIDE) 
(ii) Linker attachment and de protection 
(iii) Peptide oligomer synthesis 
(iv) Resin cleavage 
Figure 4.2 Assembly of a PNA to peptide chimera 
To minimise the amount of PNA monomer used in these test studies it was decided to 
develop the solid phase chemistry in discrete out-of-sequence stages. The first stage was 
to establish conditions for loading the linker onto a solid-supported amine and deprotect 
it (Figure 4.3). 
Q-NH2 ====> o-~-{ LINKER 1 }-OAC ====> o-~-{ LINKER 1 }-OH 
Figure 4.3 Stage one of the solid supported synthesis of the PNA to peptide chimera 
The second .stage built upon the results of the first stage by grafting amino acids onto 
the phenol. This represented two tasks. First and foremost was finding a method to 
quantitatively acylate the phenol with an amino acid. The second was to maintain the 
phenol ester linkage intact during the elaboration of the amino acid into a large 
polypeptide using standard SPPS conditions (Figure 4.4); 
Q--( LINKER 1 }-OH 
o 
o-~-{ LINKER 1 }-O~ Amino aCid) 
o 
o-~-{ LINKER 1 }-O~ Peptide 
Fig 2J~4 Stage two of development of the solid supported PNA to peptide chimera 
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The third stage was to establish conditions for the clean synthesis of a short PNA 
oligomer (Figure 4.5): 
Q-NH2 ==> o-~-{ PNA oligomer )-NHFmoc 
Fig 4.5 Stage three of development of the solid supported PNA to peptide chimera 
When all three stages were completed the conditions established therein would be used 
in the correct order (3,1,2) to synthesise a PNA to peptide chimera. By developing 
stages one and two independently of stage 3 it was thought that potentially a substantial 
amount ofPNA monomer material would be conserved. 
4.1.1 Stage 1 - Linker 1 attachment and deprotection 
It was decided to build the model chimeras upon 2-chlorotrityl resin as it offers mild 
cleavage conditions and can also be purchased in preloaded form. 
2-Chlorotrityl resin (pre loaded with glycine) 145 was coupled with linker 103 that had 
been preactivated with HCTU and DIPEA (Scheme 4.1). 
2-chlorotrityl resin 
2~ ~ CI OPh '0 NH2 Phr 
o 
145 
(i) 
(i) 103, HCTU (4.9 equiv.), diisopropylethylamine (10.0 equiv), DMF, 1 h 
Scheme 4.1 Attachment of 103 to glycine preloaded on 2-chlorotrityl resin 
146 
Treatment of an analytical sample of resin with a standard cleavage cocktail of 
TF Altriethylsilane/water (95.0:2.5:2.5) for 30 min was followed by LC-MS analysis' 
(Figure 4.6). 
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Figure 4.6 LC-MS (BPI, upper trace) and LC-UV (lower trace) data of cleaved glycine-linker hybrid 
Despite considerable noise within the ion trace (a characteristic problem with weak 
analytical samples) the product was both present and was also the major UV-active 
component. The other minor UV -active compound could not be identified. With the 
linker in place, deprotection of the phenol was undertaken. The acetate protecting group 
is well known, especially in solid-supported carbohydrate chemistry. It was thought that 
conditions used from that class of chemistry would be equally adept in the deprotection 
of 146. A procedure by Seeberger for the synthesis ofj3 1-4 linked polyglucosaccharides 
was investigated wherein an axial acetate was efficiently removed with sodium 
methoxide solutionYl The same conditions were used to cleave the acetate of 146 
(Scheme 4.2): 
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2-chlorotrityl resin 
(i) 
146 
(i) MeONa (6.0 equiv.), MeOH/CH2CI2(1 :9), RT, 2 h 
Scheme 4.2 Methanolysis of acetate protecting group 
9 HN~I 
o 0 A.J Y'" 0 N 
~NHOy ~ 
O~N~OH 
147 
Treatment of the resin with sodium methoxide gave complete acetate cleavage. Standard 
acidic cleavage of the resin liberated 147b and was detected by LC-MS analysis (Figure 
4.7). 
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Figure 4.7 LC-MS data of the acetate deprotection 
The scale of these test reactions was such that the small amounts of material used to 
make }47b were insufficient for NMR analysis. Given the limited time remaining, it 
was decided to press ahead with the synthesis of the chimeras. 
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It was felt that the conditions developed during this work were suitable for attaching 
and deprotecting the linker on a full size chimera; the second stage of chimera synthesis 
was then undertaken. 
4.1.2 Stage 2 - Growth of a peptide from the unmasked phenol 
Ultimately, in the full-size chimera ligation experiments, it is desired that the peptide 
attached to the phenol will ideally be any sequence of choice. However for the purposes 
of the test ligation, and to promote the best chance of success in the initial ligation 
experiments, the first amino acid will always be a glycine residue. This was decided 
upon so to minimise any steric repulsion between the ligating junctions, caused by the 
clashing of amino acid side-chains; it was thought that such interactions could retard the 
ligation process. 
The next stage in the synthesis to be developed was the stepwise assembly of a 
polypeptide from the unmasked linker phenol. It was known that forming and keeping a 
phenolic ester intact can be difficult, however we were confident that reaction 
conditions could be found to suit our needs. Furthermore a suitable degree of reactivity 
of the ester was welcomed as this would serve to promote the directed ligation reaction. 
Acylation of phenol 147 with Fmoc-Glycine was attempted using conditions that were 
proven for p.henolic ester synthesis (Scheme 4.3)Yl 
Q--@!V--{ Linker 1 }-OH (i) 
o 
~ Linker 1 }-o~NHFmoc 
(i) Fmocglycine (5.0 equiv.), EDC (5.0 equiv.), DMAP (5.0 Equiv.), DMF, RT, 16 h 
Scheme 4.3 Attachment of fmocglycine to the linker phenol 
A sample of the resin was cleaved under very mild acidic conditions-
(TF AI AcOH/CH2Cb, I: 1 :8) to minimise phenol ester hydrolysis that could occur as a 
result of low pH. 
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Figure 4.8 LC-MS trace of the acylation of phenol 147 with Fmoc glycine 
148 was observed as the major product although a small amount of starting phenol 147 
was also present. The resin was treated again with the peptide coupling conditions and a 
test cleavage revealed that the phenol was still present in the sample. This result 
suggested that double coupling does not improve the formation of ester 148. There were 
a few possible reasons to explain why the reaction appears to be incomplete, however it 
was most likely that the phenolic ester was slightly unstable under the basic reaction 
conditions, resulting in partial hydrolysis of the ester. 
With the Fmoc glycine residue appended onto the phenol, the remainder of the test 
peptide could then be assembled using standard SPPS conditions. The sequence of this 
test peptide was decided to be Gly-Gln-Lys-Val. After two residues had been attached 
(Gly-Gln), a portion of the resin was cleaved under standard conditions and analysed 
(Scheme 4.4). 
o G-i Hybrid }-o~NHFmoc (i) 
148 
(i) 5 x DMF/piperidine (4:1) wash 1 RT, 2 min then 5 x DMF, RT, 2 min 
o 
149 
NFmoc 
H 
(ii) Fmoc Glutamine (Trt) (5.0 equiv.), HCTU (4.9 equiv.), DIPEA (10 Equiv.), DMF, RT, 1 h 
(iii) 5 x DMF wash, RT, 2 min 
Scheme 4.4 Extension of linker bound peptide 
Mild acid cleavage of the resin repeatedly failed to give a good LC-MS trace and so it' 
was decided to proceed with strong acid cleavage conditions instead. The strong acid 
c1e~vage conditions would however now bring the stability of the phenolic ester linkage 
under scrutiny once more. A portion of the resin was dried and cleaved using a cleavage 
cocktail of TF AlTIS (95 :5) and analysed by LC-MS (Fig 4.9). 
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Figure 4.9 LC-MS trace of strong acid cleavage of resin bearing derivitised phenol 
LC-MS analysis revealed that there was only one major product but that it not the 
desired compound. The mass ion observed was equal to the mass of product 148 but 
less the mass of glycine. There are two molecules of glycine in hybrid 148 but it could 
not be established if glycine had been lost from the product (giving 149 or 150) or if the 
peak corresponded to a non-related compound. The most logical explanation was that 
148 was unstable to Fmoc deprotection conditions (20% piperidine in DMF) and that 
the ester 148 was therefore cleaved, regenerating phenol 147 (Scheme 4.4). Treatment 
of 147 with the HCTU-activated glutamine would then give the observed mass ion. 
However, if Fmoc deprotection occurred before the proposed cleavage (151) and had 
activated the cleavage process (151 to 147) was not known. 
o 
O~NHFA10C 
o ~/ 
148 
o 
o~NHFmoc 
o ~/ 
(i) Piperidine/OMF (1 :4) 
(i) 
(i) ~ ~/ 
147 
(ii) HCTU, diisopropylethyamine, Fmocglutamine(Trt) 
(ii) 
~------- ... 
(ii) 
CONHTrt 
o H ~ o~N~NHFmo A 0 c 
~/ 
149 
o 
~NHFmoc 
;l, ~CONHTrt 
~/ 
150 
Scheme 4.4. Possible fates of 148 undergoing second cycle of pepide synthesis based on observed MS data 
To determine (unambiguously) if glycine was being lost during the strong acid resin-
cleavage of the hybrid, an analogue hybrid needed to be built upon 2-chlorotrityl resin 
that was not preloaded with glycine. This analogue would therefore only contain one 
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instance of glycine in its structure (the phenolic glycine ester) and using this compound 
for the SPPS experiments would determine with absolute certainty if indeed the 
phenolic glycine ester waS base-labile. 
The hybrid analogue was designed with the 2-chlorotrityl-linked glycine being replaced 
by a T -PNA monomer, the most accessible and abundant of the four monomers (Figure 
4.1 0). 
o f) 0 
HNYy ~o~NHFmoc O~N) (NyO 0 
o oy HNAO .... NJ.lNH o-O~N~ Yo 
2-chlorotrityl Linker shown in bold 
153 
Figure 4.10 Alternative test hybrid 
2-Chlorotrityl chloride resin was loaded according to an established procedure with T-
PNA monomer 37Y] Freshly loaded 2-chlorotrityl chloride resin is unstable in the 
presence of an Fmoc group[3] and PNA monomers are unstable when unprotected, [4] 
thus immediate deprotection and coupling with linker 103 was required (Figure 4.11). 
Resin loading was adjudged to be very poor as approximately half of the resin was 
required for. cleavage to obtain a signal in the LC-MS trace. The desired intermediate 
hybrid 154 was the only product observed. 
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Figure 4.11 LC-MS of T-PNAIlinker hybrid cleaved from manually loaded 2-chlorotrity resin 
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The resin was treated with the acetate cleavage conditions of Seeberger and half of the 
remaining resin (half was necessary due to poor loading) was cleaved for LC-MS 
analysis (Figure 4.12). 
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Figure 4.12. LC-MS data of deprotected T-PNAIlinker hybrid 
Despite the weakness of the LC-MS traces, it was observed that the phenol analogue 
had been synthesised. There remained three synthetic steps to reach the desired 
dipeptide ester; coupling of Fmocglycine, deprotection of the Fmocglycine ester and 
coupling of the next amino acid (Fmocglutamine). However, at this point there was only 
enough resin sufficient for a single analytical cleavage experiment, therefore the resin 
could not be analysed until the end of the three-step synthetic sequence. 
The three step synthesis of the dipeptide was performed and all of the remaining resin 
was cleaved under anhydrous strong acid conditions (TF A/TES, 95 :5). Unfortunately:, 
LC-MS analysis was inclusive as there was insufficient material to generate an 
observable signal; poor loading of the resin had prevented there being enough material 
for .analysis of the final compound. It was thought that the resin would have to be 
pre loaded to overcome this problem. 
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The model ester 148 was resynthesised on 2-chlorotrityl resin preloaded with glycine. 
This compound was used to study the stability of the phenol ester and it was now 
assumed that only the resin-linked glycine component was not labile. 
A study to determine if (and how) the ester was being destroyed was then undertaken. 
There was conceivably more than one way in which the ester could be converted into 
the phenol (Figure 4.13) and it was necessary to determine the pathway of degradation. 
Figure 4.14 Illustration of the hypothesis that nucleophilic cleavage conditions affect 
148 and 146 equally 
To examine the effect of piperidine on the phenolic ester, 148 was treated with standard 
Fmoc deprotection conditions and an analytical portion of the resin was cleaved 
(TFA/TIS, 95:5) and analysed immediately (Figure 4.14). The sample showed 
quantitative conversion to the phenol, demonstrating that the Fmocglycine phenolic 
ester was not stable to piperidine and that SPPS in the presence of the ester was not 
possible using standard conditions. 
o 
(i) (i) o~ ~ ~, 
148 147 146 
(i) Piperidine/DMF (1 :4) 
Figure 4.13 Possible pathways of phenolic ester degradation under SPPS conditions 
To determine if the Fmocglycine ester was especially sensititive to the piperidine-
solution, the experiment was repeated with acetate-protected precursor 146 (Figure 
4.14). Treating acetate 146 with 20% piperidine/DMF, as per standard fmoe' 
deprotection conditions, did not fully remove the acetate protecting group (Figure 4.15). 
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Figure 4.15 LC-MS trace of incomplete aminolysis of phenol acetate 146 with piperidine 
Repeating the deprotection sequence completed aminolysis of acetate 146 (Figure 4.16). 
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Figure 4.16 LC-MS trace of the total aminolysis of phenol acetate 146 
It was concluded that because the aminolysis of the acetate was sluggish compared to 
148 that the, Fmocglycine ester was not undergoing simple aminolysis. Interestingly, the 
aminolysis of 146 had demonstrated a new set of deprotection conditions for the acetate. 
It was thought that the product obtained from the initial studies (Figure 4.9) was 150. It 
was believed that piperidine mediated aminolysis of the Fmocglycine ester regenerated 
the phenol which in tum was then acylated with HCTU-activated Fmocglutamine_ 
(Figure 4.17). 
o-~@!U--NHFmoc 
(i) Piperidine/DMF (1 :4) 
(ii) Diisopropylethylamine, 156 
(i) 
- 0-( Hybrid }--OH (ii) 
-
o-(Hybrid l--~NHFmoc 
Chlorohydroxybenzotriazole 
ester should not react well with ~ 
the hybrid phenol 
o 
o~NHFmoc 
I 
,N 156 
NN-O-CI 
Figure 4.17 Schematic representation of possible HCTU-activated amino acid coupling with phenol 
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It was thought however that an amino acid activated with HCTU would not efficiently 
acyl ate the phenol. To determine if the phenol could be acylated with an HCTU-
activated amino acid, phenol 147 was treated with Fmocglycine under standard 
coupling conditions. It was found that the phenol was easily converted to 148 using 
these conditions. This result confirmed that standard SPPS conditions caused ester 
aminolysis and concomitant HCTU-mediated acylation of the phenol with the next 
amino acid of the peptide sequence. 
In order to overcome this problem, alternative Fmoc deblocking conditions were 
required that would not cause aminolysis of the ester. 
Non-nucleophilic Fmoc deprotection conditions reported by Bu et al. detailed the 
synthesis of a decapeptide bound to tentagel resin via a reactive thioester linkageyl 
These conditions were thought to be suitable for the Fmoc deprotection (in the presence 
of an electrophilic ester) and were used during an attempt to couple lysine onto the 
glycine ester (Scheme 4.5). 
o BocHN~ 
Q-( Hybrid }-o~NHFmoc (i) -------- .. 
o 
148 157 
(i) 3 x DBUlHOBt (0.80 mMol:0.74 mMol) DMF, RT, 1 min then 5 x DMF, RT.\1 min 
(ii) Fmoc Lysine(Boc) (5.0 equiv.), HCTU (4.9 equiv.), DIPEA (10 Equiv.), DMF, RT, 1 h 
(iii) 5 x DMF wash, RT, 2 min 
Scheme 4.5 Non-nucleophilic peptide fmoc deblocking conditions 
NFmoc 
H 
What was observed was the conversion of 148 into a 2:1 mixture of 158 and 157 
(Figure 4.18). 
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Figure 4.18 LC-MS trace of peptide elongation experiment using non-nucleophilic base 
The Fmoc glycine was only exposed to OBU for a relatively brief period, however the 
(relative amounts of) products observed show that the majority of 152 had dissociated 
into the phenol before the coupling reaction could occur. 
This result demonstrated that the Fmoc deprotected glycine ester is not stable at basic 
pH and that aminolysis (by the Fmoc-deblocking reagent) is not required for the ester to 
degrade. 
To test if the Fmoc-protected ester was stable to hydrolysis at basic pH, an LC-MS 
sample of 148 was treated with aqueous sodium hydrogen carbonate until the pH of the 
sample had been raised to pH 9, and was then agitated for 20 min. Under these 
conditions the Fmoc group was stable and would remain intact. The sample was 
resubmitted for analysis by LC-MS, to search for evidence of ester hydrolysis at basic-
pH with the Fmoc group intact; the hydrolysed ester was not observed, strongly 
suggesting that the sample had remained unchanged. The results obtained thus far had 
shown that the Fmoc-protected ester was stable to hydrolysis up to at least pH 9.0 and 
that ester degradation occurred rapidly once deprotection had occurred. This 
degradation had been shown to be due to independent of the nucleophilicity of the 
amine used to effect Fmoc deprotection. These results therefore suggested that auto-
aminolysis of the deprotected ester was occurring; inter-chain aminolysis was possible 
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but improbable as the resin loading was too low «1 mmol per gram) for this to be a 
feasible consideration. 
To test if the ester was undergoing auto-aminolysis, 147 was synthesised on 2-
chlorotrityl resin (preloaded with glycine) and coupled with Boc-glycine. The idea was 
to trigger (acid-catalysed) global resin cleavage and ester deprotection to give the 
protonated glycine amine; in this form, auto aminolysis could not occur and therefore 
the deprotected ester would be observable by LC-MS. The resin was treated with a 
standard cleavage ofTFA/TIS (95:5) and analysed by LC-MS (Figure 4.19). 
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Figure 4.19 LC-MS trace of Boc deprotected variant of the model hybrid 
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The deprotected glycyl phenolic ester 148 was observed as the only product in the LC-
MS trace. To show that the free amine was responsible in causing the ester degradation, 
the LC-MS sample of 159 was neutralised with non-nucleophilic diisopropylethylamine 
and resubmitted for LC-MS analysis. Phenol 147 was observed as the only product. The 
experiments had shown that the free amine was unstable at neutral or basic pH. For 
auto-aminolysis to occur however, a highly strained 3-membered transition state has to 
be passed though, and this seems unlikely to occur. How the ester is degrading is 
therefore still uncertain, although in the absence of other explanations it could be that 
inter-chain aminolysis was occurring on-resin. The main conclusion from the 
investigation is that it is not possible to grow a peptide from 147 using standard Fmoc 
solid phase chemistry. It was thought that the only option available to overcome this 
problem was to attach a fully assembled polypeptide onto the phenol. Although this 
solution increased the labour involved for the chimera synthesis, it was also welcomed 
as i~ increased synthetic convergency and circumvented a potential problem that could 
have occurred when growing the polypeptide from two to three residues 
(diketopiperazine formation, Figure 4.20). 
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> ~ -~~OH 
Scheme 4.20 Potential diketopiperazine (DKP) formation after Fmoc deprotection of 
second amino acid 
To complete the synthesis of the chimera, the coupling of a small tetramer peptide with 
147 was investigated. Phenol 147 was synthesised again on 2-chlorotrityl resin and 
treated under standard coupling conditions with the protected tetramer peptide 
A VN(Trt)E(Boc)NHBoc that had been prepared previously in the group by Nagalingam 
(Scheme 4.7).[6] 
2-chlorotrityl resin 
Q-{ Hybrid }-OH 
147 
(i) 
---------~ 
160 
(i) AVN(Trt)E(Boc)NHBoc (5.0 equiv.), HCTU (4.9 equiv.), DIPEA (10 Equiv.), DMF, RT, 1 h 
(ii) 5 x DMF wash, RT, 2 min 
Scheme 4.7 Coupling of tetramer peptide to 147 
The coupling reaction was unsuccessful. Analytical portions of the resin were cleaved 
under both mild and strong acid conditions and analysed by LC-MS; both sets of 
conditions gave the same trace (Figure 4.21). 
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Figure 4.21 LC-MS trace of tetramer peptide coupling experiment 
161 has a [M+Ht of 1086 mlz and sidechain protected 161 has a [M+Ht of 1383 mlz; 
neither of the two peaks observed in the LC-MS spectrum were related to the masses of 
146 
the product or the starting materials. The sum of the two observed masses (assuming 
they are [M+Ht ions) does not equal, nor is close to, the mass required for 161 (nor its 
protected form), implying that product 160 had not degraded under acid cleavage into 
two smaller fragments ie protolysis of benzylic amine bond. 
The short peptide used as the coupling partner for 147 was analysed for contaminants 
by LC-MS and found to be a pure sample of the expected tetramer. The coupling 
experiment with this peptide was repeated with similarly unsuccessful results. 
To establish if and how the peptide was involved in the synthesis of the unknown 
compound (of mass [768]) the phenol-peptide coupling experiment was repeated with a 
different tetramer. 
In preparation of the new coupling experiment, peptide fully protected G-N(Trt)-
Glu(Bu)-Lys(Boc)NHBoc 162 was synthesised on 2-chlorotrityl resin pre loaded with 
glycine on a large (115.5 /-lMol) scale. For the purpose of the qualitative coupling 
experiment crude 162 was found to be sufficiently pure (Figure 4.22). 
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Figure 4.22 LC-MS trace of crude tetra mer peptide 162 
. 
An attempt to couple peptide 162 with 147 was made usmg HATU and DIPEA 
(Scheme 4.8). HATU was used ahead of HCTU for its superior reactivity, so to 
maximise the success of peptide activation and coupling. 
147 
Q-1 Hybrid }--OH (i) --------- .... 
(i) GN(Trt)E(Bu)L(Boc)NHBoc (10.0 equiv.), HATU (5.0 equiv.), DIPEA (10 equiv.), DMF, RT, 
1 h 
(ii) 5 x DMF wash, RT, 2 min 
Scheme 4.8 Coupling of alternative tetramer peptide to phenol 147 
The resin was treated with standard cleavage cocktail and analysed by LC-MS (Figure 
4.23). 
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Figure 4.23 LC-MS traces of G-N-E-L peptide coupling experiment 
The reaction had failed, but obtaining the same result as before with a different peptide 
was a telling result. This result proved that the unknown compound (of mass [769]) was 
not comprised in any part from the peptide component, and must therefore some other 
derivitive of the phenol. The difference in mass between the phenol and the mass of the-
observed peak is [100] and it was determined that this was the uronide cation 
component 163 of the coupling reagents HCTU/HATU (1641165, Figure 4.24). Uronide' 
163 was the only constant in the tetramer-peptide coupling experiments and it is thought 
that the product of the peptide coupling experiments is therefore cation 166. 
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Figure 4.24 Uronide capped phenol 
This result was unexpected and did not follow prior observation wherein identical 
conditions had successfully coupled 147 with Fmoc glycine (without observation of 
uronide 166). 166 could only be fonned by reaction with either HCTU or HATU. In 
order for all of 147 to be capped with uronide 163, two conditions must be true; There 
must have been a substantial amount of unreacted coupling reagent present in the 
reaction and 147 must react much faster with the coupling reagent than with the 
activated peptide. 
Given that the coupling experiment with 147 and 162 involved a large excess of 
peptide, relative to the amount of coupling reagent, it was concluded that the tetramer 
peptides must react sluggishly (relative to single amino acids) with uronium reagents 
164 and 165. It was believed that increasing the pre-activation time of the peptides five-
fold to 5 min would allow activation of the peptide to go to completion. This would 
remove the suspected reservoir of the uronide coupling reagent from the reaction, thus 
preventing formation of 166. A quick model study was perfonned to test this 
hypothesis .• 
Wang resin (only available resin at that time) was loaded with linker 103 and the phenol 
was unmasked via piperidine mediated aminolysis to give 167. Peptide 162 was 
preactivated with HCTU for 5 minutes and then agitated with the resin for 1 hour 
(Scheme 4.9). 
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Q-NHFmoc 
Wang 
(i -iv) 
(i) Piperidine/DMF (1 :4) 
(ii) 103, HATU (4.9 equiv.), DIPEA (5.0 equiv.), DMF, RT, 1 h 
(iii) Piperidine/DMF (1 :4) 
(iv) GN(Trt)E(tsu)L(Boc)NHBoc (5.0 equiv.), HCTU (4.9 equiv.), DIPEA (10 equiv.), DMF, RT, 
1 h 
Scheme 4.9 Working conditions for coupling short peptide to phenol 167 
A test cleavage of the resin with TFA/TES/water (95.0:2.5:2.5) gave a crude mixture 
that was analysed by LC-MS (Figure 4.25). 
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Figure 4.25 LC-MS traces of linker-pepide hybrid 168 
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16~ was the only product within the crude reaction mixture; the uronide capped phenol 
was not observed. A very small amount of the starting phenol was observed, however 
prolonged coupling time or double-coupling should drive the reaction to completion. 
This result suggests that the original hypothesis concerning activation time was correct 
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and that it is practical to attach polypeptides to the linker in this manner. With the 
phenol/peptide coupling procedures established, the final stage of the chimera synthesis 
was undertaken. 
4.1.3 Stage 3 - PNA oligomerisation and full assembly of a PNA - peptide chimera 
A simple PNA-peptide chimera that was suitable for use in test ligations was drafted for 
synthesis (Figure 4.26). 
H02C Linker 1 )~-NHFmoc 
~.~ ~ - - - ~ ? lJ ~ 
PNA solubllilty ~ Purification 
enhancer PNA oligomer target Phenolic ester linkage handle 
Figure 4.26 Target PNA-peptide chimera 
The PNA sequence was designed with several criteria in mind. It was required that it 
contained all four PNA monomers I nucleobases, with the stronger G-C pairs being 
distributed evenly throughout the helix, to ensure that a tight helix would form with the 
complementary strand. A G-C pair was placed at the helix terminus to minimise the 
probability of helical 'unzipping' (three hydrogen bonds compared to two hydrogen 
bonds in an A-T pair) and there were no repeat sequences (eg T -T -T) to help prevent the 
formation of hairpin structures. 
Ideally the linker unit would have been tagged with guanine or cytosine to give the most 
stable ligation site that was possible; however it was necessary to preserve the limited 
amount of G and C nucleobase acetic acid precursors available, and so T was chosen 
instead. 
It was known that PNA oligomers are poorly soluble in most solvents but that simply 
tagging either the N or C-terminus with an amino acid possessing a hydrophili~ 
sidechain greatly overcomes this problemY] It was decided to construct the PNA 
oligomer upon (readily available) Wang resin that was pre loaded with arginine in order 
to accommodate this design feature. Wang resin is acid labile and readily cleaved using 
standard conditions ofTFA/TES/H20 (95.0:2.5:2.5). 
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A PNA trimer was assembled using standard SPPS conditions upon the argmme-
preloaded Wang resin (Scheme 4.10). 
Q-@-NHFmoc 
Wang 
(i-ii) ~~-NHFmoc 
ii) Piperidine/DMF (1 :4) 
(ii) PNA monomer (5.0 equiv.), HCTU (4.9 equiv.), DIPEA (10 equiv.), DMF, RT, 
1 h; repeat sequence for next PNA monomer in sequence 
Figure 4.10 Partial PNA oligomer synthesis 
A portion of the resin was cleaved under standard conditions and analysed by LC-MS 
(Figure 4.28). 
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Figure 4.28 LC-MS trace of PNA trimer hybrid Arg-C-T-C 
The main peak at 7.54 min contained a large number of mass ions, however fully 
deprotected PNA trimer was present in the mix of mass ions detected, with the [M+Hr 
and [M + 2H]2+ ions being observed. The smaller peak at 7.23 min is comprised of what 
appears to be the [M+Ptb+Ht, [M+Ptb+2H]2+ and [M+Ptb+3H]3+ ions of 169. Ptb is 
relatively robust to acidic conditions and requires prolonged cleavage times to affect 
full cleavage and so its presence was not surprising. It was decided that the result had 
demonstrated successful trimer synthesis. The sequence for the PNA oligomer synthesis 
was completed and the linker unit coupling was attempted (Scheme 4.11). 
~NHFmoc (i) ---------.- Q-(§)-( CTCAG H Linker 1 }OAc 
Wang 170 
(i) .5.x Piperidine/DMF (1 : 4), RT, 2 min then 5 x DMF , RT, 2 min 
(ii) PNA monomer or linker (5 equiv.), HATU (4.9 equiv.), PNA base solution (3 J.1L per mg of 
monomer), RT, 1 h 
(iii) 5 x DMF , RT, 2 min 
Scheme 4.11 Partial chimera synthesis 
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A portion of the resin 170 was treated with formal cleavage conditions (TF AlTES, 
95:5), RT, 1 h) ensuring complete deprotection of the Arg/PNA side chains. The resin 
filtrate was analysed by LC-MS (Figure 4.29). 
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Figure 4.29 LC-MS trace of partially completed PNA to peptide chimera 
The synthesis had failed, giving an array of effectively inseparable compounds. Each 
peak contained many strong mass ion signals and the desired chimera was not present 
amongst them. 
To account for the many sideproducts, it was thought that the PNA monomers must 
contain contaminants. HP-LC analysis of the PNA monomers revealed that small 
amounts of PNA monomer starting materials were present in each of the respective A, C 
and G-monomers. T-PNA monomer was found to be pure. All impurities were removed 
from each PNA monomer (see Chapter 1). 
There was another possible reason or contributing factor for the failure of the PNA 
synthesis. Christensen demonstrated that backbone-unprotected PNA can undergo N-
terminal rearrangement at basic pH when using standard SPPS conditions (Figure 
4.30).[8] 
o 
HN:J:N~ 
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O-{PNA)YN~NH 
o H 
Figure 4.30 N-acyl transfer of deprotected PNA 
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Half-lives of the monomers (at pH 11) range from 1 day to several days, however the 
potential for generating small amounts of inseparable (structurally isomeric) failure 
sequence compounds was not tolerable. The optimised PNA synthesis protocol of Corey 
(for the manual oligomerisation of Bhoc/Fmoc PNA monomers) was chosen to replace 
the standard SPPS conditions that had been used in the previous failed experiment. [9] 
Using this method does not use a capping stage - for short PNA sequences, each 
coupling stage is instead driven to completion, as judged by the Kaiser test for free 
amines (no bluelblack colour). This approach is valid as the likelihood of a failure 
sequence is negligible (for short PNA sequences). 
PNA pentamer hybrid 171 was synthesised using the purified PNA monomers and the 
alternative PNA synthesis method (Scheme 4.12). 
Q-@-NHFmoc 
Wang 
(i) Q--@ill-( CTCAG }NHFmoc 
171 
(i) 1 x Piperidine/OMF (1 : 4), RT, 3 min then 2 x OMF , RT, 2 min 
(ii) 1 x Piperidine/OMF (1 : 4), RT, 3 min then 6 x OMF , RT, 2 min 
(ii) PNA monomer (5 equiv.), HATU (4.9 equiv.), PNA base solution (3 til per mg of 
monomer), RT, 1 h 
(iii) 6 x OMF , RT, 2 min 
Scheme 4.12 Hybrid PNA pentamer synthesis 
A portion of the resin 171 was cleaved under standard conditions and analysed by LC-
MS (Figure 4.31). 
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Figure 4.31 lC-MS traces of PNA oligomer CTGAG 
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The measures introduced to improve PNA synthesis had been effective. 
As all of the steps required for the synthesis of a PNA-peptide chimera had been 
achieved, the chimera assembly could then be undertaken using the methods and 
conditions developed. PNA oligomer 171 was now used in a continuing synthesis 
toward a PNA-peptide chimera. 
To expedite both the synthesis of the chimera and the first PNA-directed ligation 
reaction, it was decided that the peptide component of the chimera would be a single 
glycine residue. Transferring a single amino acid instead of a large polypeptide was a 
valid experiment for the purpose of a test ligation reaction. Using Fmocglycine as the 
transfer component also had strategic benefits for maximising success of the ligation 
reaction. Using the smallest amino acid available was thought to overcome any steric 
clashing at the ligation junction. Furthermore, a long polypeptide is less desirable (for 
the initial validation chemistry) because it could behave in a manner that would work 
against the ligation reaction e.g. obstructing the site of ligation or precipitating from 
solution. If the ligation was proven to not work with this simple chimera then it would 
be known that the linker architecture was most likely to be at fault and required 
redesign. From a practical viewpoint, transfer of Fmocglycine would be readily 
observed by the analytical techniques used to follow and characterise the reaction; It has 
a substantial mass [298] and a very UV active chromophore (Fmoc). It was decided that 
only when working conditions for PNA-directed ligation had been established that the 
scope of the work would expand toward larger chimera targets. 
To continue toward the completion of the chimera synthesis, PNA oligomer 171 was 
deprotected and thymine-containing linker 103 was appended onto the chain (Figure 
4.32). 
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Scheme 4.32 LC-MS of PNA-linker hybrid 
Deprotection of the phenol was then carried out using the Seeberger conditions for the 
prescribed 2 h.[I] Piperidine was not employed for acetate deprotection as it was found 
to introduce impurities (as assessed by LC-MS analysis) not observed with methoxide 
mediated deprotection. The resin was washed thoroughly with DMF and a small portion 
was cleaved and analysed by LC-MS (Figure 4.33). 
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Scheme 4.33 LC-MS of partially deprotected PNA-linker hybrid 
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In contrast to the earlier test studies, methoxide-mediated cleavage of 172 had not been 
completed within 2 h, evident by the presence of a significant quantity of acetate 172. 
The signal at 6.38 min could not be identified, although it was thought that it could be 
related to the chimera, given that its mass lies inbetween that of the phenol and the 
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target chimera. The resin was treated again with the phenol ester cleavage conditions for 
a longer period of 12 h. The result was not expected or favourable (Figure 4.34). 
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The expected phenol was not observed within the trace. It could not be determined if the 
proliferation of signals occurred because the hybrid had degraded under prolonged 
exposure to methoxide or if the sample had been contaminated. The PNA oligomer was 
resynthesised with freshly prepared reagents and the linker was appended to give the 
acetate 172 (Figure 4.35). 
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Figure 4.35 LC-MS of the PNA linker hybrid 
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Deprotection of the phenol was again attempted using the Seeberger conditions and an_ 
analytical portion of the resin was cleaved and then examined via LC-MS analysis 
(Figure 4.36). 
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Figure 4.36 LC-MS trace of methoxide-mediated acetate cleavage experiment 
The phenol was again not observed within the LC-MS trace. It was hypothesised that 
the sodium methoxide was cleaving the PNA hybrid from the solid support. Chimera 2 
is attached to Wang resin via a benzylic ester linkage (Figure 4.37). Whereas good LC-
MS data of the 171 and 172 was easily and reliably obtained, the phenol had proven 
very difficult to observe. Initially it was thought that the phenol was not easily ionised. 
However it" was now thought that there had been insufficient material within the 
cleavage sample for adequate detection of the phenol by the LC-MS instrument. 
Stability of the hybrids linkage to the resin had not been considered during the switch 
from 2-chlorotrityl to Wang resin. It had been assumed that the (generally) more 
chemically robust Wang resin would behave similarly to 2-chlorotrityl resin (on whiclr 
the acetate deprotection reaction had been proven successful) under the conditions used. 
However, 2-chlorotrityl resin is known to suppress DKP formation, whereas Wang resin' 
does not. [3] It is possible therefore that 2-chlorotrityl resin is more resistant to 
nucleophilic cleavage by methoxide than Wang resin. To test ifmethoxide was cleaving 
the' product from the Wang resin, the target chimera needed to be synthesised and 
deprotected on Rink amide resin. Rink amide resin is not susceptible to nucleophilic 
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cleavage conditions and was predicted to retain the phenol during acetate cleavage with 
methoxide (Figure 4.37). 
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Figure 4.37 Illustration of how the hybrids are linked to different solid supports 
Rink amide resin was not available in pre loaded form and it was felt that it was not 
necessary to append an amino acid onto the chimera C-terminus. PNA pentamer 
CTCAG was therefore synthesised upon Rink amide resin and linker 144 was appended 
in the usual manner. The acetate-protected hybrid was treated with the sodium 
methoxide deprotection conditions and a portion of the resin was cleaved and analysed 
(Figure 4.3~). 
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Figure 4.38 LC-MS data of hybrid phenol 173 
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173 was detected as the only major compound within the crude cleavage filtrate, 
proving that the Wang resin had been cleaved under the methoxide cleavage conditions. 
173 was then coupled with Fmoc glycine under standard conditions and the resin was 
shrunk, dried and cleaved with a standard cleavage cocktail (TF A/triethylsilane/water, 
95.0:2.5:2.5). The resin filtrates were triturated from cold ether and purified by 
preparative HPLC to recover 15.4 mg (53%) of 174 (Figures 4.39, 4.40). 
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Figure 4.39 LC-MS trace of purified chimera 174 
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Figure 4.40 Hi-resolution mass spectrum of chimera 174 
Molecular Weight: 1961.8977 
{M+2Hf+ 981.8790 
There was insufficient time to prepare a full-sized chimera bearing a large polypeptide 
however the chemistry to achieve this has been established. Chimera 174 had been 
completed and could be used in PNA-directed ligation experiments. 
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4.2 Peptide to PNA chimera synthesis 
Similar to the synthesis of the PNA to peptide (Figure 4.41) the main challenge in 
constructing this chimera was the development of conditions to incorporate the linker 
unit 144 into the chimera. 
Figure 4.41 Peptide to PNA chimera target 
There was no synthetic advantage to perfonning model studies for the attachment and 
deprotection of 144 because the preceding polypeptide to which the linker and PNA are 
appended was synthesised from (readily available) inexpensive materials and reagents. 
It was decided therefore that conditions for introducing the linker could be developed 
while trying to synthesise the full chimera target. 
4.2.1 Chimera design 
Design and synthesis of the chimera was constrained by three design features. The PNA 
sequence (by default) had to be complementary to its partner strand in 174 [other 
chimera]; Linker 144 had to be attached to the peptide via a glycine residue to minimise 
sterjc congestion about the ligation junction; Chemistry utilised in assembling the 
chimera had to be compatible with PNA, amino acids and the solid support (stable 
point of attachment). 
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Excepting the presence of the N-tenninal glycine, design of the short peptide sequence 
was mostly arbitrary. It was convenient however to choose arginine as the first residue 
of the sequence given that a supply of Wang resin preloaded with arginine was readily 
available. The size of the peptide was purposefully kept short to preclude physical 
complications that could arise from using longer peptides e.g. aggregation (Figure 4.42) 
H02C-~( Linker 2 )-@--(!)--@--®--@-NHFmoc 
1]' I I.. Y ) ~ 
Benzylic amine linkage 0 Complementary PNA Purification 
handle 
Figure 4.42 Schematic representaiton of target peptide-PNA chimera 
Tetramer peptide 145 was synthesised upon Wang resin preloaded with arginine, aided 
by the qualitative Kaiser test (Scheme 4.13). 
~NHFmoc 
Wang 
(i-iii) ~NHFmoc 
175 
(i) 5 x Piperidine/DMF (1 :4), RT, 2 min then 5 x DMF, RT, 2 min 
(ii) Amino acid (5.0 equiv.), HCTU (4.9 equiv.), DIPEA (10 Equiv.), DMF, RT, 1 h 
(iii) 5 x DMF wash, RT, 2 min then repeat sequence 
Scheme 4.13 Synthesis of peptide quadramer 175 
Double coupling of the threonine residue was required as indicated by a failed Kaiser 
test; the second coupling returned a negative Kaiser test. Cleavage and LC-Ms analysis 
of an analytical portion of resin showed that the peptide had been synthesised 
successfully without side-products. With the first component of the chimera in hand, 
the introduction of the linker was undertaken. 
4.2.2 Attachment of linker 2 
It was intended that linker 144 would be appended to the peptide using reductive 
amination conditions developed within the group by Nagalingam.[6] This chemistry is 
optimised for solid phase to overcome the problem of double-reductive amination of the 
starti.ng amine that would otherwise create failure sequences and dramatically lower 
final product yield; double-reductive amination is the sequential condensation and 
reduction of two equivalents of aldehyde with one equivalent of a primary amine. 
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Nagalingam reported two different sets of conditions for the solid-supported reductive 
amination of peptides with aryl aldehydes, however both utilise an amount of AcOH. 
The stability of the PNA/linker sidechain protecting group (Bhoc) was known to be very 
sensitive to acid and it was unknown if it would survive these reductive amination 
conditions. To determine the stability of 144 under these conditions, a mixture of 140 
and 144 (recovered from chromatographic purification of 144) was agitated in O.5M 
solution of AcOH dissolved in CH2Ch for 72 h and then analysed to determine the 
extent of any side-chain deprotection (Figure 4.43). 
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Figure 4.43 LC-MS trace of crude linker 144 after prolonged exposure to 0.5M acetic acid 
O.5M AcOH solution was the greatest concentration of AcOH utilised by Nagalingam 
and did not deprotect 140 or 144 to any detectable degree. With the stability of 144 in 
the acidic reaction conditions assured, the reductive amination was attempted (Scheme 
4.14). 
~NHFmoc 
Wang 
(i-iv) l"\_( 
---'---'--- v-\Arg-Tyr-Thr-Gly}{ Linker 2 }NHAlioc 
(i) 5 x Piperidine/DMF (1 :4), RT, 2 min then 5 x DMF, RT, 2 min 
(ii) Linker 144 (1.1 equiv.), CH2CI2, RT, 1 h (iii) AcOH (5.0 equiv.), NaBH(OAch (2.0 equiv.), CH2CI2, RT, 3 h (iv) 5 x CH2CI2 wash, RT, 2 min 
Scheme 4.14 Reductive amination for attachment of linker 144 to a solid supported peptide 
In this method the aldehyde was condensed with the resin bound amine to preform an 
aryl ~mine; addition of AcOH generated an iminium cation, the activated species that 
. 
undergoes reduction with sodium triacetoxyborohydride. 
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Analysis of filtrate from an aliquot of resin cleaved after 3 h (neat TF A, 5 min) 
indicated that the reduction was sluggish. The reaction was 20% complete after 3 hand 
did not appear to be evolving further. It was decided to add a further two equivalents of 
the hydride and agitate with the resin for another 3 h. Reduction was then gauged to be 
approximately 50% complete after the additional 3 h. There was no evidence that the 
addition of the excess reducing agent or prolonging of the reaction time had generated 
side products - it was therefore decided to force the reaction to completion. An 
additional eight equivalents of reducing agent were added to the resin mixture and the 
resin was agitated for a further 24 h. Analysis of a crude cleavage filtrate revealed that 
the peptide had been fully derivitised into the hybrid 176 (Figure 4.44) 
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176 was treated with an equi-molar solution of Boc anhydride and 
diisopropylethylamine in DMF to protect the glycine-linker nitrogen (protection 
required during PNA synthesis). It had to be assumed that the reaction was successful as 
it was not possible to cleave the chimera from the resin with the Boc group intact. If the 
amine had not been successfully protected, then it was thought that it would also not 
react with activated PNA monomers. 
4.2.3 Hybrid linker deprotection 
Alloc deprotection of 177 was performed using the method of Zorn. [J 0] 
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Wang V 
(i-ii) 
.. Q-{ Hybrid }-NH2 
Hybrid 
(i) 10 mol% Pd(PPh3)4, 10 mol % DABCO, CH2CI2, 1 h (ii) 8 x CH2CI2, 2 min, RT; 2 x TFAlCH2CI2 (0.2:99.8), 1 min, RT; 
5 x CH2CI2, 2 min, RT; 3 x DIPEAlCH2CI2 (5:95); 5 x CH2CI2, 2 min, RT 
Scheme 4_15 Deblocking the alloc protected hybrid 
Removing the palladium catalyst from the polymer matrix was attempted using the 
procedure of Thieret . [11] Post reaction the resin took on a grey colour and substantially 
increased in density, indicating that the Palladiumo catalyst had formed an adduct with 
the liberated amine. The workup had to be repeated at least twice to fully remove the 
palladium from the resin. It was later found that a general workup procedure used by 
Burt was much more effective at removing the palladium from the resin, and this 
procedure became the standard method.[12] Cleavage and analysis of the resin filtrate 
proved the deprotection to be successful (Figure 4.45). 
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Scheme 4.45 LC-MS trace of the hybrid after alloc deprotection 
4.2.4 Attachment of PNA; completion of the chimera 
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The chimera was to be completed by appending with the PNA oligomer CTGAG onto 
177. The hybrid was passed through the first two cycles of the PNA oligomer synthesis, 
and elaborated with a C-TFmoc PNA dimer (Scheme 4.16). 
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Oi Hybrid }-NH2 (i-iv) .. Oi Hybrid }--@-(!)-NHFmoc 
(i) 1 x Piperidine/DMF (1 : 4), RT, 3 min then 2 x DMF , RT, 2 min 
(ii) 1 x Piperidine/DMF (1 : 4), RT, 3 min then 6 x DMF , RT, 2 min 
(iii) PNA monomer (5 equiv.), HATU (4.9 equiv.), PNA base solution (3 ilL per mg of 
monomer), RT, 1 h 
(iv) 6 x DMF , RT, 2 min; repeat (i-iv) to attach next PNA monomer 
Scheme 4.16 Partial peptide to PNA chimera synthesis 
Analysis of the test cleavage filtrate indicated that 178 was the only compound present. 
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Figure 4.46 LC-MS trace of incomplete chimera 178 
The synthesis of chimera 178 was completed and the resin was dried and then cleaved 
with a standard cleavage cocktail (TF A/TIS/H20). Evaporation of the acid filtrate 
however did not yield a discemable amount of material and the product could not be 
detected by LC-MS analysis. It could not be determined why the synthesis had failed 
and so the chimera synthesis was undertaken again using the same methods. 
Peptide 175 was synthesised as per the previous method. Linker 144 was attached to the 
peptide using modified conditions to overcome the sluggish reduction that had been 
encountered earlier; the quantity of reducing agent was increased from two equivalents 
to ten and the reaction time was increased from 2 to 24 hours. Analysis of the resin-
however showed that the desired product 176 had not been synthesised - an unknown 
compound (28 amu heavier than 176, mass [944]) was the only signal observed in the' 
LC-MS. This result could not be explained. It was decided that deviating from the 
original reductive amination conditions had caused a major side reaction. 
Peptide 175 was synthesised again and treated with 144 and the original reductive 
amination conditions of Nagalingam. After the 3 h reaction period had elapsed, the resin 
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was analysed. It was found to contain a roughly equimolar mixture of the peptide and 
product -- the side-product of mass [944] was not detected. The reaction was stirred for 
an additional 24 h (without further addition of hydride) and analysed again; the relative 
amounts of product and starting material had remained unchanged. This indicated that 
the active hydride in the reaction had been exhausted. An additional two equivalents of 
the reducing agent were therefore added and agitated with the resin for a further 12h. 
Analysis of the resin revealed that the mixture was now mostly product although a small 
amount of peptide still remained (Figure 4.47). 
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With the reaction almost complete, it was decided to drive the reaction to completion 
with a final addition (two equivalents) of the hydride and agitate for 12 h. Cleavage and 
analysis of the resin proved to be illuminating (Figure 4.48). 
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Figure 4.48 LC-MS traces of reductive amination experiment 
Looking closely at the trace it was seen that the starting materials had been consumed 
and that there were two overlapping peaks. The major peak was the product and the 
smaller peak was the unknown compound of mass [944]. It appeared that following the 
complete consumption of the peptide, partial conversion of 176 into the mystery 
compound had occurred. It is thought that this process is occurring slowly relative to the 
reductive amination process and only in the presence of an excess of reducing agent. 
176 and the unknown compound were treated with boc anhydridellDIPEA for 1 hand 
then the Alloc group was removed. Cleavage and analysis of a small portion of the resin 
was conducted (Figure 4.49). 
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Figure 4.49 Alloc deprotection of the crude chimera mixture 
Within the overlapping peaks found at 5.10 min it was observed that both the product 
and a compound of mass 28 amu greater than 177 were present. This data demonstrateq 
that the Alloc group was not changed during the transformation of 176 into (176 + [28]) 
as the side product had been proven to have had an Alloc group. 
The mixture of 177 and the unidentified side product were then elaborated with the 
PNA oligomer CTGAG. Cleavage and LC-MS analysis were not conducted during 
PNA assembly so as to expedite the synthesis of the chimera target. The terminal Fmoc 
168 
group was removed from the hybrid pnor to cleavage from the solid support to 
maximise its aqueous solubility, increase the potential for ionisation (LC-MS detection) 
and minimise any clashing that could inhibit PNA duplex formation. Analysis of the 
resin revealed a number of different components within the crude cleavage mixture, 
however 179 was observed as a strong signal. The resin was cleaved with a standard 
reagent cocktail ofTFA/TIS/water (95.0:2.5:2.5) for 1 hat RT to give approximately 10 
mg of a crude residue that was purified by semi-preparative LC-MS. Of the four 
fractions collected, only one fraction was found to contain chimera 179 (Figure 4.50). 
The remaining three fractions gave incoherent LC-MS traces. 
The absolute mass of isolated 179 was less than 1 mg, an insufficient amount to 
properly execute a PNA directed ligation experiment. 
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Figure 4.50 LC-MS data of chimera 179 
179 needed to be synthesised in multi-milligram quantities. The formation of the--
unknown side product formed during the reductive amination had to be prevented in 
order to achieve this goal. It had been noted that the side-product formed gradually' 
under prolonged exposure to large amounts sodium triacetoxyborohydride added 
gradually; It was thought therefore that a short reaction time with a single addition of a 
large amount of reducing agent would promote rapid and full formation of 176. 
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Peptide 175 was synthesised, deprotected and then agititated in CH2Ch in the presence 
of 1.1 equiv. of linker 144 for 1 hat RT. 5.0 equiv of AcOH and 10.0 equiv. of sodium 
triacetoxyborohydride were added to the resin and agitation was continued for 3 h. 
Analysis of the resin after 3 h showed the reaction to be complete without formation of 
the side-product 176 (Figure 5.51): 
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Figure 5.51 LC-MS trace of optimised reductive amination conditions 
176 was treated with Boc anhydride/diisopropylethylamine in DMF to protect the naked 
amine as per the previous work. Deprotection of the hybrid via palladium-catalysed 
removal of the Alloc group proceeded smoothly (Figure 5.52). 
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Figure 5.52 LC-MS trace of alloc-deprotected hybrid 178 
178 was coupled with a C-PNA monomer under standard conditions and the resin was 
analysed (Figure 5.53). 
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180 is observed at 7.21 min, however the triad of peaks at 4.88,5.08 and 5.36 min could 
not be accounted for. It was assumed that the additional peaks were derived from 
genenll solid phase waste found in crude cleavage mixtures. 
180 was carried through to the end of the synthetic sequence without further analysis 
and prepared for cleavage in the usual manner; it was decided to retain the Fmoc group 
prior to cleavage to aid purification and also maximise the mass of the product that 
could be recovered. The dry resin was treated with a standard cleavage cocktail of 
TF A/TIS/water (95.0:2.5 :2.5) to afford 28 mg of crude material. In contrast to the other 
chimera, 181 was found to be only sparingly soluble in either water or organic solvents 
at RT. It was found that small amounts of the crude material would dissolve in DMF or 
DMSO at temperatures greater than 50°C, although slow precipitation occurred after 
heating was removed. Given the solubility issues, both purification and characterisation 
of the crude material was difficult. Analysis of a dilute sample (1 mg per mL, 0.41 
IlMol maximum amount) of crude 181 dissolved in DMF was carried out with LC-MS 
(Figure 5.54) 
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Although the LC-MS trace of the chimera was largely incoherent and noisy, 181 was 
observed within the trace. It was not known how well 181 can be detected by the LC-
MS instrument. Considering chimera 181 was readily detectable, the sample should also 
have been detectable. To complement the LC-MS analysis, the crude sample was 
examined by HP-LC and Hi Resolution mass spectrometry (Figures 5.55 - 5.57) . 
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HPLC analysis was run at a wavelength of [280 nm] which is more suitable for 
detecting nucleic acids and a strong signal was indeed observed at 22.86 min. The 
accurate mass spectrum was troubling. Although product 181 is clearly present, peptide 
175 dominates the ion count by approximately two orders of magnitude relative to 181. 
Peptide 175 can only have been generated by cleavage of the benzylic linker bond. It 
was of paramount importance to know if this cleavage occurred during ionisation of the 
sample or if 181 was destroyed during cleavage from the solid support. It is conceivabl~ 
that Boc protection of the amine, prior to the removal of the Alloc group from the 
hybr~d, activated the benzylic amine bond toward protolysis (Figure 5.58). 
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If this was true, then Boc protection of the amine is unsuitable for the chimera synthesis 
and a very acid labile nitrogen-protecting group is required instead. However, a silver 
lining to this development is that after a successful PNA-directed ligation, the post-
ligation peptide-PNA hybrid would be sufficiently activated for simple proto lytic 
cleavage of the unwanted directing group. It had been thought originally that initial 
ligation products would not be sufficiently labile toward cleavage of the linker/PNA 
hybrids and that a linker redesign would be required to accommodate this requirement 
of the methodology. It appeared that this would not be necessary and all that was 
required now was to overcome the chimera cleavage problem. 
However it should be noted that the peptide was not observed during the test cleavage 
of intermediate 180; it would have been expected to observe the peptide by LC-MS if 
indeed chimera 181 was sensitive to acid. 
At this juncture, the time remaining for the project had effectively elapsed. There was 
neither sufficent time nor material available to resynthesise the chimera. There was now 
only the opportunity to perform a simple test to search for evidence that the two 
chimeras would interact and ligate. A solution of crude 181 (6 mg) dissolved in 
DMSO/DMF (l: 1) 1 mL was purified by semi-preparative HPLC and fractions 
corresponding to the major UV-active elution peak (from the prior analytical HPLC 
trace) were collected. The combined fractions were evaporated to dryness to give 1.5 
mg of (what was assumed to be) chimera 181. This was estimated to be equal to 
approximately 0.61 IlMol of 181 and was taken up in 500 ilL of water/acetonitrile (l: 1). 
This ,.was added to a solution of 2mg (0.90 IlMol) of the complementary chimera 174 
dissolved in 500 ilL of water/acetonitrile (1: 1). The reaction mixture was neutralised 
with sodium hydrogen carbonate solution and stirred for 15 min. Analysis of the 
174 
mixture by LC-MS was difficult although UV activity correlated with two weak signals 
within the mass ion trace (Fig 5.59). 
mixchim 
banyc275-1 
10 ~ 0.97 
% 
0.75 
" 
7.98 
6.07 
2: Diode Array 
1'1 TIC 
1.80e7 
~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Time 
2.00 4.00 6.00 8.00 10.00 
mixchim 
barryc275.' 318 (5.878) 
Figure 5.59 LC-MS data from a crude PNA directed ligation experiment 
12.00 14.00 
1: Saln ESt 
18leS 
The signal at 7.98 min was 175 which (as the major component of the reaction) was 
expected to be observed. The second of the two major peaks observed in the UV -vis 
trace was identified as being PNA-linker phenol 173. How 175 was hydrolysed is nor 
clear, however it had been proven earlier that 175 was stable to saturated sodium 
hydrogen carbonate solution. The ligation product and 181 could not be detected; if 18i 
was present in the solution it would have been expected to have been annealed with 175 
and this had not been observed. Overall however there was insufficient evidence to 
state (with absolute confidence) what precisely caused chimera 175 to dissociate. The 
presence of phenol 173 could be construed as tentative evidence for a PNA-directed 
ligation, however the LC-MS data was too weak to be able to draw any firm 
175 
conclusions. The time allotted for the project the work towards PNA directed ligation of 
peptides expired at this point in the project and all work was then brought to an end. 
4.3 Conclusions 
The existing literature for the synthesis of PNA monomers is not clear nor easily 
reproducible. The absence of any example in the academic literature of the synthesis of 
Bhoc/Fmoc PNA monomers is a strong indication of this. These procedures have been 
modified so that they now reliably allow access to multi-gram quantities of the four 
major PNA monomers. 
The design and development of a set of novel linker molecules has been carried out. 
Difficulties associated with the synthesis of the PNA-derived linker units have been 
overcome and they are now accessible in multi-gram quantities. 
The chemistry required for the synthesis of the very large and architecturally rich and 
dense chimeras has been developed. Access to multigram quantities of the PNA to 
peptide chimera has been achieved and analytical quantities of the peptide to PNA 
chimera have also been synthesised. The majority of the problems encountered with the 
synthesis of the peptide to PNA chimera have been overcome. A brief investigation into 
alternative protecting groups for the linker-peptide amine linkage should be all that is 
required to optimise the current synthetic route and provide multi-gram quantities of the 
chimera. 
In summary novel methods have been developed to prepare complex conjugates ofPNA 
and peptides which have been designed to facilitate the templated synthesis of proteins. 
The preparation of these molecules has required significant optimisation of some 
technically challenging chemistry and the development of new routes to chimeras of 
peptides and PNA. With the fundamental synthesis of these molecules established 
strong foundations have been developed for the examination of PNA directed ligation 
reactions. 
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Experimental 
Chapter 5 
Chapter 5 - Experimental 
5.1 General Experimental 
THF was freshly distilled over sodium with benzophenone as an indicator, and DCM 
was distilled over calcium hydride. Ether refers to diethyl ether and petrol refers to 
petroleum ether (b.p. 40-60 0c). Solvents were removed under reduced pressure using a 
Biichi rotary evaporator and vacuubrand PC 2001 Vario pump. Samples were freed of 
remaining traces of solvents under high vacuum. 
Flash column chromatography was carried out usmg silica (35-70 ~lm particles) 
according to the method of Still, Kahne and Mitra. Thin layer chromatography was 
carried out on commercially available pre-coated plates (Merck silica Kieselgel 60F254). 
Proton and carbon NMR spectra were recorded on Bruker DPX 300 and DRX 500 
Fourier transfonn spectrometers using an internal deuterium lock. Chemical shifts are 
quoted in parts per million downfield of tetramethylsilane and values of coupling 
constants in Hertz. Carbon NMR spectra were recorded with broad band proton 
decoupling and DEPT, HMQC and HMBC and pulse sequences were routinely used to 
aid assignment of spectra. 
Melting points were detennined usmg a Reichert hot stage apparatus and are 
uncorrected. Infrared spectra were recorded on a Perkin Elmer Spectrum One FT-IR 
spectrometer. All IR spectra for solid samples were measured neat using a diamond 
compression plate system; all other samples were measured as a thin film on KBr plates. 
Nominal mass spectrometry was perfornled on a Waters/ Micromass ZMD instrument 
using electrospray ionisation. Accurate masses were obtained by the staff of the school 
of chemistry on a Micromass LCT (ToF) or Bruker MicroTOF instrument using 
electrospray ionisation. LC-MS was perfonned on a Waters/ Micromass ZQ instrument 
fitted with a Waters XTerra C 18 column (method F; MeCN :H20 with 0.1 % fonnic acid; 
"' 
1.5 min, 0:100, 6.0 min, 30:70, 6.5 min, 95:5, isocratic to 9 min). Analytical HPLC was 
perfonned on a Dionex system and preparative HPLC on a Gilson system. Reverse 
pha~e. solvents were acetonitrile and water containing 0.1 % TF A. 
Fmoc Amino acids (Advanced ChemTech and Novabiochem) contained the following 
side chain protection: Arg (Pbf), Asn and GIn (Trt), Asp and Glu (tert-butyl ester, 
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OBu\ Lys (N-Boc), Thr (tert-butyl ether, But), Tyr (tert-butyl ether, But). Peptide 
elongations were performed manually using standard Fmoc solid phase peptide 
synthesis outlined by Chan and White using a vacuum tank attached to a water 
aspirator. 2-Chloro trityl resin, Wang resin and Rink Amide Novagel™ resin were 
purchased from Novabiochem. DIC (Avocado), HOBt (Lancaster), HCTU and HA TU 
(Novabiochem) were used without further purification. Anhydrous DMF and anhydrous 
acetonitrile (Aldrich) were purchased and stored in a SureSeal bottle under nitrogen. 
Sodium benzyloxide (Aldrich) was purchased as a 1.0M solution in toluene and stored 
in a sure seal under nitrogen. All other reagents were purchased from Aldrich. 
IH NMR splitting patterns are abbreviated as follows: (s : singlet, d : doublet, t : triplet, 
q : quartet, bs : broad singlet and m : mUltiplet). In the instance of rotomeric 
compounds, the compounds are assigned as either A or B where B is the major isomer. 
5.2 Experimental 
2-( 5_methyl-2,4-dioxo-3,4-dihydropyrimidin-l (2H)-yl)acetic acid 
Methyl bromoacetate (15.2 mL, 159 mmol) was added dropwise to a vigorously stirred 
suspension of thymine (20.0g, 159mmol) and potassium carbonate (21.9 g, 159 mmol) 
in dry DMF (500 mL) at RT. The reaction was stirred for 20 h at RT and then inorganic 
salts were filtered from the reaction. The filtrate was evaporated to dryness and H20 
(150 mL) then 4M HCI (8 mL) were added to the crude residue and stirred for 30 min at 
RT. A colourless precipitate was recovered by filtration and washed with H20 (3 x 80 
mL). The solid was suspended in a mixture of H20 (160 mL) and 2M NaOH solution (8 
mt) and heated at reflux for I h, The reaction was cooled O°C and acidified with 4M 
HCl solution (50mL) while stirring for 90min. A colourless precipitate was collected by 
filtration, washed with H20 (3 x 100 mL) and dried under reduced pressure to give the 
title compound (15.96 g, 55%) as colourless amorphous crystals; Mp. 270-274°C 
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(decomp.); RfO.2 (EtOAclMeOH/AcOH, 75:20:5); IH NMR (DMSO; 300 MHz): 87.49 
(lH, s, T-6), 4.36 (2H, s, CfuC02H), 1.75 (3H, s, T-5CH3); I3C NMR (DMSO; 75 
MHz); 8 170.0 (CH2C02H), 164.7 (T-4), 151.3 (T-2), 142.1 (T-6), 108.6 (T-5), 48.7 (T-
lCH2C02H), 12.26 (T-5CH3); mlz : 185 [M+Ht; Data were in accordance with 
reported literature data.[1] 
Benzyl 2-oxo-l,2-dihydropyrimidin-4-ylcarbamate 
41 
Benzyl chloroformate (5.20 mL, 36.0 mmol) was added dropwise to a stirred 
suspension of cytosine (2.0 g, 18.mmol) in pyridine (100 mL) at 0 "C. The colourless 
precipitate was allowed to warm to RT while stirring for 48 h. The reaction was 
evaporated to dryness to give a crude pink residue that was suspended in H20 (20 mL) 
and acidified to pH 1 with 4M HCl solution. A light yellow precipitate was recovered 
by filtration and washed repeatedly with H20. The crude product was stirred as a 
suspension in EtOH (50 mL) and heated at reflux for 10 min. The title compound was 
recovered by filtration and dried under reduced pressure to give 1.54g (37%, lit. 56%)[1] 
of colourless amorphous crystals that were insoluble in common solvents; Mp. 268-
271"C(decomp.); mlz :246 [M+Ht; 
Methyl 2-( 4-amino-2-oxopyrimidin-l (2H)-yl)acetate 
43 
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Sodium hydride (1.41 g, 36.0 mmol) was added to a stirred suspension of cytosine (4.00 
g, 36.0 mmol) in DMF (80 mL) at 0 °c. After 2 h methyl bromoacetate (3.41 mL, 36.0 
mmol) was added dropwise to the grey slurry and the reaction was allowed to warm to 
RT while stirring for 48 h. The suspension was evaporated to dryness and the crude 
orange oil was triturated with ice-H20 (80 mL) and stirred at I-2°C for 1 h. The crude 
product was recovered by filtration, recrystallised (50% aq. MeOH) and dried under 
reduced pressure to yield 3.69g (56%, lit. 64%)[21 of pink rhomboid crystals; Mp 225-
6°C; RrO.55(EtOAc/MeOH, 1:1); IH NMR (DMSO; 300 MHz): 0 7.52 (lH, bs, C-
4NH1), 7.31 (lH, bs, C-4NH1), 7.77 (lH, d, J7.4, C-6), 5.90 (lH, d, J7.4, C-5), 4.56 
(2H, s, ClliC02CH3), 3.68 (3H, s, CH2C01CH3);13C NMR (DMSO; 75 MHz); 0 168.8 
(C02CH3), 163.3 (C-4), 152.3 (C-2), 148.4 (C-6), 94.1 (C-5), 52.6 (CH2C02CH3), 50.0 
(CH1C02CH3); mlz : 184 [M+Ht ; Data were in accordance with literature dataY1 
Ethyl 2-( 4-amino-2-oxopyrimidin-l (2H)-yl)acetate 
44 
Sodium hydride (1.08 g, 45.0 mmol) was added to a stirred suspension of cytosine (5.00 
g, 45.0 mmol) in DMF (l00 mL) at 0 °c. After 2 h ethyl bromo acetate (5.00 mL, 45.0 
mmol) was added dropwise to the grey slurry and the reaction was allowed to warm to 
R T while stirring for 14 h. The suspension was evaporated to dryness and the crude 
orange oil was triturated with ice-H20 (80 mL) and stirred at I-2°C for 1 h. The crude 
product was recovered by filtration, recrystallised (50% aq. MeOH) and dried under 
reduced pressure to yield 3.42g (39%) of pink rhomboid crystals; Mp. 265°C (decomp.);" 
Rr O.60 (EtOAc/MeOH, 1:1); IH NMR (DMSO; 300 MHz): 07.54 (lH, d, J7.2, C-6), 
7.17 (lH, bs, C-4Nlli), 7.11 (lH, bs, C-4Nlli), 5.67 (lH, d, J7.2, C-5), 4.41 (2H, s, 
CHZ.C01Et), 4.11 (2H, q, J 7.1, C02ClliCH3), 1.19 (3H, t, J 7.1, C02CH2Cfu); 13C 
NMR (DMSO; 75 MHz); 0 169.9 (C02C2H5), 166.7 (C-4), 156.1 (C-2), 146.6 (C-6), 
93.85 (C-5), 61.1 (CH1C02Et), 50.2 (C02CH2CH3), 14.4 (C01CH2CH3); mlz: 198 
[M+Ht; Data were in accordance with literature dataY1 
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Methyl 2-( 4-(benzyloxycarbonylamino )-2-oxopyrimidin-l (2H)-yl)acetate 
DMAP (1.60 g, 13.1 mmol) was added to a stirred solution of benzyl chloroformate 
(1.96 rhL, 13.1 mmol) in CH2Cb (12 mL) at 0 °C and cooled to -15°C after a further 5 
min stirring. Methyl 2-( 4-amino-2-oxopyrimidin-l (2H)-yl)acetate (1.20g, 6.55mmol) 
was added slowly, portionwise and stirred for 15 min at -15°C. The reaction was 
allowed to warm to RT while stirring for 6 h then evaporated to dryness to give a 
colourless oil. The crude oil was dissolved in CHCb (20 mL), washed once with each of 
1M HCI (20 mL) and H20 (25 mL) then evaporated to dryness. The colourless residual 
oil was triturated with ether to give 660 mg (32%, Lit. 77%i3] of the title compound as 
colourless amorphous crystals; Rf 0.80 (EtOAc/MeOH, 1: 1); Mp 137-8 °C; I H NMR 
(DMSO; 300 MHz): 8 8.06 (lH, d, 17.3, C-6), 7.43-7.32 (5H, m, C02CH2C6Hs), 7.04 
(1 H, d, 17.3, C-5), 5.19 (2H, s, C02CfuC6Hs), 4.63 (2H, s, CfuC02CH3), 3.68 (3H, s, 
CH2C02Cfu); 13C NMR (DMSO; 75 MHz): 8 168.8 (C02CH3), 163.8 (C-4), 155.3 
(N~02Bn), 153.4 (C-2), 150.6 (C-6), 136.2 (Ph-I), 128.8 (Ph-2), 128.5 (Ph-3), 128.3 
(Ph-4), 94.5 (C-5), 66.8 (C02CH2Ph), 52.6 (CH2C02~H3), 50.8 (CH2C02CH3); mlz : 
318 [M+Ht; Data were in accordance with literature data.[2] 
Ethyl 2-( 4-(benzyloxycarbonylamino )-2-oxopyrimidin-l (2H)-yl)acetate 
o 
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DMAP (4.66 g, 38.0 mmol) then benzyl chlorofonnate (5.45 mL, 38.0 mmol were 
sequentially dissolved in CHzCh (40 mL) at -15°C. After 15 min stirring, ethyl 2-(4-
amino-2-oxopyrimidin-l(2H)-yl)acetate (3.72 g, 19.0 mmol) was added slowly, 
portionwise and stirred for 15 min at -15°C. The reaction was allowed to warm to R T 
while stirring for 5 h then evaporated to dryness to give a pink solid. The crude product 
was ground to a fine powder and washed with ether before drying under reduced 
pressure to afford 4.41g (77%) of the title compound as pink amorphous crystals; Mp. 
142-3 DC; Rf O.77 (EtOAc/MeOH, 2:1);IH NMR (DMSO; 300 MHz): () 8.05 (IH, d, J 
7.3, C-6), 7.30 (5H, bm, COZCHZC6H5), 7.05 (1H, d,J7.3, C-5), 5.19 (2H, s, 
COzCfuPh), 4.61 (2H, s, CHzCOzEt), 4.14 (2H, q, J7.1, COzCHJCH3), 1.20 (3H, t, J 
7.1, COZCH2CH3); I3C NMR (DMSO; 125 MHz): () 167.2 (COzEt), 162.7 (C-4), 155.4 
(NC02Bn), 152.1 (C-2), 148.7 (C-6), 134.9 (Ph-I), 128.7 (Ph-2), 128.4 (Ph-3), 128.3 
(Ph-4), 95.1 (C-5), 68.1 (COzhHzPh), 62.2 (COZCH2CH3), 50.7 (hH2COzEt), 14.1 
(COzCHzhH3);m/z: 333 [M+Ht; Data were in accordance with literature dataPl 
2-( 4-(benzyloxycarbonylamino )-2-oxopyrimidin-l (2H)-yl)acetic acid 
1M sodium hydroxide solution (17.5 mL) was added to a solution of ethyl 2-(4-
(benzyloxycarbonylamino)-2-oxopyrimidin-l(2H)-yl)acetate (4.41 g, 13.9 mmol) 
dissolved in dioxane (110 mL) and was allowed to stir at RT for 16 h. Dioxane was 
removed from the reaction under reduced pressure evaporation and the resultant yellow 
solution was treated with 1 M KHS04 until a colourless precipitate fonned. The reaction 
was filtered to yield 3.4lg (81%) of the title compound as colourless amorphous 
crys.tals after drying under reduced pressure; Mp. 272-5°C (decomp.); Rf 
O.l(EtOAc/MeOH, 1:1); IH NMR (DMSO; 300 MHz): () 8.04 (lH, d, J7.3, C-6), 7.56-
7.30 (5H, m, COZCH2C6H5), 7.02 (lH, d, J7.3, C-5), 5.19 (2H, s, COzCfuPh), 4.52 
(2H, s, CHJC02H); I3C NMR (DMSO; 75 MHz) 170.2 (CH2C02H), 164.1 (C-4), 155.8 
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(C-2), 153.9 (C02Bn), 151.2 (C-6), 136.7 (Ph-I), 129.3 (Ph-2), 128.9 (Ph-3), 128.7 
(Ph-4), 94.8 (C-5), 67.3 (C02CH2Ph), 51.3 (CH2C02H); mlz :304 [M+Ht; Data were 
in accordance with literature data.[I,2) 
Ethyl 2-( 6-arnino-9 H-purin-9-yl)acetate 
48 
Sodium hydride (3.5 g, 89 mmol) was added carefully in one portion to a stirred 
suspension of adenine (20.0 g, 148 mmol) in DMF (308 mL) at RT. After 30 min an 
additional 3.5 g of sodium hydride was added and the reaction and was allowed to stir 
for 3 h. The mixture was cooled to 0 °C and ethyl bromoacetate (18.1 mL, 163 mmol) 
was added dropwise slowly, ensuring that the reaction temperature did not exceed 30 
0c. The mixture was allowed to warm to RT while stirring for 19 h and was then 
evaporated to dryness. H20 (150 mL) was added and the mixture was stirred for Ih. A 
precipitate was recovered by filtration, washed with H20 and recrystallised from EtOH 
(100 mL) to give 21.2 g (65%) of the title compound as colourless needles; Mp. 119-
120°C; RfO'.53 (Et20/MeOH, 3:2); IH NMR (DMSO; 300 MHz): () 8.12 (lH, s, A-2), 
8.11 (lH, s, A-8), 7.29 (2H, bs, A-6NH2), 5.06 (2H, s, CfuC02Et), 4.16 (2H, q, J 6.9, 
C02CfuCH3), 1.20 (3H, t, J 6.9, C02CH2CH3); l3C NMR (DMSO; 75 MHz); () 168.3 
(C02Et), 156.3 (A-6), 152.9 (A-2), 150.0 (A-4), 141.5 (A-8), 118.5 (A-5), 61.7 
(C02CH2CH3), 44.4 (CH2C02Et), 14.3 (C02CH2CH3); mlz : 222 [M+Ht ; Data were in 
accordance with literature data. [3,4) 
BenzyllH-irnidazole-l-carboxylate 
184 
Benzylchloroformate (2.0 mL, 14.0 mmol) was added in one portion to a stirred 
solution of imidazole (1.91 g, 28.0 mmol) dissolved in toluene (23.5 mL) at 0 DC. A 
colourless precipitate fomied immediately. After 5 min stirring the reaction was filtered 
and evaporated to dryness under reduced pressure to give 2.95 g of the title compound 
as a colourless oil. The product contained trace impurities and was used immediately as 
the crude material; IH NMR (DMSO; 300 MHz): 8 8.15 (lH, s, Im-2), 7.40 (5H, bs, 
C02CH2C6H5), 7.06 (2H, s, Im-4 and Im-5), 5.40 (2H, s, C02CfuPh); l3C NMR 
(DMSO; 75 MHz); 8154.2 (NC02Bn), 137.5 (Im-2), 134.4 (Ph-I), 131.1 (Im-4), 129.6 
(Ph-2), 129.3 (Ph-3), 129.1 (Ph-4), 117.5 (Im-5); mlz : 203 [M+Ht; Data were in 
accordance with literature dataP] 
1-(benzyloxycarbonyl)-3-methyl-lH-imidazol-3-ium triflate 
53 
Methyl triflate (296 !lL, 2.60 mmol) was added dropwise to a stirred solution of benzyl 
1 H-imidazole-1-carboxylate (0.50 g, 2.48 mmol) dissolved in CH2Ch (1.10 mL) at 0 DC. 
A colourless precipitate forms rapidly and additional CH2Ch (5.0 mL) was added to the 
reaction to aid stirring. After 5 min stirring at 0 °C the reaction was filtered and the 
filtrant was washed with ether and dried under reduced pressure to give 905 mg (99%) 
of the title compound as colourless amorphous crystals; Mp.78-80 °C(decomp.); IH 
NMR (DMSO; 300 MHz): 8 9.89 (lH, s, Im-2), 8.18 (lH, s, Im-4), 7.86 (lH, s, Im-5), 
7.69 (2H, m, Ph-2), 7.47 (3H, m, Ph-3 and Ph-4), 5.56 (2H, s, C02CfuPh), 3.90 (3H, s, 
Im-3Cfu); l3C NMR (DMSO; 75 MHz); 8 146.1 (NC02Bn), 139.0 (lm-2), 136.1 (Im-
4), 135.7 (Ph-I), 129.3 (Ph-2), 128.9 (Ph-3), 128.5 (Ph-4), 125.0 (Im-5), 120.3 (q, J 
320, CF 3S03), 71.7 (C02.C.H2Ph), 36.8 (Im-3 CH3); mlz : 217 (M+); Data were in 
accordance with literature data.[6] 
EthyI2-(6-(benzyloxycarbonylamino)-9H-purin-9-yl)acetate 
185 
1-(benzyloxycarbonyl)-3-methyl-lH-imidazol-3-ium triflate (3.43 g, 6.2 mmol) was 
added portionwise to a solution of ethyI2-(6-amino-9H-purin-9-yl)acetate (1.38 g, 6.2 
mmol) dissolved in DMF (20 mL) at 0 °C. The reaction was allowed to warm to RT 
while stirring for 18 h before quenching with saturated NaHC03 solution (15 mL). After 
15 min stirring the reaction was partitioned with CH2Ch (30 mL) and washed with H20 
(30 mL), 1 M KHS04 solution (2 x 30mL) and saturated brine solution (30 mL). The 
reaction was evaporated to dryness and the resultant yellow oil was triturated with 
petrol to give a fine colourless precipitate that was collected by filtration. The solid was 
dried under reduced pressure to give 1.54g (70%) of the title compound as colourless 
amorphous crystals; Mp 133-134 °C; Rf0.44 (Et20IMeOH, 9:1); IH NMR (CDCb; 500 
MHz): 0 9.05 (IH, bs, A-6), 8.82 (1H, s, A-2), 8.02 (1H, s, A-8), 7.48 (2H, m, Ph-2) 
7.46-7.39 (3H, m, Ph-3 and Ph-4), 5.35 (2H, s, NC02CH7Ph), 4.97 (2H, s, A-9 
CH2C02Et), 4.31 (2H, q, 17.1, C02CHzCH3), 1.34 (3H, t, 17.1, C0 2CH2CH3); l3C 
NMR (CDCb; 125 MHz); 0 167.1 (C02C2Hs), 153.4 (A-6), 152.0 (NC02), 151.4 (A-2 
NC02Bn), 1'50.0 (A-4), 143.6 (A-8), 135.7 (Ph-I), 129.3 (Ph-2), 129.0 (Ph-3), 128.9 
(Ph-4), 121.8 (A-5), 68.2 (C02CH2Ph), 62.9 (C02CHzCH3), 44.6 (A-9 CHz), 14.5 
(C02CH2CH3); mlz : 356 [M+Ht; Data were in accordance with literature data.[4. 6] 
2-( 6-(benzyloxycarbonylamino )-9 H-purin-9-yl)acetic acid 
186 
2M Sodium hydroxide solution (39 mL) was added to a stirred solution of ethyl 2-(6-
(benzyloxycarbonylamino)-9H-purin-9-yl)acetate dissolved in MeOH (39 mL) at RT. 
After 30 min stirring, the reaction was washed with CH2Clz (2 x 40 mL) and treated 
with 12 M HCI dropwise until a precipitate formed. The reaction was allowed to stir at 
RT for 18h and was filtered to recover 1.67g (70%) of the title compound as amorphous 
crystals after drying under reduced pressure; Mp.156-158°C; Rr 0.2 (EtOAc/MeOH, 
1:1); IH NMR (DMSO; 300 MHz): 8 8.90 (tH, s, A-2), 8.74 (tH, s, A-8), 7.48-7.34 
(5H, m, NHC02CH2C6HS), 5.28 (2H, s, NHC02CH2C6Hs), 5.20 (2H, s, A-9 CH,C02H); 
l3C NMR (DMSO; 75 MHz); 8 169.4 (CH2C02H), 153.4 (A-6), 152.5 (NHC02Ph), 
150.0 (A-2), 149.1 (A-4), 146.0 (A-8), 136.7 (Ph-I), 129.3 (Ph-2), 129.0 (Ph-3), 128.8 
(Ph-4), 120.3 (A-6), 67.8 (NHC02CH2Ph), 45.7 (CH2C02H); mlz : 328.1 [M+Ht; Data 
were in accordance with literature data. [1.4. 6] 
6-chloro-9H-purin-2-amine 
CI 
~~N~ 
H N,..A-..NJ-N 
2 H 
57 
Phosphorus oxychloride (12.5 mL, 136 mmol) was added slowly to briskly stirred DMF 
at O°C and allowed to warm to RT while stirring for 30 min. Oven-dried guanine (6.85 
g, 45 mmol) was added slowly to the rapidly stirred bright yellow reaction and was 
heat~d at 90°C for 5 h. The reaction was cooled to 0 °C and ice was added continuously 
during gentle agitation of the white and brown solid reaction mixture until only a black 
solution remained. The reaction was carefully adjusted to pH 8 with solid potassium 
carbonate and a yellow precipitate was recovered by filtration. The solid was dried 
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under reduced pressure and ground to a fine powder. The intermediate (lOg) was 
suspended in stirred 12% acetic acid (100 mL) and heated at 70°C for 3h before cooling 
to RT. The suspension was filtered to recover a bright yellow precipitate. The 
intermediate was washed with H20, dried under reduced pressure and then stirred in 
10% NaOH for 2 hat RT. The reaction was carefully neutralised at 0 °C with conc. HCI 
and was stirred for a further 1 h. The light yellow slurry was heated to 85°C and cooled 
rapidly in an ice bath. The precipitate was collected by filtration to give the title 
compound (6.69g, 88%) as light yellow amorphous crystals; Mp.>300°C; RcO.55 
(EtOAc);'H NMR (DMSO; 300 MHz): 6 8.10 (1H, s, 0-8), 6.77 (2H, bs, 0-2NH2); l3C 
NMR (DMSO;75 MHz): 160.1 (0-2), 155.4 (0-6),149.1 (0-4), 141.9 (0-8),123.3 (0-
5); mlz : 170, 172 [M+Ht. 
BenzyI2-(2-amino-6-chloro-9H-purin-9-yl)acetate 
65 
6-chloro-9H-purin-2-amine (12.67 g, 75 mmol) was heated to 85°C in rapidly stirred 
DMF (127 mL) and potassium carbonate (15.4 g, 112 mmol) was added in one portion. 
After brief stirring the reaction was cooled to -5°C and benzyl bromoacetate (4.23 mL, 
25 mmol) was added dropwise slowly to the reaction, ensuring that the temperature did 
not exceed 0 0c. The reaction was stirred for 3 h at 0 °C, with further additions of 
benzyl bromoacetate (2 x 4.23 mL, 25 mmol) every sixty minutes. The reaction was 
allowed to warm to RT while stirring for 18 h. A light yellow precipitate was collected 
by filtration and washed with DMF before being added to vigorously stirred 1M HCl 
(67 mL). After 2 h stirring the yellow suspension was filtered, washed with H20 (650 
mL) and air-dried under suction on the sinter funnel. The solid was recrystallised from 
MeCN (125 mL) and dried thoroughly under reduced pressure to give 9.37g (38%) of 
the title compound as colourless needles. The mother liquor was concentrated and 
heated briefly at reflux in a minimal amount of MeCN to yield a further crop (2.36g, 
10%) of the title compound; Mp. 187-8°C; RcO.57 (EtOAc/Petrol, 1:1); 'H NMR 
(DMSO; 300 MHz): 8.12 (1 H. s, 0-8), 7.37 (5H, m, C02CH2C6H5), 5.20 (2H, s, 0-2 
NH2), 5.20 (2H, s, C02CfuPh), 5.07 (2H, s, 0-9Cfu); l3C NMR (DMSO; 75 MHz); 
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168.5 (C02Bn), 160.7 (0-2),155.0 (0-6), 150.3 (0-4),144.2 (0-8),136.1 (Ph-I), 129.3 
(Ph-2), 129.1 (Ph-3), 128.9 (Ph-4), 123.7 (0-5), 67.6 (CfuPh), 44.8 (0-9Cfu); mlz : 
318 [M+Ht; Data were in accordance with literature dataYl 
Benzyl 2-( 4-amino-2-oxopyrimidin-l (2H)-yl)acetate 
Cytosine (2.06 g, 18 mmol) and potassium tert-butoxide (2.32 g, 21 mmol) were heated 
in dry DMF (18 mL) at 100°C for 2 h. The colourless suspension was cooled to 10 °C 
and benzyl bromoacetate (3.21 mL, 20 mmol) was added dropwise. The reaction was 
allowed to warm to RT while stirring for 18h and was then quenched with glacial acetic 
acid (1.18 mL). The pink suspension was evaporated to dryness. The residue was 
suspended in H20 (20 mL) and stirred for 4 h and a pink precipitate was collected by 
filtration and washed with H20 (4 x 30 mL). The solid was recrystallised from DMF 
and dried under reduced pressure to give the title compound (3.73g, 80%) as square 
plate crystals; Mp. 245-248 DC; RfO.20 (EtOAc/petrol, 1: 1); I H NMR (DMSO; 300 
MHz): (5 7.5.1 (lH, d, J7.1, C-6), 7.37 (5H, m, CH2C6H5), 7.22 (lH, bs, C-4NH), 7.12 
(1H, bs, C-4NH), 5.68 (tH, d,J7.1, C-5), 5.16 (2H, s, CfuPh), 4.51 (2H, s, C-ICH2); 
l3C NMR (DMSO; 75 MHz); (5 169.6 (C02Bn), 167.2 (C-4), 156.6 (C-2), 147.2 (C-6), 
136.5 (Ph-I), 129.3 (Ph-2), 129.0 (Ph-3), 128.7 (Ph-4), 94.4 (C-5), 66.9 (CH2Ph), 50.8 
(C-ICH2); mlz : 260 [M+Ht; Data were in accordance with literature dataPl 
Benzyl 2-( 4-(benzhydryloxycarbonylamino )-2-oxopyrimidin-l (2H)-yl)acetate 
189 
BenzyI2-(4-amino-2-oxopyrimidin-l(2H)-yl)acetate (956 mg, 3.69 mmol) and 
carbonyldiimidazole (944 mg, 5.91 mmol) were suspended in dry DMF (7.5 mL) and 
stirred for 5 h. Benzhydrol (878 mg, 4.80 mmol) was added and the reaction was heated 
at 60°C for 1 h. Benzhydrol (67 mg, 0.48 mmol) was added each hour for a further two 
hours reaction was heated at 60°C for 1 h after each addition. The reaction was stirred 
for 2 hat 60°C and then evaporated to dryness. The crude oil was triturated with H20 to 
give a colourless precipitate that was recrystallised from EtOH to give the title 
compound (1.42g, 82%) as colourless plates; Mp.133-135 °C; Rf0.40 (EtOAc/petrol, 
1:1); 'H NMR (DMSO; 300 MHz): (5 11.07 (1H, s, C-4NH), 8.06 (1H, d, J 7.3, C-6), 
7.46 (4H, d, J7.1, Bhoc;Ph-2), 7.37 (9H, m, C02CH2C6HS and Bhoc;Ph-3), 7.29 (2H, t, 
J7.2, Bhoc;Ph-4), 6.98 (2H, d,J7.3, C-5), 6.80 (1H, s, CHPh2), 5.l9 (2H, s, 
C02CH2Ph), 4.69 (2H, s, C-ICH2); l3C NMR (DMSO; 75 MHz); (5 168.7 C02Bn), 
164.2 (C-4), 156.1 (NC02), 151.3 (C-2), 141.2 (C-6), 136.4 (Bhoc;Ph-l, Ph-I), 129.4 
(Bhoc;Ph-2, Ph-2), 129.0 (Bhoc;Ph-3, Ph-3), 127.3 (Bhoc;Ph-4, Ph-4), 95.0 (C-5), 78.3 
(CHPh2), 67.2 (C02CH2), 51.5 (C-ICH2); mlz: 470 [M+Ht; Data were in accordance 
with literature data.(3] 
2-( 4-(benzhydryloxycarbonylamino )-2-oxopyrimidin-l (2H)-yl)acetic acid 
Benzyl 2-( 4-(benzhydryloxycarbonylamino )-2-oxopyrimidin-l (2H)-yl)acetate (1.42 g, 
3.03 mmol) was suspended in a 1:1:2:2 mixture of EtOH/H20IMeOHIMeCN (18.5 mL) 
and cooled to O°c. A solution of lithium hydroxide monohydrate (1.28g dissolved in 
9.4mL of H20) was added and the reaction was stirred until hydrolysis was complete, 
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as indicated by tIc. A solution of citric acid (2.85g dissolved in 14.2mL of H20) was 
added resulting in immediate dissolution of the precipitate. The solution was chilled to 
O°C and stirred for 2h. A colourless precipitate was recovered by filtration then 
suspended in a minimal amount of saturated brine solution and stirred for 6h. The 
precipitate was recovered by filtration and dried thoroughly to give the title compound 
(1.19g, 82%) as colourless amorphous crystals; Mp. 197-8°C; RfO.30 (EtOAc/MeOH, 
7:3); IH NMR (DMSO; 300 MHz): 88.02 (lH, d, J7.3, C-6), 7.45 (4H, d, J7.2, Ph-2), 
7.38 (4H, t, J7.2, Ph-3), 7.29 (2H, t, Ph-4), 6.96 (lH, d, J7.2, C-5), 6.81 (IH, s, 
CHPh2), 4.52 (2H, s, C-l CH2); l3C NMR (DMSO; 75 MHz); 8 170.2 (C02H), 164.0 (C-
4), 155.8 (NC02), 153.2 (C-2), 151.4 (C-6), 141.2 (Ph-I), 129.4 (Ph-2), 128.7 (Ph-3), 
127.3 (Ph-4), 94.7 (C-5), 78.3 (CHPh2), 51.5 (C-ICH2); mlz : 380 [M+Ht ; Data were 
in acc;rdance with literature data. [3] 
Ethyl 2-( 6-(benzhydryloxycarbonylamino )-9 H -purin-9-yl)acetate 
EthyI2-(6-amino-9H-purin-9-yl)acetate (2.70 g, 12.2 mmol) and carbonyl diimidazole 
(2.93 g, 18.5 mmol) were heated in dry DMF (25 mL) at 100°C for 3h and then cooled 
to 95°C. Benzhydrol (3.37 g, 18.3 mmol) was added and the mixture was allowed to 
cool to RT while stirring for 16 h. The reaction was cooled to 0 °C and acetone (10 mL), 
then H20 (50 mL) were added to the mixture. The reaction was stirred at 0 °C for 2 h 
then filtered to recover a yellow precipitate that was recrystallised from MeOH to give 
the title compound (3.28g, 63 %) as colourless needles; Mp. 88-89°C; Rf 0.75 (EtOAc); -
IH NMR (DMSO; 300 MHz): 8 10.98 (lH, s, A-6NH), 8.63 (1H, s, A-2), 8.46 (lH, s, 
A-8), 7.53 (4H, d, J 7.3, Ph-2), 7.38 (4H, t, J 7.3, Ph-3), 7.29 (2H, d, J7.3, Ph-4), 6.83 
(IH, s, CHPh2), 5.20 (2H, s, A-9CH2), 4.17 (2H, t, J 7.1, CH2CH3), 1.21 (3H, q, J 7.1, 
CH3);. 13C NMR (DMSO; 75 MHz); 8 168.5 (C02H), 152.9 (A-6), 152.6 (A-2), 151.9 
(A-6NC02Bn), 150.2 (A-4), 145.5 (A-8), 141.7 (Ph-I), 129.3 (Ph-2), 128.6 (Ph-3), 
127.3 (Ph-4), 123.5 (A-5), 78.1 (CHPh2), 62.4 (CfuCH3), 45.1 (A-9CH2), 14.8 (CH3); 
mlz: 432 [M+Ht ; Data were in accordance with literature dataY] 
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2-( 6-(benzhydryloxycarbonylamino )-9 H-purin-9-yl)acetic acid 
75 
EthyI2-(6-(benzhydryloxycarbonylamino)-9H-purin-9-yl)acetate (3.0 g, 6.96 mmol) 
was suspended in a mixture of MeCN/EtOH (1: 1, 23mL) and stirred vigorously until 
dissolution occurred. H20 (9.1 mL) was added slowly to the solution and the 
temperature was reduced to 0 °C before addition of lithium hydroxide monohydrate 
solution (4.68 g dissolved in 38 mL of H20). Upon precipitation of a colourless solid, 
citric acid solution (13.38g dissolved in 46 mL of H20) was added immediately. The 
reaction was stirred for 2 h at 0 °C and then filtered to give the title compound as its 
citrate salt. The solid was slurried in the minimum amount of saturated brine solution 
for 16h then filtered under reduced pressure to give the title compound (2.83 g, 
quantitative) as colourless amorphous crystals; Mp.l 09-111 DC; Rf 0.15 (EtOAc/MeOH, 
7:3); IH NMR (DMSO; 300 MHz): 8 10.89 (lH, s, A-6NH), 8.58 (lH, s, A-2), 8.39 
(lH, s, A-8), 7.53 (4H, d, 17.3, Ph-2), 7.37 (4H, t, 17.3, Ph-3), 7.28 (2H, d, 17.3, Ph-
4),6.82 (lH, s, CHPh2), 4.80 (2H, s, A-9CH2); I3C NMR (DMSO; 75 MHz); 8172.0 
(C02H), 155.3 (A-6), 154.5 (A-2), 154.4 (A-6NC02Bn), 152.2 (A-4), 148.5 (A-8), 
144.1 (Ph-I), 131.7 (Ph-2), 130.8 (Ph-3), 129.6 (Ph-4), 125.8 (A-5), 74.3 (CHPh2), 47.6 
(A-9CH2); mlz : 404 [M+Ht ; Data were in accordance with literature data.[3. 7] 
BenzyI2-(2-(benzhydryloxycarbonylamino)-6-chloro-9H-purin-9-yl)acetate 
192 
76 
Triphosgene (1.67 g, 5.6 mmol) was added in one portion to a stirred colourless 
supension ofbenzyI2-(2-amino-6-chloro-9H-purin-9-yl)acetate (5.00 g, 15.7 mmol) in 
THF (60 mL) at 0 °C. After 1 h stirring, DIPEA (6.03 mL, 34.6 mmol) was added 
dropwise to the yellow reaction and stirred for 2 h. Benzhydrol (3.48 g, 18.8 mmol) was 
added and the reaction was allowed to warm to RT while stirring for 18 h. The orange 
reaction was quenched with EtOH (30 mL)and washed sequentially with 10% citric acid 
solution (50 mL) and saturated NaHC03 solution (50 mL). The mixture was dried 
(MgS04) and evaporated under reduced pressure to give an orange oil. Purification of 
the crude oil by chromatography (EtOAc/petro1, 1 :4) gave the title compound (4.50 g, 
55%) as colourless amorphous crystals; Mp. 180-181°C; Rf 0.25 (EtOAc/petrol, 1:4); 1 H 
NMR (DMSO; 300 MHz): 8 11.03 (lH, s, G-2NH), 8.52 (lH, s, G-8), 7.50 (4H, d, 
Bhoc;Ph-2), 7.39-7.28 (llH, m, Bhoc;Ph-3, Bhoc;Ph-4, C02CH2C6Hs), 6.82 (lH, s, 
Bhoc;CHPh2), 5.22 (2H, s, C02CfuC6Hs), 5.19 (2H, s, G-9Cfu); 13C NMR (DMSO; 75 
MHz); 8168.1 (C02Bn), 154.0 (N~02CHPh2), 153.1 (G-2), 151.7 (G-6), 150.0 (G-4), 
147.6 (G-8), 136.0 (Bhoc;Ph-1, Ph-I), 129.3 (Bhoc;Ph-2 Ph-2), 129.1 (Bhoc;Ph-2, Ph-
2), 128.8 (Bboc;Ph-3, Ph-3), 128.8 (Bhoc;Ph-4, Ph-4), 127.3 (G-5), 77.9 (BhocCHPh2), 
67.7 (CH2Ph), 45.3 (G-9Cfu); mlz : 523 [M+Hr ; Data were in accordance with 
literature dataYl 
2-(2-(benzhydryloxycarbonylamino )-6-oxo-l H-purin-9( 6H)-yl)acetic acid 
Sodium hydride (42 mg, 1.0 mmol) was added to dry THF (1.15 mL) and chilled to -78 
°C. 3-Hydroxypropionitrile (72 ilL, 1.0 mmol) was added to the suspension. The 
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reaction was wanned to 0 °C and stirred for 2.5 h. Benzyl 2-(2-
(benzhydryloxycarbonylamino )-6-chloro-9H-purin-9-yl)acetate (100 mg, 0.21 mmol) 
was added to the reaction and the reaction was allowed to wann to R T while stirring for 
48 h. The solvent was removed by evaporation and the crude yellow residue was 
dissolved in H20 (0.66 mL). 20% citric acid solution (0.8 mL) was added to the stirred 
yellow solution. A colourless precipitate was collected by filtration and recrystallised 
(MeOH) to give the title compound (64 mg, 82%) as colourless needles; Mp. 171-2°C; 
RfO.18 (30% MeOH in EtOAc); IH NMR (DMSO; 300 MHz): 8 11.76 (lH, bs, C02H), 
11.28 (lH, bs, G-2NH), 7.93 (lH, s, G-8), 4.76 (4H, d, J 7.2, Ph-2), 7.35 (4H, t, J7.2, 
Ph-3), 7.30 (2H, t, J 7.2, Ph-4), 6.86 (lH, s, CHPh2), 4.82 (2H, s, G-9CH2); 13C NMR 
(DMSO; 75 MHz); 8170.0 (C02H), 156.0 (NC02CHPh2), 154.5 (G-2), 150.0 (G-6), 
147.9 (G-4), 141.2 (G-8), 140.9 (G-5), 135.8 (Ph-I), 129.4 (Ph-2), 128.8 (Ph-3), 127.2 
(Ph-4), 78.8 (CHPh2), 45.6 (G-9CH); mlz : 420 [M+Ht ; Data were in accordance with 
literature dataP' 7] 
(9H-fluoren-9-yl)methyI2-(methoxy(methyl)amino)-2-oxoethylcarbamate 
MOr~J 0 v--o r-' 
79 
Isobuty1chlorofonnate (2.20 mL, 16.7 mmol) was added dropwise to a mixture of2-
«(9H-fluoren-9-yl)methoxy)carbonylamino)acetic acid (5,0 g, 16.7 mmol) and N-
Methylmorpholine (1.85 mL, 16,7 mL) stirred at -20°C in THF (100 mL). After 10 min 
stirring, triethylamine (2,50 mL, 18.4 mmol) and a solution of N,O-
dimethylhydroxylamine (1,65 g, 16.7 mmol) dissolved in DMF (40mL) were added 
sequentially to the reaction and stirred for 30 min at -20°c'The reaction was allowed to 
wann to RT and a colourless precipitate was removed by filtration. The filtrate was 
diluted with H20 (166 mL) and acidified with 1M hydrochloric acid (l6mL) before 
removing the THF component under reduced pressure evaporation, The aqueous 
mixture was adjusted to pH 8 by careful addition of 2M K2C03 solution extracted with 
EtOAc (3 x 50 mL), The combined organic fractions were dried (MgS04) and 
evaporated under reduced ptressure to give the title compound (5.22 g, 92%) as a 
colourless syrup; R f 0.25 (EtOAc/petrol, 1:1); IH NMR (DMSO; 300 MHz): 87.80 (2H, 
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d, J 7.4, Fmoc 1,8), 7.66 (2H, d, J 7.4, Fmoc 4,5), 7.44 (2H, t, J 7.4, Fmoc 2,7), 7.35 
(2H, d, J7.4, Fmoc 3,6),5.66 (lH, bt, C02NH), 4.42 (2H, d, J7.2, Fmoc 10),4.29 (lH, 
t, J 7.2, Fmoc 9), 4.21 (2H, d, J 4.53, CfuNHC02), 3.77 (3H, s, CONCH30Cfu), 3.26 
(3H, s, CONCH30CH3); 13C NMR (DMSO; 75 MHz); 0 166.1 (CH2CO), 156.7 
(C02NH), 144.3 (Fmoc la,8a), 141.7 (Fmoc 4a,5a), 128.1 (Fmoc 2,7), 127.5 (Fmoc 
3,6), 125.6 (Fmoc 4,5), 120.4 (Fmoc 1,8),67.5 (Fmoc 10),61.9 (OCH3), 47.5 (Fmoc 9), 
42.6 (NCH3), 31.4 (CH2CON); mlz: 341 [M+Ht ; Data were in accordance with 
literature data. [8] 
(9H-fluoren-9-yl)methyl 2-oxoethylcarbamate 
80 
Lithium aluminium hydride (615 mg, 16.1 mmol) was added to a stirred solution of 
(9H-tluoren-9-yl)methyl 2-(methoxy(methyl)amino )-2-oxoethy1carbamate (5.0 g, 14.7 
mmol) dissolved in THF (80 mL) held at 0 DC. Upon cessation of effervescence, 1M 
KHS04 solution (36.5 mL)was added to the brown reaction mixture, resulting in 
solution becoming colourless with the formation of a grey precipitate and further 
effervescenc'e being observed. The crude reaction mixture was extracted with EtOAc (3 
x 50 mL) and the combined organics were washed with 1M HCl (2 x 50 mL) and 1M 
NaHC03 (50 mL) solutions. The organic fraction was dried (MgS04) and evaporated to 
give the title compound (3.95g, 95.9%) as a colourless foam; Rr 0.64 (EtOAc/petrol, 
1:1); IH NMR (DMSO; 300 MHz): 09.70 (lH, s, CH2CHO), 7.80 (2H, d, J 7.4, Fmoc 
1,8), 7.63 (2H, d, J 7.4, Fmoc 4,5), 7.45 (2H, t, J7.4, Fmoc 2,7), 7.36 (2H, d, J7.4, Fmoc-
3,6),5.51 (lH, bm, C02NH), 4.46 (2H, d, J 7.2, Fmoc 10),4.28 (lH, t, J 7.2, Fmoc 9), 
4.20 (2H, d, J 5.0, CHICHO); 13C NMR (DMSO; 75 MHz); 0 197.0 (CH2CHO), 156.7" 
(C02NH), 144.1 (Fmoc la,8a), 141.7 (Fmoc 4a,5a), 128.2 (Fmoc 2,7), 127.5 (Fmoc 
3,6), ~125.4 (Fmoc 4,5), 120.4 (Fmoc 3,6), 67.6 (Fmoc 10), 47.5 (Fmoc 9), 31.4 
(,C,H;CO); mlz : 282.1 [M+Ht. ; Data were in accordance with literature data.[8] 
Tert-butyl 2-(2-aminoethylamino )acetate 
195 
A solution of tert-butyl bromoacetate (4.0 mL, 27.1 mmol) dissolved in CHzCb (30 
mL) was added dropwise to a stirred solution of ethylene diamine (16.3 mL, 244 mmol) 
dissolved in CHzCb (130 mL) at 0 °C. The reaction was allowed to warm to RT while 
stirring for 14 h before the crude mixture was washed with H20 (3 x 30 mL) and the 
combined aqueous phases back-extracted with CH2Ch (2 x 30 mL). The combined 
organics were dried (MgS04) and evaporated to dryness to give the title compound 
quantitatively as a colourless gum; Rf 0.50 (MeOHINH3, 65:35); IH NMR (CDCh; 300 
MHz): () 3.18 (2H, s, CH2CO/Bu), 2.67 (2H, t, J 5.9, CfuCH2NH2), 2.54 (2H, t, J 5.9, 
CHzCfuNH2), 1.45 (2H, bs, NHz), 1.35 (9H, s, C(CH3h); l3C NMR (DMSO; 75 MHz); 
() 172.3 (C02), 81.6 (.c(CH3h), 52.6 (CfuC02C4H9), 52.0 (CfuCH2NH2), 42.2 
(CHzNHz), 28.5 (C(CH3)3); mlz: 175.2[M+Ht ; Data were in accordance with 
literature data.[4] 
2-(2-aminoethylamino )acetic acid 
Chloroacetic acid (10.0 g, 106 mmol) was added portionwise to freshly distilled 
ethylene diamine (48 mL, 719 mmol) at 5°C. The reaction was allowed to warm to RT 
while stirring for 48h. Excess ethylene diamine was removed under reduced pressure 
and the resultant yellow oil was triturated with DMSO (lOOmL) and stirred at RT for 
24h. The colourless precipitate was recovered under reduced-pressure filtration and 
washed with ether. The crude product was recrystallised from aqueous EtOH 
(EtOH/H20, 2: 1) to give the title compound (8.13g, 65%) as colourless needles; Mp. 
153°C; RfO.10 (MeOH); IH NMR (D20; 500 MHz): 63.23 (2H, s, CfuC02H), 2.99 
(2H; r, J 6.1, NHCfuCHz), 2.86 (2H, t, J 6.1, NHzCH2); l3C NMR (D20; 75 MHz); 6 
178.2 (C02H), 51.5 (CH2C02H), 46.4 (NHCHz), 38.5 (NHzCH2); mlz : 119 [M+Ht; 
Data were in accordance with literature data.[9] 
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2-(2-« (9H -fluoren-9-yl)methoxy)carbonylamino )ethylamino )acetic acid 
Hydrochloride salt 
H 0 FmocHN~N0oH .Hel 
89a 
A solution of N-(9-Fluorenylmethoxycarbonyloxy)succinimide (16.6 g, 49.2 mmol) 
dissolved in DMF (100 mL) was added dropwise to a stirred solution of N,O-
bis(trimethylsilyl)acetamide (48.7 mL, 197 mmol) and (2-aminoethylamino) acetic acid 
(5.53g, 46.9 mmol) dissolved in DMF (120 mL). After stirring at RT for 1 h the reaction 
was cooled to 0 dc. MeOH (50 mL) and H20 (50 mL) were added concurrently to the 
reaction and stirred for 10 min. The reaction was allowed to warm to RT and 6M HCl 
(8.3 mL) was added slowly to the vigorously stirred reaction. After 10 min, the solvent 
was removed under reduced pressure evaporation and the resultant yellow oil was 
cooled to O°C and triturated with CH2Ch (100 mL). The precipitate was stirred for 1 hat 
O°C and additional CH2Ch (100 mL) was added gradually during a further 1 h of 
stirring. The precipitate was filtered rapidly and washed with (100 mL) CH2Ch. The 
crude compound was added to warm (45°C) EtOAc (120 mL) and stirred thoroughly for 
2 h. The suspension was filtered and the recovered solid was washed thoroughly with 
warm EtOAc and CH2Ch before drying under reduced pressure to give the title 
compound Q5.3g, 83%) as amorphous colourless crystals; Mp. 137-8 DC; Rr O.55 (2:2:1 
n-butanoIlH20IAcOH; 'H NMR (OMSO; 300 MHz): [) 7.89 (2H, d, J7.5, Fmoc 1,8), 
7.69 (2H, d, J7.5, Fmoc 4,5),7.47 (lH, t, J 5.5, FmocNH), 7.42 (2H, t, J7.5, Fmoc-
2,7), 7.34 (2H, t, J7.5, Fmoc-3,6), 4.33 (2H, d, J 7.2, Fmoc-lO), 4.23 (1H, t, J 7.2, 
Fmoc-9), 3.52 (2H, s, CfuC02H), 3.29 (2H, t, J 5.8, FmocNHCH2Cfu), 2.95 (2H, t, J 
5.8, FmocNHCH7); 13C NMR (OM SO; 75 MHz); [) 173.2 (C02H), 156.6 (Fmoc;C02N), _ 
144.1 (Fmoc-la,8a), 141.1 (Fmoc-4a,5a), 127.9 (Fmoc-2,7), 127.4 (Fmoc-3,6), 125.5 
(Fmoc-4,5), 120.5 (Fmoc-1 ,8), 65.8 (Fmoc-1 0), 47.1 (Fmoc-9), 46.9 (~H2C02H), 46.7 .. 
(FmocNHCH2), 40.2 (FmocNHCH2CH2); Mlz: 341[M+Ht; Data were in accordance 
with literature dataY' 10] 
2-(2-« (9 H-fluoren-9-yl)methoxy )carbonylamin 0 )ethylamino )acetic acid 
197 
H 0 FmOCHN~N~OH 
89 
2-(2-«(9H-fluoren-9-yl)methoxy)carbonylamino )ethylamino )acetic acid Hydrochloride 
salt (5.0g, l2.6mmol) was suspended in 87mL MeOH and heated with stirring until 
dissolution occurred. The stirred solution was allowed to cool to RT and a solution of 
NaOH (478mg, 11.95mmol) dissolved in dry MeOH (l05mL) was added dropwise over 
a period of 30 min, during which time a precipitate forms. H20 (9mL) was added to the 
mixture and heating was applied until a clear solution was obtained and the reaction was 
cooled slowly to O°C and stirred for 1h. The resulting colourless precipitate was 
recovered by vacuum filtration, washed Istirred thoroughly three times with 90% 
aqueous MeOH (3x20mL) and dried under vacuum in a desiccator for 48h. The title 
compound (3.06g, 71 %) was obtained as colourless amorphous crystals; Mp. 136-8"C; 
RrO.55 (2:2:1 n-butanollH20/acetic acid; IH NMR (DMSO; 500 MHz): b 7.88 (2H, d, J 
7.5, Fmoc 1,8),7.68 (2H, d,J7.5, Fmoc 4,5),7.51 (lH, t,J5.5, FmocNH), 7.34 (2H, t, 
J7.5, Fmoc 2,7), 7.33 (2H, t,J7.5, Fmoc 3,6), 4.31 (2H, d,J7.2, Fmoc 10),4.22 (lH, t, 
J 7.2, Fmoc-9) 3.25 (4H, m, CH2NHCH2C02H), 2.86 (2H, t, J 5.8, FmocNHCfu); l3C 
NMR (DMSO; 75 MHz); b 168.3 (C02H), 157.0 (Fmoc;NC02), 144.6 (Fmoc la,8a), 
141.5 (Fmoc 4a,5a), 128.4 (Fmoc 2,7), 127.9 (Fmoc 3,6), 126.0 (Fmoc 4,5), 120.9 
(Fmoc 1,8),66.3 (Fmoc 10),47.1 (Fmoc 9),50.6 (CH2C02H), 47.5 (FmocNHCH2), 
38.1 (Fmoc~HCH2~H2); mlz: 341 [M+Ht; Data were in accordance with literature 
data. [3, 10] 
2-(N-(2-«(9H-fluoren-9-yl)methoxy)carhonylamino)ethyl)-2-(S-methyl-2,4-dioxo-
3,4-dihydropyrimidin-l (2H)-yl)acetamido )acetic acid 
o 
'(1:
0 yO 
H02C~N~NHFmoc 
37 
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2-(5-methyl-2,4-dioxo-3,4-dihydropyrimidin-l(2H)-yl)acetic acid (750 mg, 4.1 mmol) 
and NMM (895 ilL, 8.2 mmol) were stirred together in MeCN (13.9 mL) for 10 min. 
The mixture was cooled to O°C and added dropwise to vigorously stirred pivaloyl 
chloride (503 ilL, 4.1 mmol) at O°C. 2-(2-«(9H-fluoren-9-
yl)methoxy)carbonylamino )ethylamino )acetic acid (1.39 g, 4.1 mmol) was suspended in 
a vigorously stirred 3:4 mixture of H20/MeCN and triethylamine was added dropwise 
until dissolution occurred. After 25 min the two solutions were combined and allowed 
to stir together for 30 min while warming to RT. The reaction was cooled to 0 °C and 
acidified with 3M HCI to pH 2 and allowed to warm to RT while stirring for 48 h. A 
colourless precipitate was recovered by filtration, washed thoroughly with H20 and then 
ether before drying under reduced pressure to give the title compound (935 mg, 45%) as 
colourless amorphous crystals; Mp.197 -8°C; Rr 0.55 (EtOAc/MeOH, 1: 1); 1 H NMR 
(DMSO; 300 MHz; Rotomeric mixture (3 :4): 0 11.33 (2H, s, C02H; RA and RB), 7.89 
(4H, d, J7.4, Fmoc-l,8; RA and RB), 7.68 (4H, d, J7.4, Fmoc-4,5; RA and RB), 7.41 
(4H, t, J7.4, Fmoc-2,7; RA and RB), 7.34-7.26 (6H, m, Fmoc-3,6 and T-6; RA and RB), 
4.65 (2H, S, T-ICH2;RB), 4.47 (2H, S, T-ICH2;RA), 4.35-4.20 (6H, m, Fmoc-9,10; RA, 
RB and CfuC02H;RA), 3.98(2H, S, CfuC02H;RB), 3.40 (2H, m, CfuNHFmoc;RB), 3.40 
(2H, m, CfuNHFmoc;RB), 3.35-3.20 (4H, m, CfuNHFmoc;RA and 
CH2CH2NHFmoc;RB), 3.10 (2H, q, J 5.8, CH,CH2NHFmoc;RA), 1.72 (3H, s, T-
5CH3);\3C NMR (DMSO; 75 MHz): 0171.7 (C02H;RA), 170.8 (C02H;RB), 167.9 (T-
lCH2CON;RA), 167.5 (T-ICH2CON;RB), 164.7 (T-4), 156.6 (Fmoc;C02N;RB), 156.4 
(Fmoc;C02N;RA), 151.3 (T-2), 144.2(Fmoc-la,8a), 142.4(T-6), 141.0 (Fmoc-4a,5a), 
127.9 (Fmoc-2,7), 127.4(Fmoc-3,6), 125.4(Fmoc-4,5), 120.4(Fmoc-l,8), 108.5(T-5;RA), 
108.4(T-5;RB), 65.8(Fmoc-l0), 49.3 (CfuNHFmoc;RA), 48.01 CfuNHFmoc;RB), 
47.0(Fmoc-9), 38.9 (CH2CH2NHFmoc;RB), 38.2 (CH2CH2NHFmoc;RA), 12.3 (T-
5CH3); mlz: 507 [M+Ht ; Data were in accordance with literature data.[3,4] 
2-(N-(2-( «9H-fluoren-9-yl)methoxy)carbo nylamino )ethyl)-2-( 6-
(benzhydryloxycarbonylamino )-9 H -purin-9-yl)acetamido )acetic acid 
199 
NHBhoc 
N~N~ C02H ~NJlN ( F-NHFmoc 
'-(N-./ 
o 
32 
A mixture of 2-( 6-(benzhydryloxycarbonylamino )-9H -purin-9-yl)acetic acid (608 mg, 
1.5mmol) and NMM (185 ilL, 3.0 mmol) in MeCN (5 mL) was cooled to -20°C and 
added dropwise to vigorously stirred pivaloyl chloride (206 ilL, 1.5 mmoL). 2-(2-«(9H-
fluoren-9-yl)methoxy)carbonylamino )ethylamino )acetic acid (572 mg, 1.5 mmol) was 
suspended in a vigorously stirred mixture of H20IMeCN (1: 1, 10 mL) and 
triethylamine was added dropwise until dissolution occurred. After 20 min, the two 
solutions were combined and the reaction was allowed to warm to R T while stirring for 
45 min. The reaction was evaporated to dryness, dissolved in the minimum amount of 
hot MeOH and added dropwise to 15 mL of rapidly stirred 20% citric acid solution. The 
precipitate was collected by filtration, washed and agitated thoroughly with brine on the 
sinter. A sample was dissolved in OMF and checked for purity by HP-LC. The solid 
was repeatedly treated to cycles of dissolution in hot MeOH and trituration by dropwise 
addition to stirred citric acid solution until all impurities had been removed. The 
precipitate was dried and analysed by NMR to determine if any PNA-citrate adduct had 
formed. Ifthe citrate was present, the solid was ground to a fine powder and slurried 
with saturated brine solution for 36 hours. The slurry was filtered and washed 
repeatedly with H20. The precipitate was dried under reduced pressure to give the title 
compound (812 mg, 74%) as colourless amorphous crystals; Mp. 142-3 DC; RfO.50 
(EtOAc/MeOH, 1:1); IH NMR (OMSO; 500 MHz, Rotomeric mixture (3:5»: [) 10.85 
(2H, s, C02H; RA and RB), 8.55 (I H, s, A-2;RA), 8.50(1 H, s, A-2;RB)' 8.30(2H, s, A-8; 
RA and RB), 7.86 (4H, d, J 7.3, Fmoc 1,8; RA and RB), 7.66 (2H, d, J7.3, Fmoc 4,5;RB), -
7.64 (2H, d, J7.3, Fmoc 4,5;RA), 7.51(8H, d, J7.5, Bhoc;Ph-2; RA and RB), 7.37 (12H, 
m, Bhoc;Ph-3 and Bhoc;Ph-4; RA and RB), 7.26 (8H, m, Fmoc 2,3,6,7; RA and RB), 6.80" 
(2H, s, CHPh2; RA and RB), 5.32 (2H, s, A-9CH2;RB), 5.l4(2H, s, A-9CH2;RA), 4.36-
4.27(2H, m, Fmoc-l O;RB and CfuC02H;RA), 4.25-4.18 (3H, m, , Fmoc-l0;RA, 
.. 
CH2C02H;RB and Fmoc-9), 3.52(2H, t, J 5.9, CfuCH2NHFmoc;RA), 3.34-3.32(4H, m, 
CfuCH2NHFmoc;RB and CfuNHFmoc;RB), 3.12 (2H, m, CfuNHFmoc;RA); 13C NMR 
(OM SO; 125 MHz): [} 170.7 (C02H;RA), 170.2 (C02H;RB), 166.9(A-9CH2CON;RB), 
166.5(A-9CH1CON;RA), 156.3(Fmoc;C01N;RB), 156.0 (Fmoc;C01N;RA), 152.2 (A-6), 
200 
151.4 (A-2), 151.0 (Bhoc;C02N), 149.1 (A-4), 146.6 (Fmoc-la,8a;RB), 146.4 (Fmoc-
la,Sa;RB), 145.2(A-S;RA), 145.1(A-S;RB), 143.S(Fmoc-4a and Fmoc-5a), 140.S 
(Bhoc;Ph-l), 128.5(Bhoc;Ph-2), 127.6(Bhoc;Ph-3), 127.5(Fmoc-2 and Fmoc-7), 126.9 
(Fmoc-3 and Fmoc-6), 126.4 (Bhoc;Ph-4), 125.1(Fmoc-4,5;RA), 125.0 (Fmoc-4,5;RB), 
122.5 (A-5), 120.8(Fmoc-l and Fmoc-8), 77.2(CHPh2), 65.4(Fmoc-1O;RB), 65.3(Fmoc-
10;RA), 47.6(CH2C02H;RA)' 46.9(~H2C02H;RB), 46.7(Fmoc-9), 
44.0( CH2CH2NHFmoc;RA), 43.S(CH2CH2NHFmoc;RB), 3S.7(CH2NHFmoc;RA), 
37.8(CH2NHFmoc;RB); mlz : 726 [M+Ht ; Data were in accordance with literature 
data.[3] 
2-(N -(2-( «9 H -fluoren-9-yl)methoxy)carbonylamino )ethyl)-2-( 4-
(benzhydryloxycarbonylamino )-2-oxopyrimidin-l (2 H)-yl)acetamido )acetic acid 
34 
2-( 4-(benzhydryloxycarbonylamino )-2-oxopyrimidin-1 (2H)-yl)acetic acid (124 mg, 
0.32 mmol) was suspended in MeCN (1 mL) and treated with NMM (72 ilL, 0.64 
mmol). The solution was added dropwise to pivaloyl chloride (40 ilL) at -15°C and 
stirred for 20 min. 2-(2-« (9H -fluoren-9-yl)methoxy)carbonylamino )ethylamino )acetic 
acid (111 mg, 0.32 mg) was suspended in a vigorously stirred mixture (3:7) of 
H20/MeCN and triethylamine was added dropwise until dissolution occurred. The two 
solutions were combined and the reaction was allowed to warm to R T while stirring for 
30 min. The reaction was adjusted to pH 3 at 0 °C with 1 M citric acid solution and was 
then allowed to warm to R T while stirring for 1 h. The reaction was evaporated to 
dryl}ess, dissolved in the minimum amount of hot MeOH and added dropwise to 15 mL 
of rapidly stirred 20% citric acid solution. The precipitate was collected by filtration and 
washed on the sinter funnel with saturated brine solution. A sample was dissolved in 
DMF and checked for purity by HP-LC. If impurities were present, the precipitate was 
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dissolved in the minimum amount of hot DMF (80°C) and allowed to cool to RT. The 
slightly cloudy solution was filtered and the clear filtrate was added dropwise to a 15-
fold volume of rapidly stirred ice-HzO. A colourless precipitate was recovered by 
filtration and analysed by LC-MS to determine purity. The recovered was repeatedly 
treated with cycles of dissolution in hot MeOH and trituration by dropwise addition to 
stirred citric acid solution until all impurities had been removed. The precipitate was 
dried thoroughly and analysed by NMR to determine if a PNA-citrate adduct had 
formed. If citrate was present, the solid was ground to a fine powder and slurried with 
saturated brine solution for 36 hours. The slurry was filtered and washed repeatedly 
with HzO and dried under reduced pressure to give the title compound (120 mg, 54%) 
as colourless amorphous crystals; Mp. 144-147 DC; RfO.60 (EtOAc/MeOH, 1:1); IH 
NMR (DMSO; 300 MHz, Rotomeric mixture (3:4)): 6 7.90-7.82 (6H, m, C-6 and 
Fmoc-l,8; RA and RB), 7.70-7.64 (4H, m, Fmoc-4,5; RA and RB), 7.45 (8H, d, J7.3, 
Bhoc;Ph-2; RA and RB), 7.41-7.25 (22H, m, Bhoc;Ph-3,4 and Fmoc-2,3,6,7; RA and RB), 
6.95 (lH, d,J6.4, C-5;RA), 6.91 (lH, d,J6.4, C-5;RB), 6.79 (2H, s, CHPhz; RA and 
RB), 4.81 (2H, s, C-ICHz;RB), 4.62 (2H, s, C-ICHz;RA), 4.35-4.28(2H, m, Fmoc-lO;RB 
and CHzCOzH;RA), 4.27-4.18 (4H, m, Fmoc-lO;RA, CfuCOzH;RB and Fmoc-9; RA and 
RB), 3.44 (2H, m, CHzCHzNHFmoc;RA), 3.26-3.16 (4H, m, CHzCHzNHFmoc;RB and 
CHzNHFmoc;RB), 3.12 (2H, m, CHzNHFmoc;RA); I3C NMR (DMSO; 75 MHz): 171.1 
(COzH;RA) 170.7(COzH;RB), 167.8 (C-ICHzCON;RA), 167.3 (C-ICH2CON;RB), 163.4 
(C-4), 156.6(Fmoc;C02N;RB), 156.4 (Fmoc;C02N;RA), 155.3 (C-2), 152.7 
(Bhoc;C02N), 151.2 (C-6), 144.2 (Fmoc-Ia,8a), 141.0 (Fmoc-4a,5a), 140.7(Bhoc;Ph-
I), 128.9(Bhoc;Ph-2), 128.2(Bhoc;Ph-3), 127.9(Fmoc-2 and Fmoc-7), 127.9(Fmoc-3 
and Fmoc-6), 126.7 (Bhoc;Ph-4), 125.4(Fmoc-4,5), 120.4(Fmoc-2 and Fmoc-7), 
95.1(C-5), 65.8 (Fmoc-l0), 50.9 (CH2C02H;RA), 49.8 (CH2C02H;RB), 
48. 1 (CHzCH2NHFmoc;RB), 47.2(CH2CH2NHFmoc;RA), 47.1 (Fmoc-9), 
39.0(CHzNHFmoc;RB), 38.2(CH2NHFmoc;RA); mlz : 702 [M+Ht ; Data were in 
accordance with literature dataYl 
2_(N_(2_«(9H-fluoren-9-yl)methoxy)carbonylamino)ethyl)_2-(2-
(benzhydryloxycarbonylamino )-6-oxo-lH-purin-9( 6H)-yl)acetamido )acetic acid 
202 
33 
NMM (33 ilL, 0.30 mmol) was added dropwise to 2-(2-(benzhydryloxycarbonylamino)-
6-oxo-IH-purin-9(6H)-yl)acetic acid (64 mg, 0.15 mmol) suspended in a mixture of 
DMF:MeCN (2:3, 1.3 mL) and the resulting solution was stirred for 20 min. 2-(2-«(9H-
fluoren-9-yl)methoxy)carbonylamino)ethylamino)acetic acid (52 mg, 0.15 mmol) was 
suspended in a mixture of H20IMeCN (2:3, 1.3mL) and triethylamine was added 
dropwise to the vigorously stirred mixture until dissolution occurred. The two solutions 
were combined at -15°C then allowed to warm to R T while stirring for 15 min. The 
reaction was acidified to pH 4 with 20% citric acid solution and the reaction was 
evaporated to dryness. The crude residue was dissolved in the minimum amount of 
warm MeOH then added dropwise to vigorously stirred ice-H20. The resulting 
precipitate was collected by filtration and washed with saturated brine solution on the 
sinter. A sample was dissolved in DMF and checked for purity by LC-MS. If impurities 
were present, the precipitate was dissolved in the minimum amount of hot methanol and 
was added dropwise to a 15-fold volume of rapidly stirred ice-20% citric acid solution. 
A colourless precipitate was recovered by filtration and analysed by LC-MS to 
determine purity. The recovered was repeatedly treated with cycles of dissolution in hot 
MeOH and trituration by dropwise addition to stirred citric acid solution until all 
impurities had been removed. The precipitate was dried thoroughly and analysed by 
NMR to determine if a PNA-citrate adduct had formed. If citrate was present, the solid 
was ground to a fine powder and slurried with saturated brine solution for 36 hours. The 
slurry was filtered and washed repeatedly with H20 and dried under reduced pressure to -
give the title compound (55mg, 49%) as colourless amorphous crystals; Mp. 221-
232°C; Rr0.40 (EtOAc/MeOH, 1:1);IH NMR (DMSO; 300 MHz, Rotomeric mixture 
(3:5)): b (2H, s, C02H; RA and RB), 7.87 (4H, d, 17.3, Fmoc-I,8; RA and RB), 7.82 (IH, 
s, G-8;RB), 7.81(lH, s, G-8;RA), 7.67 (2H, t, 17.3, Fmoc4,5;RB)' 7.65 (2H, t, 17.3, 
~ 
Fmoc 4,5;RA)' 7.45 (8H, d, 17.0, Bhoc;Ph-2; RA and RB), 7.46-7.28 (20H, m, Bhoc;Ph-
3,4; RA and RB and Fmoc-2,3,6,7; RA and RB), 6.86 (2H, s, CHPh2; RA and RB), 
5.11(2H, s, G-9CH2;RB), 4.94(2H, s, G-9CH2;RA), 4.35-4.33 (2H, m, Fmoc-l0;RB and 
CH2C02H;RA), 4.32-4.20(4H, m, Fmoc-lO;RA and Fmoc-9; RA and RB), 4.01 (2H, s, 
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CH2COzH;Rs), 3.50(2H, m, CfuCH2NHFmoc;RA), 3.35-3.33(4H, m, 
CfuCH2NHFmoc;Rs and CfuNHFmoc;Rs), 3.12 (2H, m, CfuNHFmoc;RA); l3C NMR 
(DMSO; 125 MHz): [) 171.6 (C02H;Rs), 170.7 (COzH;RA), 166.8(G-9CHz.GON;Rs), 
166.7(G-9CHz.GON;RA), 156.7(Fmoc;C02N;Rs), 156.4 (Fmoc;COzN;RA), 155.4 (G-2), 
154.0 (Fmoc;COzN), 149.1 (G-6), 147.3 (G-4) 144.1(G-8), 141.1 (Fmoc-la,8a), 140.0 
(Fmoc-4a,5a) 140.3 (Bhoc;Ph-l), 128.9(Bhoc;Ph-2), 128.3(Bhoc;Ph-3), 127.9(Fmoc-2 
and Fmoc-7), 126.9(Fmoc-3 and Fmoc-6), 127.3 (Bhoc;Ph-4), 125.0(Fmoc-4,5), 120.4 
(G-5), 119.6(Fmoc-l and Fmoc-8), 78.3(CHPh2), 65.7(Fmoc-l0;Rs), 65.4(Fmoc-
lO;RA), 47.5 (CfuCH2NHFmoc), 47.4 (Fmoc-9), 44.8(CHzC02H;RA), 
44.7(.GH2COzH;RB), 37.8(CHzNHFmoc;RA), 37.4(CHzNHFmoc;RA); mlz : 742 [M+Ht 
; Data were in accordance with literature dataPl 
Ethyl 2-(3-hydroxybenzylamino) acetate 
98 
Ethyl glycinate (6.95 g, 50 mmol) and potassium hydroxide (2.80 g, 50.0 mmol) were 
stirred in EtOH (500 mL) and heated until dissolution. The reaction was cooled to RT 
and 3-hydro}{ybenzaldehyde (6.61g, 54.2 mmol) was added to the vigorously stirred 
solution. After 1 h stirring the reaction was placed in an ice bath and sodium 
borohydride (1.89 g, 50 mmol) was added portionwise slowly over 30 min. The reaction 
was allowed to stir for 30 min and was quenched by addition of H20 (300 mL). The 
majority of MeOH was removed by evaporation and the aqueous mixture was extracted 
with EtOAc (5 x 100mL) and adsorbed onto silica. The crude product was purified by_ 
flash chromatography (EtOAc/petrol, 1:1) to give the title compound (4.6g, 47%) as 
colourless amorphous crystals; Mp 88-89°C; Rf: 0.55 (EtOAc); FT-IR V max 3449, 3301,., 
3048, 2936, 2885, 2841, 2596, 2841, 2596, 1729, 1586, 1486, 1378, 1222, 115, 871, 
784, 695, 592; IH NMR (DMSO; 500 MHz): [) 9.28 (IH, s, Ph-3 OH), 7.08 (IH, t, J 
7.5, ph-5), 6.73 (lH, s, Ph-2), 6.69 (lH, d, J 7.5, Ph-6), 6.62( IH, d, J 8.0, Ph-4), 4.09 
(2H, q, J 7.1, CfuCH3), 3.62 (2H, s, Ph-3Cfu), 3.28, (2H, s, CfuCOzEt), 1.20 (3H, t, J 
7.1, CH3); l3C NMR (DMSO; 75 MHz); [) 172.4 (C02Et ), 158.0 (Ph-I), 141.9 (Ph-3), 
129.4 (Ph-5), 118.6 (Ph-6), 115.2 (Ph-2), 114.0 (Ph-4), 60.1 (CH2CH3), 52.4 (Ph-3CHz), 
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49.7 (CH2C02Et), 14.5 (ClliCH3); mlz 210 [M+Ht: (calculated for CI 1HlSN03 [M+Ht 
209.1052, found 210.1138) 
Ethyl 2-(N-(3-hydroxybenzyl)-2-(5-methyl-2,4-dioxo-3,4-dihydropyrimidin-l (2H)-
yl)acetamido) acetate 
101 
2-(5-methyl-2,4-dioxo-3,4-dihydropyrimidin-l(2H)-yl)acetic acid (626 mg, 3.4 mmol) 
and NMM (747 ilL, 6.8 mmol) were stirred together in MeCN at RT for 15 min. The 
solution was cooled to 0 °C and added dropwise to pivaloyl chloride (417 ilL, 3.4 
mmol) and stirred vigorously for 30 min. A solution of methyl 2-(3-
hydroxybenzylamino)acetate (711 mg, 3.4 mmol) dissolved in MeCN (2.15 mL) was 
added dropwise to the reaction and stirred for 30 min at RT. The mixture was 
evaporated to dryness and 6M HCI solution (5mL) was added to the crude residue and 
stirred for 5min. A colourless precipitate was recovered by filtration, washed with 2M 
HCI solution. and dried via repeated azeotropic distillation of trace water with toluene to 
give the title compound (1.10 g, 86%) as colourless amorphous crystals; Mp. 221-222 
°C;Rr0.45(4:1 EtOAc/MeOH);FT-IRvmax 3179,3039, 1743, 1701, 1638, 1591, 1466, 
1413, 1345, 1279, 1233, 1212, 1151, 796, 712, 574; IH NMR (DMSO; 500 MHz, 
Rotomeric mixture (2:3)): 9.48 (lH, s, Ph-IOH;RB), 9.39 (lH, s, Ph-IOH;RA), 7.41 
(lH, s, T-6;RB), 7.36 (IH, s, T-6;RA), 7.18 (lH, t, J7.7, Ph-5;RB), 7.11 (lH, t, J 7.7, Ph- -
5;RA), 6.78 (lH, d,J7.6, Ph-6;RB), 6.74-6.70 (3H, m, Ph-6;RA, Ph-2;RA and Ph-4;RA), 
6.68-6.65(2H, m, Ph-2;Rs and Ph-4;Rs) 4.67 (2H, s, T -1 CH2;Rs), 4.60(2H, s, Ph-
3CH2;RB), 4.59(2H, s, T-ICH2;RA) 4.60(2H, s, Ph-3CH2;RA), 4.10 (2H, s, 
CH2C02Et;RA), 4.01-3.98 (4H, m, ClliCH3;RA and RB), 3.87 (2H, s, CH2C02Et;RB), 
1.68"(3H, s, T-3CH3;RA), 1.67 (3H, s, T-3CH3;RB), 1.09 (6H, t,J7.1, CH2CH3; RA and 
RS);13C NMR (DMSO; 75 MHz); 169.2 (C02Et;RA), 169.1 (C02Et;RB) 168.0 (T-
lCH2CON), 164.8 (T-4), 158.0(Ph-l;Rs) 157.9 (T-2;RA), 151.3 (T-2) , 142.6 (T-6;RB), 
142.5 (T-6;RA), 138.1 (Ph-3;RA), 137.9 (Ph-3;Rs), 130.0 (Ph-5;Rs), 129.7 (Ph-5;RA), 
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119.0 (Ph-6;RA), 118.0 (Ph-6;RB), 11504 (Ph-4), 114.5 (Ph-2), 10804 (T-5), 61.1 
(CH2CH3;RA), 60.9 (~H2CH3;RB), 51.1 (PhCH2;RB), 50.0 (PhCH2;RA), 48.2 (T-ICH2), 
47.9 (~H2C02Et), 14.3 (CH2CH3), 12.2 (T-5CH3); mlz [M+Ht 376.1: (calculated for 
C1sH21 N3Na06 [M+Nat 398.1328, found 398.1336 
2-(N-(3-hydroxybenzyl)-2-(5-methyl-2,4-dioxo-3,4-dihydropyrimidin-l (2H)-
yl)acetamido)acetic acid 
Methy I 2-(N-(3 -hydroxybenzy I )-2-( 5-methy 1-2,4-dioxo-3 ,4-dihydropyrimidin-l (2H)-y 1) 
acetamido)acetate (375 mg, 1 mmot) was suspended in H20 (3.5 mL) and cooled to 0 
DC. A solution ofLiOH.H20 (715 mg dissolved in 5.3 mL of H20) was added and the 
mixture was stirred until hydrolysis was complete, as indicated by tlc. Citric acid 
solution (1.92 g dissolved in 6 mL of H20) was added and the reaction was stirred in an 
ice bath for 1 h and then 2 h at RT. A colourless precipitate was recovered by filtration 
and suspended in a minimal amount of saturated brine solution. The slurry was stirred at 
RT for 18h and then filtered and washed repeatedly with water. The recovered 
precipitate was dried under reduced pressure to give the title compound (335 mg, 97%) 
as colourless amorphous crystals; Mp. 268°C(decomp.); Rf:OAO (4:1, EtOAc/MeOH, 1-
2 drops AcOH); FT-IR Vmax 3421, 2957, 2833, 2343, 1607, 1483, 1284, 1221, 1155, 
908,842,781,659,471; IH NMR (020; 500 MHz, Rotomeric mixture (2:3»: () 11.32 
(2H, bs, C02H; RA and RB), 9.51 (lH, bs, Ph-l0H;RA), 9043 (IH, bs, Ph-l0H;RB), 7041 
(lH, s, T-6;RB), 7040 (lH, s, T-6;RA), 7.17 (lH, t, J 8.0, Ph-5;RB), 7.09 (IH, t, J 8.0, Ph- .-
5;RA), 6.75 (lH, d, J7A, Ph-6;RB), 6.71-6.69(3H, m, Ph-6;RA, Ph-4;RA and Ph-2;RA), 
6.68-6.50 (2H, m, Ph-4;RB and Ph-2;RB), 4.66 (2H, s, T -1 CH2;RB), 4.56 (2H, s, T-
lCH2 ;RA) 4.54 (2H, s, Ph-3CH2;RB), 4044 (2H, s, Ph-3CH2;RA), 3.89 (2H, s, 
CH2C02H;RA), 3.85 (2H, s, CfuC02H;RB), 1.80 (3H, s, T-3CH3;RA), 1.77 (3H, s, T-
3CH3;RB);\3C NMR (020; 75 MHz); () 170.6 (C02H;RB), 170.3 (C02H;RB), 167.9 (T-
lCH2CON), 164.8 (T-4), 158.0(Ph-l), 151.3 (T-2), 142.6 (T-6) 138.1 (Ph-3;RB), 13704 
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(Ph-3;Rs), 130.7 (Ph-5;RB), 129.7 (Ph-5;RA), 117.2 (Ph-6;RA), 116.8 (Ph-6;RB), 116.6 
(Ph-4), 115.8 (Ph-4), 111.3 (Ph-2), 108.4 (T -5), 51.4(PhCH2), 50.9 (CH2C02H), 49.2 
(T-ICH2), 12.4 (T-5CH3);mlz 348 [M+Ht:(calculated for CI6H17N3Na06 [M+Nat 
370.1015, found 370.1021 
2-(N-(3-acetoxybenzyl)-2-(5-methyl-2,4-dioxo-3,4-dihydropyrimidin-l (2H)-
yl)acetamido)acetic acid 
2-(N-(3 -hydroxybenzy 1)-2-( 5-methyl-2,4-dioxo-3 ,4-dihydropyrimidin-l (2H)-
y1)acetamido)acetic acid (100 mg, 0.28 mmol) was dissolved in NaOH solution (45 mg 
NaOH dissolved in 1 mL of H20) and ice was added to the solution. Acetic anhydride 
(72 /!L, 0.76 mmol) was added and the reaction was shaken vigorously by hand for 2 
min. The reaction was acidified to pH 1 with 2M HCI solution then extracted with 
EtOAc (2 x 3mL). The combined organic phases were evaporated and dried by 
repeated azegtropic distillation of trace water with toluene to give the title compound 
(192 mg, 85%) as colourless amorphous crystals; Mp.148 °C; Rf: 0.46 (4: 1 
EtOAc/MeOH, 1-2 drops AcOH); FT-IR V max 3417, 2988, 2831, 2346, 2098,1668, 
1483, 1308, 1221, 1155, 1053,908,842,659,602; IH NMR (DMSO; 500 MHz, 
Rotomeric mixture (2:3)): 6 11.30 (2H, bs, C02H; RA and RB), 7.44 (2H, m, T-6;RA and 
Ph-5;R13), 7.38 (2H, m, T-6;RB and Ph-5;RA), 7.27 (1H, d, J7.7, Ph-6;RA), 7.17 (2H, m, -
Ph-6;RB and Ph-2;RB), 7.09 (1 H, d, J7. 7, Ph-4;RA), 7.06 (2H, m, Ph-4;RB and Ph-2;RA)' 
4.70 (2H, s, T-1CH2;RA), 4.65 (2H, s, PhCH2;RA), 4.58 (2H, s, PhCH2;RB), 4.37 (4H, s, ., 
T-1CH2; RA and RB), 4.15 (CfuC02H;RA), 3.90 (CfuC02H;Rs), 2.28 (3H, s, 
OCOCH3;RA), 2.27 (3H, s, OCOCH3;Rs), 1.77 (3H, s, T-5CH3);13C NMR (DMSO; 75 
MHt);6 170.7 (C02H), 170.3 (Ph-1C02CH3), 169.5 (CH3C02Ph-l), 168.2 
(CH2CON;RB), 167.9 (CH2CON;RA), 164.8 (T-4), 151.3 (Ph-1;R13), 151.1 (T-2), 150.8 
(Ph-1;RA)' 144.1 (T-2), 142.6 (T-6), 139.1(Ph-3;RA) 138.8 (Ph-3;Rs), 130.4 (Ph-5;Rs), 
130.2 (Ph-5;RA) 125.8(Ph-6;RA), 125.3 (Ph-6;Rs), 121.8 (Ph-4), 121.2 (Ph-2), 108.5 (T-
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5),51.3 (PhCH2), 48.6 (T-ICH2), 48.0 (CH2C02H), 21.2 (Ph-3C02CH3 12.4 (T-5CH3); 
mlz 412 [M+Ht calculated for CI8HI9N307 : 412.1120, found: 412.1121 
3-( methoxycarbonyl)benzoic acid 
o 0 
MeO~OH 
108 
Dimethyl isophthalate (9.70 g, 60 mmol) was added to a solution of sodium hydroxide 
(2.3 g, 60 mmol) dissolved in MeOH (75 mL) and stirred at RT for 20 h. The stirred 
reaction was acidified to pH 1 with concentrated HCl at 0 °C and a colourless 
precipitate was formed. The reaction slurry was filtered and washed with MeOH to give 
a crude solid that was dissolved in EtOAc (300 mL) and washed with H20 (10 X 25 
mL). The organic fraction was evaporated to dryness to give a colourless residue that 
was dissolved in saturated Na2C03 solution (50 mL) and washed with CH2Cb (2 x 25 
mL). The aqueous fraction was acidified to pH 2 with concentrated hydrochloric acid to 
give a colourless slurry that was filtered and the recovered solid was dissolved in ethyl 
actate (300 mL) and dried (MgS04). Evaporation of the solution under reduced pressure 
gave the title compound (3.90 g, 48%) as colourless amorphous crystals; Mp 189-190 
0C; Rf 0.75 (EtOAc, 1-2 drops AcOH); IH NMR (DMSO; 300 MHz): 88.48 (IH, s, Ph-
2),8.21- 8.16 (2H, m, Ph-4, Ph-6), 7.66 (IH, t,J7.8, Ph-5), 3.82 (3H, s, CH3); \3C NMR 
(DMSO; 75 MHz); 8 167.3 (C02 H), 166.4 (C02Me), 134.6 (Ph-I), 134.1 (Ph-3), 132.2 
(Ph-4), 130.9 (Ph-6), 130.6 (Ph-2), 130.2 (Ph-5), 53.3 (CH3); mlz: 180.3[M+Ht; Data 
were in accordance with literature data. [II] 
Tert-butyl 2-aminoethylcarbamate 
208 
Boc Anhydride (874 mg, 4 mmol) dissolved in CHCh (20 mL) was added dropwise to a 
stirred solution of ethylenediamine (28 mL, 40 mmol) dissolved in CHCh (40 mL) at 0 
°C over 15 min. The reaction was allowed to warm to RT while stirring for 30 min. The 
colourless opaque solution was washed with H20 (1 x 10 mL), dried (MgS04) and 
evaporated to dryness to give the title compound (696 mg, quantitative) as a colourless 
oil; RrOAO (CH2CblMeOH, 1:1); IH NMR (CDCh; 500 MHz): () 5.70 (lH, bs, 
NHCH2C02tBu), 3.15 (2H, bm, NH2CH2Cfu), 2.78 (2H, t, J5.8, NH2CH2CH2), 1.44 
(9H, s, CCCfuh); \3C NMR (DMSO; 75 MHz); () 15604 (NC02), 7804 (CCCH3)3), 44.5 
(NH2CH2Cfu), 4204 (NH2CfuCH2), 29.1 (CH3); mlz : 161 [M+Ht ; Data were in 
accordance with literature data. [12] 
Methyl 3-(2-(tert-blltoxycarbonylamino)ethylcarbamoyl)benzoate 
N-methylmorpholine (439 ilL, 4 mmol) was added to a solution of 3-
(methoxycarbonyl)benzoic acid (360 mg, 2 mmol) dissolved in MeCN (1.5 mL) and 
stirred for 15min at RT. The reaction was cooled to O°C and pivaloyl chloride (245 ilL, 
2 mmol) was added dropwise to the mixture and stirred for 15 min. Tert-butyl 2-
aminoethylcarbamate (320 mg, 2 mmol) was added to the reaction and allowed to stir 
for 25 min while the reaction warmed to RT. The solvent was removed under reduced 
pressure evaporation to give a crude residue that was taken up in saturated NaHC03 
solution (5 mL) and extracted with EtOAc (3 x 5mL). The combined organics were 
washed with 10% citric acid solution (5 mL), dried (MgS04) and purified by 
chromatography (EtOAc/petrol, 1:1) to give the title compound (447 mg, 67%) as 
colourless amorphous crystals; Mp. 126-128 °C; Rr 0.58 (EtOAc/petrol, 1:1); IH NMR 
(DMSO; 500 MHz): () 8.50 (lH, s, Ph-2), 8.20 (lH, d, J 7.8, Ph-4), 8.10 (IH, d, J7.8, 
Ph-6), 7.56 (lH, t, J7.8, Ph-5), 7048 (tH, bs, ArCONH), 5.12 (tH, bs, NHBoc), 3.98 
(3H, s, COZCH3) 3.62 (2H, t, J 5.6, CONHCfu), 3046 (2H, t, J 5.6, CfuNHBoc), 1048 
(9H, s, C(Cfu)3); \3C NMR (DMSO; 75 MHz): () 167.1 (ArCONH), 166.8 (C02Me), 
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158.1 (NC02), 134.9 (Ph-3), 132.8 (Ph-4), 132.0 (Ph-6), 130.9 (Ph-I), 129.1 (Ph-5), 
128.2 (Ph-2), 80.5 (C(CH3)3), 52.7 (C02CH3), 42.7 (ArCONHCH2), 40.4 
(CH2NHC02tBu), 28.7 (C(CH3)3); mlz : 323 [M+Ht :(calculated for Cl 6H22N2NaOs 
[M+Nat 345.1421, found 345.1412) 
MethyI3-(2-aminoethylcarbamoyl)benzoate 
S!C02Me 10 o N~NH2 
H 
105 
TFA (2 mL) was added dropwise to a solution ofmethyI3-(2-(tert-
butoxycarbonylamino )ethylcarbamoyl)benzoate (201 mg, 0.6 mmol) dissolved in 
CH2Ch (2 mL) at 0 °C and allowed to warm to RT while stirring for 2 h. The reaction 
was evaporated to dryness to give a crude residue that was taken up in saturated 
NaHC03 (5 mL) and extracted with EtOAc (3 x 5mL). The combined organics were 
dried (Na2S04) and evaporated to give the title compound (l15 mg, 53%) as a pale 
yellow oil; Rf O.2 (Petrol/Acetone, 4:1); IH NMR (DMSO; 500 MHz): (58.50 (IH, s, Ph-
2), 8.14 (IH, d, J 7.8, Ph-4), 8.09 (lH, d, J 7.8, Ph-6), 7.57 (IH, t, J 7.8, Ph-5), 3.93 
(3H, s, C02CH3), 3.62 (2H, t, J 5.6, CONHCfu), 3.46 (2H, t, J 5.6, CfuNH2); l3C NMR 
(DMSO; 75 MHz): (5 166.8 (Ar.cONH), 166.6 (C02Me), 135.4 (Ph-3), 132.9 (Ph-4), 
132.7 (Ph-6), 130.6 (Ph-I), 129.8 (Ph-5), 128.8 (Ph-2), 53.2 (C02CH3), 41.5 
(ArCONHCH2), 38.0 (CH2NH2), 24.1 (C(CH3)3); mlz : 223 [M+Ht. 
Methyl 3-(2-cyanoacetyl) benzoate 
210 
C02Me ~~JN 
o 
114 
EDC (1.15 g, 5.5 mmol) was added to a solution of3-(methoxycarbonyl)benzoic acid 
(900 mg, 5.0 mmol), hydroxybenzotriazole (740 mg, 5.5 mmol) and triethylamine (1.40 
mL, 10.0 mmol) dissolved in DMF (15 mL) and stirred for 1 hat RT. A solution of 
aminoacetonitrile hydrochloride (463 mg, 5.0 mmol) and triethylamine (0.70 mL, 5.0 
mmol) dissolved in DMF (5.0 mL) was added to the reaction and stirred for 16 h at RT. 
The reaction was evaporated to dryness under reduced pressure at 50°C and the crude 
residue was partitioned between H20 (100 mL) and EtOAc (50 mL). The aqueous phase 
was extracted with EtOAc (3 x 50 mL). The combined organics were washed with 
75mL each of 10% KHS04 solution, saturated sodium bicarbonate solution and 
saturated brine solution, dried (Na2S04) then evaporated to dryness. The residue was 
purified by chromatography (EtOAc/petrol, 1: I) to give 780 mg (72%) of the title 
compound as colourless amorphous crystals; Mp. I 14-5°C; Rf 0.65 (EtOAc/petrol, I: I); 
IH NMR (CDCb; 500 MHz): () 7.32 (IH, t, J7.5, Ph-5), 7.31 (lH, s, Ph-2), 7.24 (2H, d, 
J7.5, Ph-4/Ph-6), 4.62 (4H, s, CH2); BC NMR (CDCb; 75MHz): 167.0 (~OCH2), 
166.6 (C02Me), 133.6 (Ph-6), 133.3 (Ph-I), 132.5 (Ph-4), 130.9 (Ph-3), 129.5 (Ph-5), 
128.3(Ph-2), 116.6 (CN), 65.4 (CH2); Mlz: 219.2 [M+Ht: (calculated for 
C 11H lON2Na03 [M+Nat 241.0584, found 241.0577) 
(3_«2_aminoethylamino)methyl)phenyl)methanol) 
(3-(chloromethyl)phenyl)methanol (156 mg, Immol) was added dropwise via syringe 
pump (lmL per hour) to stirred EDA (667 JlL, 10 mmol) at 0-5 °C. The reaction was 
allowed to wann to RT over 18h and was then evaporated to dryness under reduced 
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pressure (1 mBar) with heating to give the title compound (143 mg, 79%) as a yellow 
syrup; lH NMR (DMSO; 300 MHz): 67.28-7.21 (4H, m, Ph-2,4,5,6), 4.48 (2H, s, Ph-
lCH~OH), 3.75 (2H, s, Ph-3CH2), 2.81 (2H, t, J 5.9, CH~CH2NH2), 2.81 (2H, t, J 5.9, 
CH2CfuNH2); ; I3C NMR (DMSO; 75 MHz): 142.7 (Ph-I), 140.7 (Ph-3), 128.1 (Ph-5), 
126.4 (Ph-6), 126.4 (Ph-4), 125.0 (Ph-2), 63.1 (Ph-lCH2), 53.3 (Ph-3CH2), 48.9 
(CH2CH2NH2), 40.1 CH2CH2NH2); mlz: 181 [M+Ht: (calculated for C IOH17N20 
[M+Ht 181.1335, found 181.1329). 
1,3-phenylenedimethanoI 
HO ~OH 
120 
Sodium borohydride (76 mg, 2.0 mmol) was added to a stirred solution of 
isophthaldehyde (134 mg, 1.0 mmol) dissolved in MeOH (2.0 mL) at RT. After 24 h of 
stirring the reaction was cooled to 0 °C and 2M sodium hydroxide solution (2.0 mL) 
was added to the reaction. The reaction was allowed to warm to RT over 20 min and the 
MeOH was removed by reduced pressure evaporation from the mixture. The aqueous 
solution was extracted with EtOAc (3 x 5.0 mL) and the combined organics were dried 
(MgS04) and evaporated under reduced pressure to give 130 mg (94%) of the title 
compound as a pale yellow oil; RrO.65 (EtOAc/petrol, 1:1); lH NMR (CDCh; 500 
MHz): 6 7.32 (lH, t, J7.5, Ph-5), 7.31 (lH, s, Ph-2), 7.24 (2H, d, J7.5, Ph-4/Ph-6), 
4.62 (4H, s, CH2); I3C NMR (CDCh; 125 MHz): 141.6 (Ph-I, Ph-3), 129.1 (Ph-4, Ph-
6), 126-6 (Ph-2), 125.9 (Ph-5), 65.4 (CH2); Mlz : 139 [M+Ht. 
(3-( ch~oromethyI)phenyI)methanoI 
212 
CI ~OH 
121 
Concentrated hydrochloric acid (8.0 mL) was added to a stirred solution of 1,3-
phenylenedimethanol (2.20 g, 15.9 mmol) dissolved in toluene (79.0 mL) at RT. The 
reaction became an intense red colour upon addition of the acid and this slowly changed 
to yellow as the reaction was stirred for 24 h at RT. The reaction was repeatedly washed 
with aliquots of sodium hydrogen carbonate solution (5.0 mL) until there was no further 
effervescence observed and then extracted with CH2Clz (3 x 10.0 mL). The combined 
organics were dried (MgS04) and evaporated under reduced pressure to give 1.97 g 
(79%) of the title compound as a pale yellow oil; Rf 0.75 (EtOAc/petrol, 1: 1); lH NMR 
(CDCh; 500 MHz): lH NMR (CDCh; 500 MHz): b 7.36-7.34 (2H, m, Ph-2, Ph-5), 
7.33-7.31 (2H, m, Ph-4, Ph-6), 4.71 (2H, s, CH2Cl), 4.59 (2H, s, CH20H);13C NMR 
(CDCh; 125 MHz): 140.7 (Ph-I, Ph-3), 128.2 (Ph-6), 127.6 (Ph-4), 126.3 (Ph-2), 126.2 
(Ph-2), 65.4 (CH20H), 45.4 (CH2CI); mlz: 157.0, 159.1 [M+Ht ; Data were in 
accordance with literature dataY3] 
MethyI3-(methoxy(methyl)carbamoyl)benzoate 
I 
'o'X 
~OMe 
o 
133 
Isobuty1chloroformate (132 ilL, 1 mmol) was added dropwise to a stirred solution of 3-
(methoxycarbonyl)benzoic acid (180 mg, 1 mmol) and N-methylmorpholine (110 ilL, 1 
mmol) dissolved in THF (6 mL) at -20°C. After 10 min, triethylamine (153 ilL, 1.1 
mmol) and then a solution of N,O-dimethylhydroxylamine hydrochloride (98 mg, 1 
mmo!).dissolved in DMF (2.4 mL) were added dropwise to the reaction and allowed to 
warm to RT while stirring for 30 min. A colourless precipitate was removed by 
filtration and the filtrate was diluted with H20 (10 mL) and acidified with 1M 
hydrochloric acid (ImL) before removing the THF component under reduced pressure 
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evaporation. The aqueous mixture was extracted with EtOAc (5 x 20 mL) and the 
combined organics were dried (Na2S04) and to give the title compound (166 mg, 60%) 
as a colourless syrup; Rf 0.44 (EtOAc/petrol, 1:1); lH NMR (DMSO; 300 MHz): 6 8.35 
(IH, s, Ph-2), 8.13 (lH, d, 17.8, Ph-6), 7.88 (lH, d, 17.8, Ph-4), 7.52 (IH, t, 17.8, Ph-
5), 3.93 (3H, s, C02CH3), 3.55 (3H, s, NCH30CH3), 3.38 (3H, s, NCfuOCH3); J3C 
NMR (DMSO; 75 MHz): 169.2 (C02CH3), 166.8 (CON(CH3)OCH3), 134.8 (Ph-I), 
132.9 (Ph-4), 131.9 (Ph-6), 130.4 (Ph-3), 129.7 (Ph-2), 128.6 (Ph-5), 61.5 
(CON(CH3)OCH3), 52.6 (C02CH3), 33.9 (CON(CH3)OCH3); mlz : 224 [M+Ht. 
3-(hydroxymethyl)benzaldehyde 
HO ~o 
131 
Sodium borohydride (150 mg, 3.9 mmo!) was added in one portion to a stirred slurry of 
isophthalaldehyde (1.5 g, 11.2 mmol) suspended in THF (10 mL) at 0 °C and allowed to 
warm to RT over 1 h. The slurry initially dissolved to give a rose coloured solution that 
effervesced and then become yellow and opaque. The reaction was evaporated to 
dryness and the crude residue was treated with 1M sodium hydroxide solution (10 mL), 
1M HCI solution (10 mL) and extracted with EtOAc (3 x lOmL). The combined 
~ 
organics were dried (MgS04), concentrated under reduced pressure and adsorbed on 
silica. The crude mixture was purified by chromatography (EtOAc/petrol, 1: 1) to give 
the title compound (733mg, 49%) as a yellow oil; Rf 0.75 (EtOAc/petrol, 1: 1); lH NMR 
(CDCh; 500 MHz): 8 9.90 (lH, s, ArCHO), 7.80 (lH, s, Ph-2), 7.72 (lH, d, 17.5, Ph-
6), 7.57 (lH, d, 17.5, Ph-4), 7.46 (lH, t, 17.5, Ph-5), 4.70 (2H, s, CH2);J3C NMR 
(CDCb; 125 MHz); 8 192.3 (CHO), 141.9(Ph-l), 136.6 (Ph-4), 132.8 (Ph-6), 129.2(Ph-
3), 127.2 (Ph-2), 128.2(Ph-5), 64.9(CH2); mlz : 136.2 [M+Ht ; Data were in accordance .-
with literature data.(J4] 
N-Tertbutoxycarbonyl N'-(9H-fluoren-9-yl)methylcarbamate) ethane 1,2-diamine 
214 
134 
A solution of FmocOSuccinimide (1.41 g, 4.2mmol) in MeCN (8.4 mL) was added to a 
solution of tert-butyl 2-aminoethylcarbamate (670 mg, 4.2 mmol) dissolved in H20 (4.2 
mL) at pH 9.0. The reaction was stirred at RT for 10 min and filtered to recover a 
colourless solid. The filtrant was washed with H20 and MeCN and then dissolved in a 
mixture of CHCh/MeOH (8.4 mL, 1:1) and co-evaporated with toluene (5.0 mL). The 
residue was dried under reduced pressure to afford the title compound (816 mg, 53%) as 
colourless amorphous crystals; Mp.l58-159°C; Rr: 0.65 (EtOAc/Petrol, 1:1); IH NMR 
(CDCh; 500 MHz): b 7.75 (2H, d, J9.0, Fmoc-l,8), 7.60 (2H, t, J9.0, Fmoc-4,5), 7.40 
(2H, t, J 9.0, Fmoc-2,7), 7.30 (2H, t, J 9.0, Fmoc-3,6), 4.41 (2H, d, J 7.8, Fmoc-lO), 
4.18 (IH, t, J 7.8, Fmoc-9), 3.28-3.24 (4H, m, CH2CH2), 1.45 (9H, s, C(CH3)3); ; I3C 
NMR (DMSO; 125 MHz): 156.5 (C02NH), 144.0 (Fmoc-la,8a), 142.4 (Fmoc-4a,5a), 
127.9 (Fmoc-2,7), 127.0 (Fmoc-3,6), 125.0 (Fmoc-4,5), 119.3 (Fmoc-l,8), 67.0 (Fmoc-
10), 47.3 (Fmoc-9), 41.8 (CH2NHFmoc), 40.3 (CH2NHBoc), 29.0 (C(CH3)3); mlz : 
383.3 [M+Ht ; Data were in accordance with literature dataY5] 
(9H-fluoren-9-yl)methyl 2-aminoethylcarbamate hydrochloride salt 
132 
Acetyl chloride (235 ~L, 3.0 mmol) was dissolved in MeOH (1.22 mL) at O°C and 
allowed to stir for 30 min, The reaction was allowed to warm to RT N-tert 
butoxycarbonyl N'-((9H-fluoren-9-yl)methylcarbamate) ethane 1 ,2-diamine 
(383' mg, 1.0mmol) was added to the solution. The reaction was stirred for 5h and then 
evaporated to dryness. The crude foam was used immediately without further 
purification; mlz : 283 [M+Ht; 
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N-tert-butyl carbamate N'-allyl carbamate ethylenediamine 
A solution ofallylchloroformate (17.65 mL, 162 mmol) dissolved in CH2Clz (800 mL) 
was added dropwise to a stirred solution of tert-butyl 2-aminoethylcarbamate (25.91 g, 
162 mmol) and triethylamine (22.5 mL, 162 mmol) dissolved in CH2Clz (800 mL) at 0 
dc. The reaction was allowed to warm to RT while stirring for 24 h and was washed 
with 10% citric acid solution (3 x 50 mL), saturated NaHC03 solution (2 x 50 mL) and 
dried (Na2S04). The organic fraction was evaporated to dryness to give the title 
compound (37.49 g, 89 %) as colourless amorphous crystals; Mp. Ill-2°C; Rr 0.83 
(EtOAc/petrol, 1:1); IH NMR (DMSO; 300 MHz): 8 5.92 (lH, m, Allyl-2), 5.37 (lH, 
bs, NH), 5.26 (1H, d, J 17.2, Allyl-3T), 5.22 (2H, d, J 10.7, Allyl-3c), 5.05 (2H, d, J 5.2, 
Allyl-I), 3.29 (4H, bm, CH2CH2), 1.45 (9H, s, C(CH3)3); \3C NMR (DMSO; 75 MHz); 
8 157.1 (NHC02Allyl), 156.9 (NHC02tBu), 133.2 (Allyl-2), 118.1 (Allyl-3), 79.9 
(C(CH3)3), 64.8 (Allyl-I), 41.8 (AllocNHCH2), 41.0 (Boc NHCH2); mlz: 245 [M+Ht. 
Data were in accordance with literature data.[16] 
Allyl 2-aminoethylcarbamate 
Acetyl chloride (235 ilL, 3.0 mmol) was dissolved in MeOH (1.22 mL) at O°C and 
allowed to stir for 30 min, The reaction was allowed to warm to RT and N-tert-butyl .-
carbamate N' -allyl carbamate ethylenediamine (244 mg, 1.0mmol) was added to the 
solution. The reaction was stirred for 5 h and then evaporated to dryness. The crude 
residue was taken up in saturated NaHC03 solution (3 mL) and extracted with EtOAc (5 
x 3mL). The combined organics were dried (Na2S04) and evaporated to dryness to give 
the title compound (142 mg, 99%) as a pale yellow foam; RfO.65 (EtOAc/MeOH, 1:1); 
IH NMR (D20; 500 MHz): 85.93 (IH, m, Allyl-2), 5.26 (1H, d, J 17.2, Allyl-3T), 5.22 
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(2H, d, J 10.5, Allyl-3c), 4.51 (2H, d, J 4.6, Allyl-I), 3.38 (2H, t, J 5.5, AllocNHCH2), 
3.07 (2H, t, J 5.5, NH2Cfu); I3C NMR (DMSO; 75 MHz); 8 156.3 (C02N), 133.7 
(Allyl-2), 117.4 (Allyl-3), 64.8 (Allyl-I), 38.8 (AllocNHCH2), 38.2 (CH2NH2); mlz : 
145 [M+Ht; Data were in accordance with literature dataY6] 
AllyI2-(3-(hydroxymethyl)henzylamino)ethylcarhamate 
139 
A solution of allyl2-aminoethylcarbamate (5.41 g, 30 mmol) dissolved in saturated 
NaHC03 solution (10 mL) was added to 3-(hydroxymethyl)benzaldehyde (3.72 g, 27 
mmol) and stirred at RT for 3 h. The reaction was evaporated to dryness and a cold (0-5 
°C) solution ofNaBH4 (1.14 g. 30 mmol) dissolved in H20 (30 mL) was added to the 
residue. The reaction was allowed to stir for 30 min while warming to RT and was then 
chilled to 0 °C and acidified to pH 0 with 2M HCl. The black suspension was 
neutralised and filtered through a thin pad of celite and the filtrate was evaporated to 
dryness. MeOH (50 mL) was added to the colourless residue and stirred vigorously at 
RT until a colourless slurry had formed. The slurry was filtered and the recovered 
insoluble material was extracted with MeOH (2 x 50 mL) in an identical manner. The 
_. 
combined organic extracts were evaporated to dryness and the residue was heated at 
reflux in MeCN briefly with the dropwise addition of H20 until colourless crystals had 
precipitated. The colourless insoluble crystals were removed by filtration and the filtrate 
evaporated to give a pale yellow oil that was purified via ion-exchange chromatography 
(method x) and then flash silica chromatography (EtOAc/MeOH, 7:3) to give the title 
compound (6.43 g, 90%) as a colourless oil; Rf 0.35 (EtOAc/MeOH, 7:3); IH NMR 
(DMSO; 300 MHz): 8 7.36-7.22 (4H, m, Ph-2, Ph-4, Ph-5, Ph-6), 5.92 (lH, ddt, J 17.3, .' 
11.8,5.6, allyl-2), 5.48 (lH, bs, NHAlloc), 5.32 (IH, d, J 17.3, allyl-3T), 5.23 (lH, d, J 
11.7, allyl-3c), 4.67 (2H, s, CfuOH), 4.57 (2H, 'd, J 5.6, allyl-I), 3.79 (2H, s, 
ArCfuNH), 3.29 (2H, dt,J5.9, CH2NHAlloc), 2.78 (2H, t,J5.6, CH2CH2NHAlloc); I3C 
NMR (DMSO; 75 MHz); 8 156.9 (NHh02), 141.9 (Ph-3), 139.9 (Ph-I), 133.3 (Allyl-
2), 129.1 (Ph-2), 127.9 (Ph-5), 127.2 (Ph-6), 126.3 (Ph-4), 118.1 (allyl-3), 66.0 
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(CH20H), 65.3 (allyl-I), 53.7 (CH2NH), 48.7 (CfuNHAlloc), 40.8 (CfuCH2NHAlloc); 
mlz: 265.2 [M+Ht: (calculated for C14H21N203 [M+Ht 265.1558, found 265.1547). 
BenzhydryI9-(2-((2-(allylcarboxyamino)ethyl)(3-(hydroxymethyl)benzyl)amino)-2-
oxoethyl)-9 H-purin-6-ylcarbamate 
140 
NMM (623 ilL, 5.7 mmol) was add to a suspension of2-(6-
(benzhydryloxycarbonylamino)-9H-purin-9-yl)acetic acid (1.15 g, 2.85 mmol) and 
stirred at RT until a solution was obtained. The reaction was cooled to -15°C and 
pivaloyl chloride (349 ilL, 2.85 mmol) was added dropwise and allowed to stir for 30 
min at -15°C. A solution of allyl 2-(3-(hydroxymethyl)benzylamino )ethylcarbamate 
(502 mg, 1.90 mmol) dissolved in 50% aqueous MeCN (25 mL) was added to the 
reaction and stirred for 30 min while the reaction was allowed to warm to RT. The 
yellow solution was evaporated to dryness and the crude residue was taken up in a 
minimal volume of MeOH/CH2Ch (7.5:92.5) and adsorbed onto silica. Purification by 
chromatography (MeOH/EtOAc, 3:7) gave of the title compound (1.18g, 96%) as a 
colourless oil; Rr O.30 (EtOAc); FT-IR V max 3692, 2939, 1754, 1711, 1662, 1615, 1588, 
1538, 1469, 1215, 1157,987, 732, 642;IH NMR (CD2Ch; 300 MHz, Rotomeric mixture -
(4:5)): b 9.43 (2H, bs, Bhoc;C02NH; RA and RB), 8.61 (2H, s, A-2; RA and RB), 8.05 
(1H, s, A-8;RA)' 8.00(1H, s, A-8;RB), 7.45 (8H, d, J7.3, Bhoc;Ph-2; RA and RB), 7.40- .-
7.19 (18H, m, Bhoc;Ph-3, Bhoc;Ph-4, Ph-2, Ph-5, Ph-6; RA and Rs), 7.16-7.08 (1 H, m, 
Ph-4;RA and Ph-4;Rs), 6.93 (2H, s, CHPh2; RA and Rs), 6.01-5.81 (3H, m, NHAlloc;RA 
and a"llyl-2; RA and RB), 5.57 (1 H, bs, NHAlloc;Rs), 5.26 (2H, d, J 17.3, allyl-3 T; RA 
and Rs), 5.19 (2H, d, J 11.4, allyl-3T; RA and RB), 5.13 (2H, s, A-9CH2;RA), 4.99 (2H, s, 
A-9CH2;RB), 4.69-4.50 (12H, m, CfuOH, PhCfuN and allyl-I; RA and Rs), 3.47 (4H, 
m, CH2NHAlloc; RA and Rs), 3.30 (4H, CfuCH2NHAlloc; RA and RS);13C NMR 
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(CD2Ch; 75 MHz): 167.7 (A-9CH2CON;RA), 167.0 (A-9CH2CON;RB), 157.5 
(alloc;NC02;RA), 157.2 (alloc;NC02;RB), 153.2(A-2), 152.3(A-6;RA), 152.2(A-6;RB), 
151.1(A-4), 150.0(Bhoc;NC02), 145.2(A-8;RB)' 145.0(A-8;RA)' 143.5(Bhoc;Ph-l), 
140.9(Ph-l), 137.6 (Ph-3;RB), 136.5(Ph-3;RA), 133.9(allyl-2;RB)' 133.7(allyl-2;RB), 
129.9 (Ph-4;RB), 129.4 (Ph-4;RA), 129.3 (Bhoc;Ph-2), 128.7(Bhoc;Ph-3) 
127.7(Bhoc;Ph-4 and Ph-5), 127.3 (Ph-6;RAIB), 127.0 (Ph-6;RA/B), 126.2 (Ph-2;RAlB) 
125.4(Ph-2;RAIB), 121.9 (A-5), 118.2 (allyl-3;RA)' 117.8 (allyl-3;RB)' 79.3(CHPh2), 
66.4(allyl-l ;RA), 66.1 (allyl-l ;RB), 65.2(CH20H), 52.2 (PhCH2;RA), 50.0(PhCH2;RB), 
47.7 (CH2NHAlloc;RB), 46. 9( CH2NHAlloc;RA), 45 .2( A -9CH2;RB), 44. 9( A -9CH2 ;RA), 
39.8(CH2CH2NHAlloc;RA), 39.7«(H2CH2NHAlloc;RB); mlz 650 [M+Ht:(calculated 
for C35H35N7Na06 [M+Nat 672.2524, found 672.2541) 
BenzhydryI9-(2-((2-(allylcarboxyamino)ethyl)(3-Jormylbenzyl)amino)-2-oxoethyl)-
9 H-purin-6-ylcarbamate 
144 
A solution of benzhydryl 9-(2-«2-( allylcarboxyamino )ethyl)(3-
(hydroxymethyl)benzyl)amino )-2-oxoethyl)-9H-purin-6-ylcarbamate (365 mg, 0.56 
mmol) and Dess-Martin periodinane (369 mg, 0.84 mmol) dissolved in CH2Ch (4.0 
mL) was stirred at R T for 30 min. The reaction was poured into a vigorously stirred 
mixture of saturated Na2S203 and saturated Na2C03 solutions (16.0 mL, 1: 1) and stirred 
at RT for 30 min. The quenched reaction was extracted with dichloromethane (2 x 10.0 -' 
mL) and the combined organics were dried (Na2S03) and evaporated to dryness. 
Purification of the crude solid with chromatography (EtOAc) gave 217 mg (60%) of the 
~ 
title compound as colourless amorphous crystals; Mp. 82-3°C; Rr0.40 (EtOAc); FT-IR 
V max 3689, 2940, 1754, 1703, 1665, 1614, 1587, 1467, 1214,988, 732, 700, 642;IH 
NMR (CDCh; 500 MHz, Rotomeric mixture (4:5)): b 10.04 (IH, s, CHO;RA), 9.89 
(lH, CHO;RB), 8.78 (2H, bs, Bhoc;NH; RA and RB), 8.73 (lH, s, A-2;RB), 8.70 (lH, s, 
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A-2;RA), 8.09 (lH, s, A-8;RB), 8.06 (lH, s, A-8;RA), 7.85 (IH, d,J7.4, Ph-6;RA), 7.79 
(IH, d, J7.4, Ph-6;RB), 7.79 (IH, s, Ph-2;RB)' 7.74 (IH, s, Ph-2;RA), 7.60 (IH, t, J7.4, 
Ph-5;RA), 7.56 -7.47 (2H, m, Ph-5;RB, Ph-4;RB, Ph-4;RA), 7.42 (8H, d,J7.3, Bhoc;Ph-
2; RA and RB), 7.35 (8H, t, J7.3, Bhoc;Ph-3; RA and RB), 7.30 (4H, t, J7.3, Bhoc;Ph-4; 
RA and RB), 7.00 (2H, s, Bhoc;CHPh2; RA and RB) 5.88 (2H, ddt, J 17.0, 11.3,5.3, allyl-
2; RA and RB), 5.88 5.73 (lH, bs, NHAlloc;RB), 5.31 (lH, bs, NHAlloc;RA), 5.28 (lH, 
d, J 17.3, allyl-3T; RB), 5.24 (IH, d, J 17.3, allyl-3T; RA), 5.17 (3H, m, allyl-3C ; RA, RB 
and A-9CH2;RA), 5.02 (2H, s, A-9CH2;RB), 4.82 (2H, s, PhCH2;RA), 4.69 (2H, s, 
PhCH2;RB), 4.56 (2H, d, J 5.3, allyl-1 ;RB), 4.54 (2H, d, J 5.3, allyl-1;RA), 3.58 (4H, m, 
CH2NHAlloc; RA and RB), 3.44 (2H, m, CfuCH2NHAlloc;RB), 3.40 (2H, m, 
CH2CH2NHAlloc;RA);13C NMR (CDCh; 125 MHz): b 191.9(CHO;RA), 
191.6(CHO;RB), 166.8(A-9CH2CON ;RA), 166.3(A9CH2CON ;RB), 156.7 (Alloc;NC02), 
152.8 (A-2), 151.5(A-6;RB), 151.4(A-6;RA), 150. 1 (Bhoc;NC02), 149.1 (A-4), 144.0 (A-
8;RB), 143.8 (A-8;RA), 139.6 (Bhoc;Ph-l), 137.7 (Ph-3;RA), 137.2 (Ph-l;RB), 136.8 
(Ph-3 ;RB), 136.7 (Ph-l ;RA), 134.1 (Ph-4;RB), 132.7 (Allyl-2;RA)' 132.4 (Allyl-2;RB), 
132.1(Ph-4;RA), 130.1(Ph-5;RA), 130.0(Ph-6;RA)' 129.6 (Ph-5;RB. Ph-6;RB), 128.5 (Ph-
2;RA, Bhoc;Ph-3), 128.0 (Bhoc;Ph-4), 127.3 (Bhoc;Ph-2), 126.8 (Ph-2;RB), 121.3 (A-
5;RA), 121.2 (A-5;RB)' 118.1(allyl-3;RB), 117.1 (allyl-3;RA)' 78.7(Bhoc;CHPh2), 65.9 
(allyl-1;RB)' 65.6(allyl-l;RA), 51.9 (PhCH2;RA), 49.1 (PhCH2;RB), 46.9 
(CH2NHAlloc;RA), 46.5 (CH2NHAlloc;RB) 44.1(A9-CH2;RA), 43.9(A9-CH2;RB), 
39.1(CH2CH2NHAlloc;RB), 38.8 (CH2CH2NHAlloc;RA); ); mlz 648 [M+Ht:(ca1culated 
for C3sH33N7.Na07 [M+Nat 670.2385, found 670.2374). 
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5.3 General Solid Phase Synthesis Protocols 
5.3.1Resin Loading 
Method A : 2-Chlorotrityl Chloride Resin 
2-Chlorotrityl chloride resin (26 mg, 36 ~Mol) was swelled in CHzCh for 10 min and 
isolated by filtration. A solution ofT-PNA monomer (72 ~Mol) and DIPEA (180 ~Mol) 
in CHzCh (2.0 mL) was added to the dry resin and the mixture was agitated for 1 h. The 
resin was filtered and washed repeatedly with DMF (5 x 2.0 mL x 2 min), 
(MeOH/DIPEAi CHzCh, 1: 1 :8) (2 x 2.0 mL x 2 min), and DMF (5 x 2.0 mL x 2 min) 
with orbital agitation. The resin was treated with a solution of 20% piperidine dissolved 
in DMF (5 x 2.0 mL x 2 min) and washed repeatedly with DMF (5 x 2.0 mL x 2 min), 
CHzCh (5 x 2.0 mL x 2 min) and MeOH (5 x 2.0 mL x 2 min) and dried over KOH 
pellets under reduced pressure. 
Method B : Rink Amide Novogel ™ 
Rink Amide Novogel ™ resin (30 mg, 15 ~Mol) was swelled in DMF for 1 hand 
isolated by filtration. The resin was treated with a solution of 20% piperidine dissolved 
in DMF (5 x 2.0 mL x 2 min) and washed repeatedly with DMF (5 x 2.0 mL x 2 min). 
A positive Kaiser test confirmed successful deprotection. HATU (70 ~Mol) was added 
to a solution of C-PNA monomer (75 ~Mol) and PNA base solution (150 ~Mol) 
dissolved in DMF (1.0 mL) and agitated for 1 min before being added to the dry resin. 
The mixture was agitated for 1 h. The resin was isolated by filtration, washed repeatedly 
with DMF (5 x 2.0 mL x 2 min), CH2Ch (5 x 2.0 mL x 2 min) and MeOH (5 x 2.0 mL 
x 2 min) and dried over KOH pellets under reduced pressure. 
5.3.2 Manual Solid Phase Peptide synthesis 
General Swelling protocol 
The resin was swelled in DMF for 1 h, isolated by filtration and treated with a solution 
of 20% piperidine in DMF (5 x 2.0 mL x 2 min) with gentle orbital agitation. After 
repeated washes with DMF (5 x 2.0 mL x 2 min), a positive Kaiser test confirmed 
successful Fmoc deprotection. 
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Fmoc Amino Acid Coupling 
Method C: Single coupling with HCTV activation 
Fmoc amino acid (75 J.lMol) and HCTU (67 J.lMol) were dissolved in DMF (1.0 mL). 
DIPEA (150 J.lMol) was added and the solution was added to the dry resin (15 J.lMol). 
The mixture was gently agitated for 1 h and the resin was isolated by by filtration and 
washed with DMF (5 x 2.0 mL x 2 min). A negative Kaiser test signified a complete 
reaction. The resin was treated with a solution of 20% piperidine in DMF (5 x 2.0 mL x 
2 min) and then washed repeatedly with DMF (5 x 2.0 mL x 2 min). A positive Kaiser 
test confinned successful Fmoc deprotection. 
Metho~ D: Double coupling with HCTV activation 
Fmoc amino acid (75 J.lMol) and HCTU (67 J.lMol) were dissolved in DMF (1.0 mL). 
DIPEA (150 J.lMol) was added and the solution was added to the dry resin (15 J.lMol). 
The mixture was gently agitated for 1 h and the resin was isolated by by filtration and 
washed with DMF (5 x 2.0 mL x 2 min). The process was repeated. A negative Kaiser 
test signified a complete reaction. The resin was treated with a solution of 20% 
piperidine in DMF (5 x 2.0 mL x 2 min) and then washed repeatedly with DMF (5 x 2.0 
mL x 2 min). A positive Kaiser test confirmed successful Fmoc deprotection. 
Method E : Kaiser Colour Test 
A small number of beads were collected and washed with EtOH. The beads were treated 
with two drops each of phenol (80% in EtOH, xlv), potassium cyanide (0.001 M, 1 mL, 
in pyridine, 98 mL) and ninhydrin (5% in EtOH, w/v). The beads were heated at 120°C 
for 3 min and the colour change was observed; A blue solution indicated a positive test, 
indicating the presence of an NH2 group. 
5.3.3 Manual solid phase PNA synthesis 
Method F: Single coupling with HA TV activation 
PNA monomer (75 J.lMol) and HATU (67 J.lMol) were dissolved in DMF (1.0 mL) .. '
DIPEA (150 J.lMol) was added and the solution was added to the dry resin (15 J.lMol). 
The mixture was gently agitated for 1 h and the resin was isolated by by filtration and 
~ 
washed with DMF (5 x 2.0 mL x 2 min). A negative Kaiser test signified a complete 
reaction. The resin was treated with a solution of 20% piperidine in DMF (1 x 2.0 mL x 
3 min) and then agitated vigourously and repeatedly with DMF (2 x 2.0 mL x 1 min). 
The resin was treated once more with 20% piperidine in DMF (1 x 2.0 mL x 3 min) and 
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again agitated vigourously and repeatedly with DMF (6 x 2.0 mL x 1 min). A positive 
Kaiser test confirmed successful Fmoc deprotection. 
Method G: Double coupling with HATU activation 
PNA monomer (75 IlMol) and HATU (67 IlMol) were dissolved in DMF (1.0 mL). 
DIPEA (150 IlMol) was added and the solution was added to the dry resin (15 IlMol). 
The mixture was gently agitated for 1 h and the resin was isolated by by filtration and 
washed with DMF (5 x 2.0 mL x 2 min). The process was repeated. A negative Kaiser 
test signified a complete reaction. The resin was treated with a solution of 20% 
piperidine in DMF (1 x 2.0 mL x 3 min) and then agitated vigourously and repeatedly 
with D~F (2 x 2.0 mL x 1 min). The resin was treated once more with 20% piperidine 
in DMF (1 x 2.0 mL x 3 min) and again agitated vigourously and repeatedly with DMF 
(6 x 2.0 mL x 1 min). A positive Kaiser test confirmed successful Fmoc deprotection. 
5.3.4 Manual solid phase linker integration methods 
Method H: Linker 2 Attachment; Reductive amination 
Dried peptidyl resin (15 IlMol) was swelled in CH2Ch (2.0 mL) with orbital agitation 
for 30 min. The resin was drained and a solution of benzhydryl 9-(2-«2-
(ally lcarboxyamino )ethyl)(3 -formy Ibenzyl)amino )-2-oxoethy 1)-9 H -purin-6-ylcarbamate 
(1.1 equiv.) dissolved in CH2Ch (2.0 mL) was added to the dry resin and gently agitated 
for 1 h. AcOH (5.0 equiv) and NaBH(OAch were added sequentially to the mixture and 
agitated gently for 3 h, with venting of the reaction tube every 15 min. The resin 
isolated by filtration and repeatedly washed with CH2Ch (5 x 2.0 mL x 2 min), MeOH 
(5 x 2.0 mL x 2 min), DMF (5 x 2.0 mL x 2 min) and CH2Ch (5 x 2.0 mL x 2 min). A 
negative Kaiser test and analytical LC-MS indicated that the reaction was complete. The -
resin was isolated by filtration and a solution of Boc anhydride (10 equiv.) dissolved in 
CH2Ch was added to the resin and agitated gently for 1 h. The resin was isolated by ,-
filtration and washed repeatedly with CH2Ch (5 x 2.0 mL x 2 min) and MeOH (5 x 2.0 
mL x 2 min) and dried over KOH pellets under reduced pressure. 
~ 
Method I: Linker 2 Deprotection; Alloc deprotection 
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Dried peptidyl resin (15 ~Mol) was swelled in CH2Ch (2.0 mL) and gently agitated for 
30 min. The resin was isolated by filtration and a solution of Pd(PPh3)4 (3 ~Mol) and 
DABCO (75 ~L) dissolved in CH2Ch was added to the dry resin and agitated for 3 h. 
The resin was isolated by filtration and washed repeatedly with each of CH2Ch (3 x 2.0 
mL x 2 min), DMF (3 x 2.0 mL x 2 min), DIPEAlDMF (5:95, v/v)(3 x 2.0 mL x 2 
min), diethyldithiocarbamic acid disodium saltlDMF (0.5:99.5, w/v) (3 x 2.0 mL x 2 
min), DMF (3 x 2.0 mL x 2 min), CH2Ch (3 x 2.0 mL x 2 min), DMF (3 x 2.0 mL x 2 
min). A positive Kaiser test indicated a complete reaction. 
Method J: Linker 1 Attachment 
2-(N-(3-acetoxybenzyl)-2-(5-methyl-2,4-dioxo-3,4-dihydropyrimidin-l (2H)-
yl)acetamido)acetic acid (75 ~Mol) and HATU (67 ~Mol) were dissolved in DMF (1.0 
mL). DIPEA (150 ~Mol) was added and the solution was added to the dry resin (15 
~Mol). The mixture was gently agitated for 1 h and the resin was isolated by by 
filtration and washed with DMF (5 x 2.0 mL x 2 min). A negative Kaiser test signified a 
complete reaction. 
Method K: Linker 1 Deprotection; Phenyl Acetate Cleavage 
Hybrid derivitised resin was swelled in DMF for 1 h, isolated by filtration and washed 
repeatedly with CH2Ch (3 x 2.0 mL x 2 min). A mixed solution of (0.5M sodium 
methoxide dissolved in MeOH/CH2Ch, 1:9 v/v (1 mL) was added to the dry resin and 
agitated for 2 h. The resin was isolated by filtration and washed repeatedly with each of 
MeOH/CH2Ch (1:4, v/v)(3 x 2.0 mL x 2 min), MeOH (1 x 2.0 mL x 2 min), THF (3 x 
2.0 mL x 2 min) and CH2Ch (3 x 2.0 mL x 2 min). LC-MS analysis indicated a 
complete reaction. 
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5.3.5 Peptide and Chimera CleavagelDeprotection 
Method L : Mild cleavage of 2-chlorotrityl resin 
The dried derivitised resin (20 /lMol) was treated with a solution of AcOH/TFE/CH2Ch 
(1:1:8, v/v/v) (2.0 mL) and agitated gently for 1 h. The resin was rinsed with 
TFE/CHzCh (1:9, v/v) (2 x 2 ,mL). The combined filtrates were diluted with hexane (8 
mL) and concentrated under reduced pressure. 
Method M : Cleavage/deprotection of acid-labile resin 
The dried derivitised reSIn (15 /lMol) was treated with a cleavage cocktail of 
TFAITIS/HzO (95.0:2.5:2.5) for 1 h with gentle agitation. The resin was rinsed with 
TFA (2 x 2 mL) and the combined filtrates were concentrated under reduced pressure 
and the resulting yellow oil added dropwise to ice-cold EtzO. The ether was decanted 
away from the colourless precipitate and dried under a stream of Nz before being 
analysed by LC-MS and purified. 
5.3.6 Chimera/Model Hybrid Synthesis 
PNA to Peptide chimera CTCAG-Linker 1-0GlyNHFmoc (174) 
Rink resin (15.0 /lMol) was swelled as according to the general swelling protocol. PNA 
synthesis proceeded using the single coupling procedure F except after the G-PNA 
coupling which required a double coupling (procedure G). Linker 1 was coupled and 
deprotected as per procedures J and K. Fmoc glycine was coupled onto the unprotected 
hybrid using the standard peptide single coupling protocol. The resin was cleaved using -
the standard cleavage protocol M. Purification by preparative HPLC gave 15.4 mg 
(53%) of the title compound as a colourless powder; mlz 981 [M+Ht:(calculated for .. 
CS6H99N330z3 [M+2Hf+ 981.8790, found 981.8802) 
~ 
Peptide to PNA chimera Arg-Tyr-Thr-Gly-Linker 2-CTGAGNHFmoc 
Wang resin (15.1 /lMo\) pre\oaded with Fmoc arginine(Pbf) was swelled as according 
to the general swelling protocol. The tetramer was assembled with using the single 
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coupling procedure J with the following exceptions: Tyrosine was pre activated as the 
pentafluorophenol ester and a coupling reagent was not required; Coupling of threonine 
required the double coupling procedure K. Linker attachment and deprotection 
proceeded as according to the standard procedures H and I. PNA synthesis was carried 
out without intervening analysis using single coupling procedure G. Cleavage of the 
resin using standard cleavage protocol M gave 28.0 mg of a crude colourless solid; mlz 
981 [M+Ht:( calculated for CI07H13oN4S024 [M+Ht 2430.0307, found 2430.0312) 
5.3.7 Miscellaneous Chromatography methods 
Reverse-Phase Chromatographic Purification of A-PNA monomer 32 
Three 600mg Maxi-Clean™ SPE pre-packed large-pore C 18 cartridges (Alltech) were 
assembled into a single contiguous column. The column was activated by flushing with 
MeOH (1SmL, flow rate 3mL per min) and then H20 (ISmL, flow rate 3mL per min). 
Crude A-PNA monomer 32 (20mg) was suspended in H20(SOO)lL) and DMF (600)lL) 
was added. The suspension was agitated with gentle heating until the crude material had 
fully dissolved and was then carefully loaded onto the column (injection rate I mL per 
min). The column was flushed with water (2.20mL, double the loading volume of the 
sample) to wash away the loading solvent from the crude sample prior to elution. The 
column was eluted with a H20/MeCN gradient at a flowrate of 1 mL per min with an 
initial eluent ~atio of (H20lMeCN, 9:1). The eluent was collected in ImL fractions and 
the gradient was stepped with a 10% increase in MeCN after every 2mL of eluent 
collected, up to a maximum gradient of (H20/MeCN, 3:7); a total of 8mL of the final 
eluent was collected. Fractions containing pure 32 (as determined by tlc and LC-MS 
analysis) were combined and evaporated to give Smg of a single compound that was 
confirmed by spectroscopic analysis to be 32. 
Anion-exchange chromatographic purification of Linker 2 intermediate 139 
A 10.0 g prepacked SCX column was mounted on a vacuum tank and activated by 
elution '"With methanol (SO mL) at a flow rate of S mL per min. A solution of crude 
amine 139 (SOO mg) dissolved in a minimum volume of methanol was loaded onto the 
column at a flow rate of 1 mL per min. The column was eluted with methanol (2S mL) 
at flow rate of 1 mL per minute and then IS mL of ammonia saturated methanol at a 
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flow rate of 3 mL per min; the ammonia-containing fractions were collected as 3 x 5 
mL fractions. Fractions containing pure 139 (as determined by LC-MS analysis) were 
combined and evaporated to give 453mg of a single compound that was confirmed by 
spectroscopic analysis to be 139. The SCX column was regenerated by flushing first 
with a solution of saturated ammonia in methanol (until all base line material had been 
removed) and then with an equal volume of methanol; the column was reused to purify 
further batches of material in the same manner. 
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